	gsm_name	X.2	X.1	X	sample_id	series_id	platform_id	gpl_name	gse_name	drug_cisplatin	n2_brca	er_pos	er_neg	grade_3_brca	grade_2_brca	drug_capecitabine	n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative	stage_t1	stage_t3	stage_t2	n0	grade_1_brca	pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide	drug_anastrozole	n1_brca	her2_positive	pcr_no	er	her2	pr	grade	stage	prc	ClassCode	OriginCode	Source	drug
1	GSM1030079	1265	1265	2206	315837	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide
2	GSM1030080	1266	1266	2207	315838	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide
3	GSM1030081	1267	1267	2208	315839	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide
4	GSM1030082	1268	1268	2209	315840	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide
5	GSM1030083	1269	1269	2210	315841	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide
6	GSM1030084	1270	1270	2211	315842	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide
7	GSM1030085	1271	1271	2212	315843	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
8	GSM1030086	1272	1272	2213	315844	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
9	GSM1030087	1273	1273	2214	315845	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
10	GSM1030088	1274	1274	2215	315846	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
11	GSM1030089	1275	1275	2216	315847	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
12	GSM1030090	1276	1276	2217	315848	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
13	GSM1030091	1277	1277	2218	315849	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
14	GSM1030092	1278	1278	2219	315850	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
15	GSM1030093	1279	1279	2220	315851	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
16	GSM1030094	1280	1280	2221	315852	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
17	GSM1030095	1281	1281	2222	315853	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
18	GSM1030096	1282	1282	2223	315854	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
19	GSM1030097	1283	1283	2224	315855	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
20	GSM1030098	1284	1284	2225	315856	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
21	GSM1030099	1285	1285	2226	315857	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
22	GSM1030100	1286	1286	2227	315858	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
23	GSM1030101	1287	1287	2228	315859	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
24	GSM1030102	1288	1288	2229	315860	7922	9	GPL571	GSE41998		NA	er_pos															pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
25	GSM1030103	1289	1289	2230	315861	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
26	GSM1030104	1290	1290	2231	315862	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
27	GSM1030105	1291	1291	2232	315863	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
28	GSM1030106	1292	1292	2233	315864	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
29	GSM1030107	1293	1293	2234	315865	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
30	GSM1030108	1294	1294	2235	315866	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
31	GSM1030109	1295	1295	2236	315867	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
32	GSM1030110	1296	1296	2237	315868	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
33	GSM1030111	1297	1297	2238	315869	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
34	GSM1030112	1298	1298	2239	315870	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
35	GSM1030113	1299	1299	2240	315871	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
36	GSM1030114	1300	1300	2241	315872	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
37	GSM1030115	1301	1301	2242	315873	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
38	GSM1030116	1302	1302	2243	315874	7922	9	GPL571	GSE41998		NA	er_pos															pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
39	GSM1030117	1303	1303	2244	315875	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
40	GSM1030118	1304	1304	2245	315876	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
41	GSM1030119	1305	1305	2246	315877	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
42	GSM1030120	1306	1306	2247	315878	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
43	GSM1030121	1307	1307	2248	315879	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
44	GSM1030122	1308	1308	2249	315880	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
45	GSM1030123	1309	1309	2250	315881	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
46	GSM1030124	1310	1310	2251	315882	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
47	GSM1030125	1311	1311	2252	315883	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
48	GSM1030126	1312	1312	2253	315884	7922	9	GPL571	GSE41998		NA	er_pos															pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
49	GSM1030127	1313	1313	2254	315885	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide
50	GSM1030128	1314	1314	2255	315886	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
51	GSM1030129	1315	1315	2256	315887	7922	9	GPL571	GSE41998		NA	er_pos															pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
52	GSM1030130	1316	1316	2257	315888	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
53	GSM1030131	1317	1317	2258	315889	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
54	GSM1030132	1318	1318	2259	315890	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
55	GSM1030133	1319	1319	2260	315891	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
56	GSM1030134	1320	1320	2261	315892	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
57	GSM1030135	1321	1321	2262	315893	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
58	GSM1030136	1322	1322	2263	315894	7922	9	GPL571	GSE41998		NA	er_pos															pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
59	GSM1030137	1323	1323	2264	315895	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
60	GSM1030138	1324	1324	2265	315896	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
61	GSM1030139	1325	1325	2266	315897	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
62	GSM1030140	1326	1326	2267	315898	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
63	GSM1030141	1327	1327	2268	315899	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
64	GSM1030142	1328	1328	2269	315900	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
65	GSM1030143	1329	1329	2270	315901	7922	9	GPL571	GSE41998		NA		er_neg														pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
66	GSM1030144	1330	1330	2271	315902	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative											pre_treatment	drug_cyclophosphamide					er_pos	her2_negative					NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
67	GSM1030145	1331	1331	2272	315903	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
68	GSM1030146	1332	1332	2273	315904	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
69	GSM1030147	1333	1333	2274	315905	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
70	GSM1030148	1334	1334	2275	315906	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
71	GSM1030149	1335	1335	2276	315907	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
72	GSM1030150	1336	1336	2277	315908	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
73	GSM1030151	1337	1337	2278	315909	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
74	GSM1030152	1338	1338	2279	315910	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
75	GSM1030153	1339	1339	2280	315911	7922	9	GPL571	GSE41998		NA	er_pos									pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
76	GSM1030154	1340	1340	2281	315912	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
77	GSM1030155	1341	1341	2282	315913	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
78	GSM1030156	1342	1342	2283	315914	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
79	GSM1030157	1343	1343	2284	315915	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
80	GSM1030158	1344	1344	2285	315916	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
81	GSM1030159	1345	1345	2286	315917	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
82	GSM1030160	1346	1346	2287	315918	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
83	GSM1030161	1347	1347	2288	315919	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
84	GSM1030162	1348	1348	2289	315920	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
85	GSM1030163	1349	1349	2290	315921	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
86	GSM1030164	1350	1350	2291	315922	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
87	GSM1030165	1351	1351	2292	315923	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
88	GSM1030166	1352	1352	2293	315924	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
89	GSM1030167	1353	1353	2294	315925	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
90	GSM1030168	1354	1354	2295	315926	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
91	GSM1030169	1355	1355	2296	315927	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
92	GSM1030170	1356	1356	2297	315928	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
93	GSM1030171	1357	1357	2298	315929	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
94	GSM1030172	1358	1358	2299	315930	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
95	GSM1030173	1359	1359	2300	315931	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
96	GSM1030174	1360	1360	2301	315932	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
97	GSM1030175	1361	1361	2302	315933	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
98	GSM1030176	1362	1362	2303	315934	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
99	GSM1030177	1363	1363	2304	315935	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
100	GSM1030178	1364	1364	2305	315936	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
101	GSM1030179	1365	1365	2306	315937	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
102	GSM1030180	1366	1366	2307	315938	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
103	GSM1030181	1367	1367	2308	315939	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
104	GSM1030182	1368	1368	2309	315940	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
105	GSM1030183	1369	1369	2310	315941	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
106	GSM1030184	1370	1370	2311	315942	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
107	GSM1030185	1371	1371	2312	315943	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
108	GSM1030186	1372	1372	2313	315944	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
109	GSM1030187	1373	1373	2314	315945	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
110	GSM1030188	1374	1374	2315	315946	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
111	GSM1030189	1375	1375	2316	315947	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
112	GSM1030190	1376	1376	2317	315948	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
113	GSM1030191	1377	1377	2318	315949	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
114	GSM1030192	1378	1378	2319	315950	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide
115	GSM1030193	1379	1379	2320	315951	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide
116	GSM1030194	1380	1380	2321	315952	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide
117	GSM1030195	1381	1381	2322	315953	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
118	GSM1030196	1382	1382	2323	315954	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
119	GSM1030197	1383	1383	2324	315955	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
120	GSM1030198	1384	1384	2325	315956	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide
121	GSM1030199	1385	1385	2326	315957	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
122	GSM1030200	1386	1386	2327	315958	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
123	GSM1030201	1387	1387	2328	315959	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
124	GSM1030202	1388	1388	2329	315960	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
125	GSM1030203	1389	1389	2330	315961	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
126	GSM1030204	1390	1390	2331	315962	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
127	GSM1030205	1391	1391	2332	315963	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
128	GSM1030206	1392	1392	2333	315964	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
129	GSM1030207	1393	1393	2334	315965	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
130	GSM1030208	1394	1394	2335	315966	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
131	GSM1030209	1395	1395	2336	315967	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
132	GSM1030210	1396	1396	2337	315968	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
133	GSM1030211	1397	1397	2338	315969	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
134	GSM1030212	1398	1398	2339	315970	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
135	GSM1030213	1399	1399	2340	315971	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
136	GSM1030214	1400	1400	2341	315972	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
137	GSM1030215	1401	1401	2342	315973	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
138	GSM1030216	1402	1402	2343	315974	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
139	GSM1030217	1403	1403	2344	315975	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
140	GSM1030218	1404	1404	2345	315976	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
141	GSM1030219	1405	1405	2346	315977	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
142	GSM1030220	1406	1406	2347	315978	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
143	GSM1030221	1407	1407	2348	315979	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
144	GSM1030222	1408	1408	2349	315980	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
145	GSM1030223	1409	1409	2350	315981	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
146	GSM1030224	1410	1410	2351	315982	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
147	GSM1030225	1411	1411	2352	315983	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
148	GSM1030226	1412	1412	2353	315984	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
149	GSM1030227	1413	1413	2354	315985	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide;drug_ixabepilone
150	GSM1030228	1414	1414	2355	315986	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
151	GSM1030229	1415	1415	2356	315987	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
152	GSM1030230	1416	1416	2357	315988	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
153	GSM1030231	1417	1417	2358	315989	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
154	GSM1030232	1418	1418	2359	315990	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
155	GSM1030233	1419	1419	2360	315991	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
156	GSM1030234	1420	1420	2361	315992	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
157	GSM1030235	1421	1421	2362	315993	7922	9	GPL571	GSE41998		NA	er_pos															pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
158	GSM1030236	1422	1422	2363	315994	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
159	GSM1030237	1423	1423	2364	315995	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
160	GSM1030238	1424	1424	2365	315996	7922	9	GPL571	GSE41998		NA		er_neg														pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
161	GSM1030239	1425	1425	2366	315997	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
162	GSM1030240	1426	1426	2367	315998	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
163	GSM1030241	1427	1427	2368	315999	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
164	GSM1030242	1428	1428	2369	316000	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
165	GSM1030243	1429	1429	2370	316001	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
166	GSM1030244	1430	1430	2371	316002	7922	9	GPL571	GSE41998		NA	er_pos															pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
167	GSM1030245	1431	1431	2372	316003	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
168	GSM1030246	1432	1432	2373	316004	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
169	GSM1030247	1433	1433	2374	316005	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
170	GSM1030248	1434	1434	2375	316006	7922	9	GPL571	GSE41998		NA		er_neg														pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
171	GSM1030249	1435	1435	2376	316007	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
172	GSM1030250	1436	1436	2377	316008	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
173	GSM1030251	1437	1437	2378	316009	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
174	GSM1030252	1438	1438	2379	316010	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
175	GSM1030253	1439	1439	2380	316011	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
176	GSM1030254	1440	1440	2381	316012	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
177	GSM1030255	1441	1441	2382	316013	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
178	GSM1030256	1442	1442	2383	316014	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
179	GSM1030257	1443	1443	2384	316015	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
180	GSM1030258	1444	1444	2385	316016	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
181	GSM1030259	1445	1445	2386	316017	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
182	GSM1030260	1446	1446	2387	316018	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
183	GSM1030261	1447	1447	2388	316019	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
184	GSM1030262	1448	1448	2389	316020	7922	9	GPL571	GSE41998		NA		er_neg														pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
185	GSM1030263	1449	1449	2390	316021	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
186	GSM1030264	1450	1450	2391	316022	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
187	GSM1030265	1451	1451	2392	316023	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
188	GSM1030266	1452	1452	2393	316024	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
189	GSM1030267	1453	1453	2394	316025	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
190	GSM1030268	1454	1454	2395	316026	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
191	GSM1030269	1455	1455	2396	316027	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
192	GSM1030270	1456	1456	2397	316028	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
193	GSM1030271	1457	1457	2398	316029	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
194	GSM1030272	1458	1458	2399	316030	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
195	GSM1030273	1459	1459	2400	316031	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
196	GSM1030274	1460	1460	2401	316032	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
197	GSM1030275	1461	1461	2402	316033	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
198	GSM1030276	1462	1462	2403	316034	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
199	GSM1030277	1463	1463	2404	316035	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
200	GSM1030278	1464	1464	2405	316036	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
201	GSM1030279	1465	1465	2406	316037	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
202	GSM1030280	1466	1466	2407	316038	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
203	GSM1030281	1467	1467	2408	316039	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
204	GSM1030282	1468	1468	2409	316040	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
205	GSM1030283	1469	1469	2410	316041	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
206	GSM1030284	1470	1470	2411	316042	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
207	GSM1030285	1471	1471	2412	316043	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
208	GSM1030286	1472	1472	2413	316044	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
209	GSM1030287	1473	1473	2414	316045	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
210	GSM1030288	1474	1474	2415	316046	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide
211	GSM1030289	1475	1475	2416	316047	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
212	GSM1030290	1476	1476	2417	316048	7922	9	GPL571	GSE41998		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
213	GSM1030291	1477	1477	2418	316049	7922	9	GPL571	GSE41998		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
214	GSM1030292	1478	1478	2419	316050	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
215	GSM1030293	1479	1479	2420	316051	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
216	GSM1030294	1480	1480	2421	316052	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
217	GSM1030295	1481	1481	2422	316053	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
218	GSM1030296	1482	1482	2423	316054	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
219	GSM1030297	1483	1483	2424	316055	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide
220	GSM1030298	1484	1484	2425	316056	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
221	GSM1030299	1485	1485	2426	316057	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
222	GSM1030300	1486	1486	2427	316058	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
223	GSM1030301	1487	1487	2428	316059	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
224	GSM1030302	1488	1488	2429	316060	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
225	GSM1030303	1489	1489	2430	316061	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
226	GSM1030304	1490	1490	2431	316062	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
227	GSM1030305	1491	1491	2432	316063	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
228	GSM1030306	1492	1492	2433	316064	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
229	GSM1030307	1493	1493	2434	316065	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
230	GSM1030308	1494	1494	2435	316066	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
231	GSM1030309	1495	1495	2436	316067	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
232	GSM1030310	1496	1496	2437	316068	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
233	GSM1030311	1497	1497	2438	316069	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
234	GSM1030312	1498	1498	2439	316070	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_cyclophosphamide
235	GSM1030313	1499	1499	2440	316071	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
236	GSM1030314	1500	1500	2441	316072	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
237	GSM1030315	1501	1501	2442	316073	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
238	GSM1030316	1502	1502	2443	316074	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
239	GSM1030317	1503	1503	2444	316075	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
240	GSM1030318	1504	1504	2445	316076	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
241	GSM1030319	1505	1505	2446	316077	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
242	GSM1030320	1506	1506	2447	316078	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
243	GSM1030321	1507	1507	2448	316079	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
244	GSM1030322	1508	1508	2449	316080	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
245	GSM1030323	1509	1509	2450	316081	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
246	GSM1030324	1510	1510	2451	316082	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
247	GSM1030325	1511	1511	2452	316083	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
248	GSM1030326	1512	1512	2453	316084	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
249	GSM1030327	1513	1513	2454	316085	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
250	GSM1030328	1514	1514	2455	316086	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
251	GSM1030329	1515	1515	2456	316087	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
252	GSM1030330	1516	1516	2457	316088	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
253	GSM1030331	1517	1517	2458	316089	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
254	GSM1030332	1518	1518	2459	316090	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
255	GSM1030333	1519	1519	2460	316091	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
256	GSM1030334	1520	1520	2461	316092	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
257	GSM1030335	1521	1521	2462	316093	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
258	GSM1030336	1522	1522	2463	316094	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
259	GSM1030337	1523	1523	2464	316095	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
260	GSM1030338	1524	1524	2465	316096	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
261	GSM1030339	1525	1525	2466	316097	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
262	GSM1030340	1526	1526	2467	316098	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
263	GSM1030341	1527	1527	2468	316099	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
264	GSM1030342	1528	1528	2469	316100	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
265	GSM1030343	1529	1529	2470	316101	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
266	GSM1030344	1530	1530	2471	316102	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
267	GSM1030345	1531	1531	2472	316103	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
268	GSM1030346	1532	1532	2473	316104	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
269	GSM1030347	1533	1533	2474	316105	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
270	GSM1030348	1534	1534	2475	316106	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
271	GSM1030349	1535	1535	2476	316107	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
272	GSM1030350	1536	1536	2477	316108	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
273	GSM1030351	1537	1537	2478	316109	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
274	GSM1030352	1538	1538	2479	316110	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
275	GSM1030353	1539	1539	2480	316111	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
276	GSM1030354	1540	1540	2481	316112	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
277	GSM1030355	1541	1541	2482	316113	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
278	GSM1030356	1542	1542	2483	316114	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
279	GSM1030357	1543	1543	2484	316115	7922	9	GPL571	GSE41998		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative				NA	GPL571_GSE41998	GEO	drug_doxorubicin;drug_paclitaxel;drug_cyclophosphamide
280	GSM1050577	1544	1544	2485	321764	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative						stage_t2	n0		pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
281	GSM1050578	1545	1545	2486	321765	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine								stage_t2			pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive		er_neg	her2_positive	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
282	GSM1050579	1546	1546	2487	321766	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative						stage_t2			pr_positive		pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
283	GSM1050580	1547	1547	2488	321767	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine		her2_negative						stage_t2	n0		pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive		stage_t2	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
284	GSM1050581	1548	1548	2489	321768	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine				stage_t4									pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive	pcr_no	er_neg	her2_positive		grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
285	GSM1050582	1549	1549	2490	321769	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine	n3_brca	her2_negative					stage_t3				pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
286	GSM1050583	1550	1550	2491	321770	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine							stage_t3		n0		pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
287	GSM1050584	1551	1551	2492	321771	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3				pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
288	GSM1050585	1552	1552	2493	321772	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine		her2_negative					stage_t3			grade_1_brca	pr_positive		pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
289	GSM1050586	1553	1553	2494	321773	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine		her2_negative					stage_t3		n0			pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative			stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
290	GSM1050587	1554	1554	2495	321774	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative						stage_t2					pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
291	GSM1050588	1555	1555	2496	321775	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine		her2_negative					stage_t3					pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_neg	her2_negative			stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
292	GSM1050589	1556	1556	2497	321776	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2			pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
293	GSM1050590	1557	1557	2498	321777	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
294	GSM1050591	1558	1558	2499	321778	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine							stage_t3			grade_1_brca			pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive	pcr_no	er_neg	her2_positive		grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
295	GSM1050592	1559	1559	2500	321779	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine		her2_negative					stage_t3		n0		pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive		stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
296	GSM1050593	1560	1560	2501	321780	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine		her2_negative					stage_t3					pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_neg	her2_negative			stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
297	GSM1050594	1561	1561	2502	321781	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3				pr_positive		pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
298	GSM1050595	1562	1562	2503	321782	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine		her2_negative					stage_t3		n0	grade_1_brca	pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
299	GSM1050596	1563	1563	2504	321783	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
300	GSM1050597	1564	1564	2505	321784	8126	2	GPL96	GSE42822		NA			grade_3_brca		drug_capecitabine								stage_t2	n0				pre_treatment	drug_cyclophosphamide				pcr_no				grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
301	GSM1050598	1565	1565	2506	321785	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative		stage_t4								pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_neg	her2_negative		grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
302	GSM1050599	1566	1566	2507	321786	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2					pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg	her2_negative		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
303	GSM1050600	1567	1567	2508	321787	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine							stage_t3			grade_1_brca		pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive		grade_1_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
304	GSM1050601	1568	1568	2509	321788	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
305	GSM1050602	1569	1569	2510	321789	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
306	GSM1050603	1570	1570	2511	321790	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3				pr_positive		pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
307	GSM1050604	1571	1571	2512	321791	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine								stage_t2			pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive		er_neg	her2_positive	pr_positive		stage_t2	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
308	GSM1050605	1572	1572	2513	321792	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine		her2_negative						stage_t2					pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg	her2_negative			stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
309	GSM1050606	1573	1573	2514	321793	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine		her2_negative					stage_t3			grade_1_brca	pr_positive		pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
310	GSM1050607	1574	1574	2515	321794	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3				pr_positive		pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
311	GSM1050608	1575	1575	2516	321795	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine				stage_t4									pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive	pcr_no	er_neg	her2_positive		grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
312	GSM1050609	1576	1576	2517	321796	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine							stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg				stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
313	GSM1050610	1577	1577	2518	321797	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2				pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_neg	her2_negative		grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
314	GSM1050611	1578	1578	2519	321798	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine		her2_negative					stage_t3		n0	grade_1_brca		pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative		grade_1_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
315	GSM1050612	1579	1579	2520	321799	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2					pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
316	GSM1050613	1580	1580	2521	321800	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3				pr_positive		pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
317	GSM1050614	1581	1581	2522	321801	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine							stage_t3				pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive		er_pos	her2_positive	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
318	GSM1050615	1582	1582	2523	321802	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine		her2_negative		stage_t4						grade_1_brca	pr_positive		pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t4	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
319	GSM1050616	1583	1583	2524	321803	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2					pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg	her2_negative		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
320	GSM1050617	1584	1584	2525	321804	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine	n3_brca	her2_negative						stage_t2				pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative		grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
321	GSM1050618	1585	1585	2526	321805	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine							stage_t3		n0	grade_1_brca		pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive		grade_1_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
322	GSM1050619	1586	1586	2527	321806	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3				pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
323	GSM1050620	1587	1587	2528	321807	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3				pr_positive		pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
324	GSM1050621	1588	1588	2529	321808	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine	n3_brca	her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
325	GSM1050622	1589	1589	2530	321809	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine		her2_negative						stage_t2		grade_1_brca	pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
326	GSM1050623	1590	1590	2531	321810	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3					pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_neg	her2_negative		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
327	GSM1050624	1591	1591	2532	321811	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
328	GSM1050625	1592	1592	2533	321812	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0			pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
329	GSM1050626	1593	1593	2534	321813	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2	n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
330	GSM1050627	1594	1594	2535	321814	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative		stage_t4								pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative		grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
331	GSM1050628	1595	1595	2536	321815	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine		her2_negative					stage_t3		n0	grade_1_brca	pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
332	GSM1050629	1596	1596	2537	321816	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine		her2_negative					stage_t3		n0	grade_1_brca			pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative		grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
333	GSM1050630	1597	1597	2538	321817	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine		her2_negative					stage_t3		n0			pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative			stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
334	GSM1050631	1598	1598	2539	321818	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2					pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg	her2_negative		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
335	GSM1050632	1599	1599	2540	321819	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine							stage_t3		n0		pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos		pr_positive		stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
336	GSM1050633	1600	1600	2541	321820	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2			pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
337	GSM1050634	1601	1601	2542	321821	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0			pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
338	GSM1050635	1602	1602	2543	321822	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine		her2_negative				stage_t1				grade_1_brca	pr_positive		pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t1	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
339	GSM1050636	1603	1603	2544	321823	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0		pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
340	GSM1050637	1604	1604	2545	321824	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine	n3_brca	her2_negative						stage_t2				pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative		grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
341	GSM1050638	1605	1605	2546	321825	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine		her2_negative						stage_t2		grade_1_brca	pr_positive		pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
342	GSM1050639	1606	1606	2547	321826	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine		her2_negative						stage_t2	n0			pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative			stage_t2	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
343	GSM1050640	1607	1607	2548	321827	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine		her2_negative						stage_t2		grade_1_brca	pr_positive		pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
344	GSM1050641	1608	1608	2549	321828	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2	n0		pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
345	GSM1050642	1609	1609	2550	321829	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine							stage_t3		n0				pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive			stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
346	GSM1050643	1610	1610	2551	321830	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine								stage_t2	n0		pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
347	GSM1050644	1611	1611	2552	321831	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine								stage_t2				pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive		er_neg	her2_positive		grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
348	GSM1050645	1612	1612	2553	321832	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine								stage_t2		grade_1_brca		pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive		er_neg	her2_positive		grade_1_brca	stage_t2	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
349	GSM1050646	1613	1613	2554	321833	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine				stage_t4						grade_1_brca	pr_positive		pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_1_brca	stage_t4	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
350	GSM1050647	1614	1614	2555	321834	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine							stage_t3		n0	grade_1_brca	pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
351	GSM1050648	1615	1615	2556	321835	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine							stage_t3			grade_1_brca		pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive		er_neg	her2_positive		grade_1_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
352	GSM1050649	1616	1616	2557	321836	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine							stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive	pcr_no	er_neg	her2_positive		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
353	GSM1050650	1617	1617	2558	321837	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0		pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
354	GSM1050651	1618	1618	2559	321838	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine							stage_t3					pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive		er_neg	her2_positive			stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
355	GSM1050652	1619	1619	2560	321839	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine								stage_t2					pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
356	GSM1050653	1620	1620	2561	321840	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine							stage_t3				pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive		stage_t3	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
357	GSM1050654	1621	1621	2562	321841	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine								stage_t2	n0		pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
358	GSM1050655	1622	1622	2563	321842	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine							stage_t3		n0			pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
359	GSM1050656	1623	1623	2564	321843	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine								stage_t2		grade_1_brca	pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
360	GSM1050657	1624	1624	2565	321844	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine							stage_t3			grade_1_brca		pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive		er_neg	her2_positive		grade_1_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
361	GSM1050658	1625	1625	2566	321845	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine				stage_t4						grade_1_brca		pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive		grade_1_brca	stage_t4	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
362	GSM1050659	1626	1626	2567	321846	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine				stage_t4								pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive		er_neg	her2_positive			stage_t4	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
363	GSM1050660	1627	1627	2568	321847	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine								stage_t2					pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive	pcr_no	er_neg	her2_positive		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
364	GSM1050661	1628	1628	2569	321848	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine								stage_t2			pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
365	GSM1050662	1629	1629	2570	321849	8126	2	GPL96	GSE42822		NA	er_pos				drug_capecitabine								stage_t2		grade_1_brca	pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive	grade_1_brca	stage_t2	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
366	GSM1050663	1630	1630	2571	321850	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine	n3_brca						stage_t3					pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
367	GSM1050664	1631	1631	2572	321851	8126	2	GPL96	GSE42822		NA		er_neg			drug_capecitabine							stage_t3			grade_1_brca		pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive		er_neg	her2_positive		grade_1_brca	stage_t3	pcr_yes	1	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
368	GSM1050665	1632	1632	2573	321852	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine				stage_t4									pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive		grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
369	GSM1050666	1633	1633	2574	321853	8126	2	GPL96	GSE42822		NA	er_pos		grade_3_brca		drug_capecitabine								stage_t2			pr_positive		pre_treatment	drug_cyclophosphamide		n1_brca	her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
370	GSM1050667	1634	1634	2575	321854	8126	2	GPL96	GSE42822		NA		er_neg	grade_3_brca		drug_capecitabine								stage_t2	n0				pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE42822	GEO	drug_docetaxel;drug_capecitabine;drug_herceptin;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
371	GSM107986	1635	1635	2576	359218	9116	67	GPL1352	GSE4779		NA	er_pos											stage_t3							drug_cyclophosphamide		n1_brca		pcr_no	er_pos				stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
372	GSM1232992	1737	1737	2719	381839	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
373	GSM1232993	1738	1738	2720	381840	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
374	GSM1232994	1739	1739	2721	381841	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
375	GSM1232995	1740	1740	2722	381842	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
376	GSM1232996	1741	1741	2723	381843	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
377	GSM1232997	1742	1742	2724	381844	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca													pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
378	GSM1232998	1743	1743	2725	381845	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
379	GSM1232999	1744	1744	2726	381846	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
380	GSM1233000	1745	1745	2727	381847	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
381	GSM1233001	1746	1746	2728	381848	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
382	GSM1233002	1747	1747	2729	381849	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
383	GSM1233003	1748	1748	2730	381850	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
384	GSM1233004	1749	1749	2731	381851	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca													pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
385	GSM1233005	1750	1750	2732	381852	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
386	GSM1233006	1751	1751	2733	381853	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
387	GSM1233007	1752	1752	2734	381854	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
388	GSM1233008	1753	1753	2735	381855	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
389	GSM1233009	1754	1754	2736	381856	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
390	GSM1233010	1755	1755	2737	381857	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
391	GSM1233011	1756	1756	2738	381858	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
392	GSM1233012	1757	1757	2739	381859	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca												pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
393	GSM1233013	1758	1758	2740	381860	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
394	GSM1233014	1759	1759	2741	381861	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
395	GSM1233015	1760	1760	2742	381862	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
396	GSM1233016	1761	1761	2743	381863	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
397	GSM1233017	1762	1762	2744	381864	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
398	GSM1233018	1763	1763	2745	381865	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
399	GSM1233019	1764	1764	2746	381866	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
400	GSM1233020	1765	1765	2747	381867	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
401	GSM1233021	1766	1766	2748	381868	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
402	GSM1233022	1767	1767	2749	381869	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
403	GSM1233023	1768	1768	2750	381870	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
404	GSM1233024	1769	1769	2751	381871	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
405	GSM1233025	1770	1770	2752	381872	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
406	GSM1233026	1771	1771	2753	381873	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
407	GSM1233027	1772	1772	2754	381874	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
408	GSM1233028	1773	1773	2755	381875	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
409	GSM1233029	1774	1774	2756	381876	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
410	GSM1233030	1775	1775	2757	381877	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
411	GSM1233031	1776	1776	2758	381878	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
412	GSM1233032	1777	1777	2759	381879	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
413	GSM1233033	1778	1778	2760	381880	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
414	GSM1233034	1779	1779	2761	381881	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
415	GSM1233035	1780	1780	2762	381882	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
416	GSM1233036	1781	1781	2763	381883	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
417	GSM1233037	1782	1782	2764	381884	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
418	GSM1233038	1783	1783	2765	381885	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
419	GSM1233039	1784	1784	2766	381886	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
420	GSM1233040	1785	1785	2767	381887	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
421	GSM1233041	1786	1786	2768	381888	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
422	GSM1233042	1787	1787	2769	381889	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
423	GSM1233043	1788	1788	2770	381890	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
424	GSM1233044	1789	1789	2771	381891	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca												pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
425	GSM1233045	1790	1790	2772	381892	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca												pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
426	GSM1233046	1791	1791	2773	381893	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
427	GSM1233047	1792	1792	2774	381894	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca												pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
428	GSM1233048	1793	1793	2775	381895	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
429	GSM1233049	1794	1794	2776	381896	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca													pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
430	GSM1233050	1795	1795	2777	381897	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca													pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_positive	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
431	GSM1233051	1796	1796	2778	381898	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca													pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_positive	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
432	GSM1233052	1797	1797	2779	381899	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca												pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_positive	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
433	GSM1233053	1798	1798	2780	381900	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
434	GSM1233054	1799	1799	2781	381901	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca													pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_positive	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
435	GSM1233055	1800	1800	2782	381902	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
436	GSM1233056	1801	1801	2783	381903	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca												pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
437	GSM1233057	1802	1802	2784	381904	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
438	GSM1233058	1803	1803	2785	381905	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
439	GSM1233059	1804	1804	2786	381906	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
440	GSM1233060	1805	1805	2787	381907	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
441	GSM1233061	1806	1806	2788	381908	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
442	GSM1233062	1807	1807	2789	381909	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
443	GSM1233063	1808	1808	2790	381910	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
444	GSM1233064	1809	1809	2791	381911	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
445	GSM1233065	1810	1810	2792	381912	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca												pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_positive	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
446	GSM1233066	1811	1811	2793	381913	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
447	GSM1233067	1812	1812	2794	381914	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca				her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
448	GSM1233068	1813	1813	2795	381915	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
449	GSM1233069	1814	1814	2796	381916	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca			her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
450	GSM1233070	1815	1815	2797	381917	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
451	GSM1233071	1816	1816	2798	381918	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
452	GSM1233072	1817	1817	2799	381919	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca			her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
453	GSM1233073	1818	1818	2800	381920	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
454	GSM1233074	1819	1819	2801	381921	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
455	GSM1233075	1820	1820	2802	381922	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca												pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
456	GSM1233076	1821	1821	2803	381923	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
457	GSM1233077	1822	1822	2804	381924	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
458	GSM1233078	1823	1823	2805	381925	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
459	GSM1233079	1824	1824	2806	381926	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
460	GSM1233080	1825	1825	2807	381927	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
461	GSM1233081	1826	1826	2808	381928	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca													pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
462	GSM1233082	1827	1827	2809	381929	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
463	GSM1233083	1828	1828	2810	381930	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
464	GSM1233084	1829	1829	2811	381931	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
465	GSM1233085	1830	1830	2812	381932	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca			her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
466	GSM1233086	1831	1831	2813	381933	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca				her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
467	GSM1233087	1832	1832	2814	381934	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
468	GSM1233088	1833	1833	2815	381935	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca												pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_positive	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
469	GSM1233089	1834	1834	2816	381936	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
470	GSM1233090	1835	1835	2817	381937	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
471	GSM1233091	1836	1836	2818	381938	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
472	GSM1233092	1837	1837	2819	381939	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
473	GSM1233093	1838	1838	2820	381940	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
474	GSM1233094	1839	1839	2821	381941	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
475	GSM1233095	1840	1840	2822	381942	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca													pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
476	GSM1233096	1841	1841	2823	381943	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
477	GSM1233097	1842	1842	2824	381944	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca												pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_positive	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
478	GSM1233098	1843	1843	2825	381945	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
479	GSM1233099	1844	1844	2826	381946	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
480	GSM1233100	1845	1845	2827	381947	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
481	GSM1233101	1846	1846	2828	381948	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
482	GSM1233102	1847	1847	2829	381949	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
483	GSM1233103	1848	1848	2830	381950	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
484	GSM1233104	1849	1849	2831	381951	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
485	GSM1233105	1850	1850	2832	381952	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
486	GSM1233106	1851	1851	2833	381953	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca						pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
487	GSM1233107	1852	1852	2834	381954	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
488	GSM1233108	1853	1853	2835	381955	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca				her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
489	GSM1233109	1854	1854	2836	381956	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca			her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
490	GSM1233110	1855	1855	2837	381957	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca			her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
491	GSM1233111	1856	1856	2838	381958	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
492	GSM1233112	1857	1857	2839	381959	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
493	GSM1233113	1858	1858	2840	381960	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca				her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
494	GSM1233114	1859	1859	2841	381961	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
495	GSM1233115	1860	1860	2842	381962	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
496	GSM1233116	1861	1861	2843	381963	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca			her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
497	GSM1233117	1862	1862	2844	381964	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca							pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
498	GSM1233118	1863	1863	2845	381965	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca						pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
499	GSM1233119	1864	1864	2846	381966	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
500	GSM1233120	1865	1865	2847	381967	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
501	GSM1233121	1866	1866	2848	381968	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca			her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
502	GSM1233122	1867	1867	2849	381969	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca							pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
503	GSM1233123	1868	1868	2850	381970	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca			her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
504	GSM1233124	1869	1869	2851	381971	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca				her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
505	GSM1233125	1870	1870	2852	381972	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca			her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
506	GSM1233126	1871	1871	2853	381973	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca				her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
507	GSM1233127	1872	1872	2854	381974	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
508	GSM1233128	1873	1873	2855	381975	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca				her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
509	GSM1233129	1874	1874	2856	381976	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca			her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative	grade_2_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
510	GSM1233130	1875	1875	2857	381977	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca			her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
511	GSM1233131	1876	1876	2858	381978	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
512	GSM1233132	1877	1877	2859	381979	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_positive	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
513	GSM1233133	1878	1878	2860	381980	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca			her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
514	GSM1233134	1879	1879	2861	381981	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca				her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
515	GSM1233135	1880	1880	2862	381982	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca			her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
516	GSM1233136	1881	1881	2863	381983	9647	4	GPL570	GSE50948		NA		er_neg		grade_2_brca			her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
517	GSM1233137	1882	1882	2864	381984	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca			her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
518	GSM1233138	1883	1883	2865	381985	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
519	GSM1233139	1884	1884	2866	381986	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
520	GSM1233140	1885	1885	2867	381987	9647	4	GPL570	GSE50948		NA	er_pos			grade_2_brca			her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
521	GSM1233141	1886	1886	2868	381988	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
522	GSM1233142	1887	1887	2869	381989	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
523	GSM1233143	1888	1888	2870	381990	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca				her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
524	GSM1233144	1889	1889	2871	381991	9647	4	GPL570	GSE50948		NA	er_pos		grade_3_brca				her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
525	GSM1233145	1890	1890	2872	381992	9647	4	GPL570	GSE50948		NA		er_neg	grade_3_brca				her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
526	GSM1233146	1891	1891	2873	381993	9647	4	GPL570	GSE50948		NA		er_neg								pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
527	GSM1233147	1892	1892	2874	381994	9647	4	GPL570	GSE50948		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE50948	GEO	drug_doxorubicin;drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_methotrexate
528	GSM1334958	1893	1893	2875	405369	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes	pre_treatment						er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	NA
529	GSM1334959	1894	1894	2876	405370	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes	pre_treatment						er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	NA
530	GSM1334960	1895	1895	2877	405371	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes	pre_treatment						er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	NA
531	GSM1334961	1896	1896	2878	405372	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes	pre_treatment						er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	NA
532	GSM1334962	1897	1897	2879	405373	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes	pre_treatment						er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	NA
533	GSM1334963	1898	1898	2880	405374	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes	pre_treatment						er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	NA
534	GSM1334964	1899	1899	2881	405375	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes	pre_treatment						er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	NA
535	GSM1334965	1900	1900	2882	405376	10319	674	GPL10558	GSE55374		NA																	pcr_yes	pre_treatment											pcr_yes	1	GPL10558_GSE55374	GEO	NA
536	GSM1334966	1901	1901	2883	405377	10319	674	GPL10558	GSE55374		NA																	pcr_yes	pre_treatment											pcr_yes	1	GPL10558_GSE55374	GEO	NA
537	GSM1334967	1902	1902	2884	405378	10319	674	GPL10558	GSE55374		NA																	pcr_yes	pre_treatment											pcr_yes	1	GPL10558_GSE55374	GEO	NA
538	GSM1334968	1903	1903	2885	405379	10319	674	GPL10558	GSE55374		NA																	pcr_yes	pre_treatment											pcr_yes	1	GPL10558_GSE55374	GEO	NA
539	GSM1334969	1904	1904	2886	405380	10319	674	GPL10558	GSE55374		NA																	pcr_yes	pre_treatment											pcr_yes	1	GPL10558_GSE55374	GEO	NA
540	GSM1334970	1905	1905	2887	405381	10319	674	GPL10558	GSE55374		NA																	pcr_yes	pre_treatment											pcr_yes	1	GPL10558_GSE55374	GEO	NA
541	GSM1334971	1906	1906	2888	405382	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
542	GSM1334972	1907	1907	2889	405383	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
543	GSM1334973	1908	1908	2890	405384	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
544	GSM1334974	1909	1909	2891	405385	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
545	GSM1334975	1910	1910	2892	405386	10319	674	GPL10558	GSE55374		NA																	pcr_yes												pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
546	GSM1334976	1911	1911	2893	405387	10319	674	GPL10558	GSE55374		NA																	pcr_yes												pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
547	GSM1334977	1912	1912	2894	405388	10319	674	GPL10558	GSE55374		NA																	pcr_yes												pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
548	GSM1334978	1913	1913	2895	405389	10319	674	GPL10558	GSE55374		NA																	pcr_yes												pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
549	GSM1334979	1914	1914	2896	405390	10319	674	GPL10558	GSE55374		NA																	pcr_yes												pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
550	GSM1334980	1915	1915	2897	405391	10319	674	GPL10558	GSE55374		NA																	pcr_yes												pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
551	GSM1334981	1916	1916	2898	405392	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
552	GSM1334982	1917	1917	2899	405393	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
553	GSM1334983	1918	1918	2900	405394	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
554	GSM1334984	1919	1919	2901	405395	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
555	GSM1334985	1920	1920	2902	405396	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
556	GSM1334986	1921	1921	2903	405397	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
557	GSM1334987	1922	1922	2904	405398	10319	674	GPL10558	GSE55374		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
558	GSM1334988	1923	1923	2905	405399	10319	674	GPL10558	GSE55374		NA																	pcr_yes												pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
559	GSM1334989	1924	1924	2906	405400	10319	674	GPL10558	GSE55374		NA																	pcr_yes												pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
560	GSM1334990	1925	1925	2907	405401	10319	674	GPL10558	GSE55374		NA																	pcr_yes												pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
561	GSM1334991	1926	1926	2908	405402	10319	674	GPL10558	GSE55374		NA																	pcr_yes												pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
562	GSM1334992	1927	1927	2909	405403	10319	674	GPL10558	GSE55374		NA																	pcr_yes												pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
563	GSM1334993	1928	1928	2910	405404	10319	674	GPL10558	GSE55374		NA																	pcr_yes												pcr_yes	1	GPL10558_GSE55374	GEO	drug_letrozole
564	GSM139539	1636	1636	2577	359219	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0					drug_cyclophosphamide				pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
565	GSM139540	1637	1637	2578	359220	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2	n0		pr_positive			drug_cyclophosphamide				pcr_no	er_pos		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
566	GSM139541	1638	1638	2579	359221	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2			pr_positive	pcr_yes		drug_cyclophosphamide		n1_brca			er_pos		pr_positive		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
567	GSM139542	1639	1639	2580	359222	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
568	GSM139543	1640	1640	2581	359223	9116	67	GPL1352	GSE4779		NA	er_pos											stage_t3				pr_positive	pcr_yes		drug_cyclophosphamide		n1_brca			er_pos		pr_positive		stage_t3	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
569	GSM139544	1641	1641	2582	359224	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3		n0					drug_cyclophosphamide				pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
570	GSM139545	1642	1642	2583	359225	9116	67	GPL1352	GSE4779		NA	er_pos									pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
571	GSM139546	1643	1643	2584	359226	9116	67	GPL1352	GSE4779		NA	er_pos									pr_negative			stage_t2	n0					drug_cyclophosphamide				pcr_no	er_pos		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
572	GSM139547	1644	1644	2585	359227	9116	67	GPL1352	GSE4779		NA		er_neg											stage_t2	n0		pr_positive			drug_cyclophosphamide				pcr_no	er_neg		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
573	GSM139548	1645	1645	2586	359228	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
574	GSM139549	1646	1646	2587	359229	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
575	GSM139550	1647	1647	2588	359230	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2				pcr_yes		drug_cyclophosphamide		n1_brca			er_neg		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
576	GSM139551	1648	1648	2589	359231	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3					pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t3	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
577	GSM139552	1649	1649	2590	359232	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3		n0					drug_cyclophosphamide				pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
578	GSM139553	1650	1650	2591	359233	9116	67	GPL1352	GSE4779		NA	er_pos									pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
579	GSM139554	1651	1651	2592	359234	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
580	GSM139555	1652	1652	2593	359235	9116	67	GPL1352	GSE4779		NA	er_pos											stage_t3				pr_positive			drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_positive		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
581	GSM139556	1653	1653	2594	359236	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2	n0		pr_positive			drug_cyclophosphamide				pcr_no	er_pos		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
582	GSM139557	1654	1654	2595	359237	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0			pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
583	GSM139558	1655	1655	2596	359238	9116	67	GPL1352	GSE4779		NA	er_pos											stage_t3		n0		pr_positive	pcr_yes		drug_cyclophosphamide					er_pos		pr_positive		stage_t3	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
584	GSM139559	1656	1656	2597	359239	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2			pr_positive	pcr_yes		drug_cyclophosphamide		n1_brca			er_pos		pr_positive		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
585	GSM139560	1657	1657	2598	359240	9116	67	GPL1352	GSE4779		NA	er_pos											stage_t3		n0					drug_cyclophosphamide				pcr_no	er_pos				stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
586	GSM139561	1658	1658	2599	359241	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative	stage_t1						pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t1	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
587	GSM139562	1659	1659	2600	359242	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2			pr_positive			drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
588	GSM139563	1660	1660	2601	359243	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
589	GSM139564	1661	1661	2602	359244	9116	67	GPL1352	GSE4779		NA	er_pos									pr_negative			stage_t2	n0					drug_cyclophosphamide				pcr_no	er_pos		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
590	GSM139565	1662	1662	2603	359245	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2			pr_positive			drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
591	GSM139566	1663	1663	2604	359246	9116	67	GPL1352	GSE4779		NA	er_pos									pr_negative			stage_t2				pcr_yes		drug_cyclophosphamide		n1_brca			er_pos		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
592	GSM139567	1664	1664	2605	359247	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
593	GSM139568	1665	1665	2606	359248	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3							drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
594	GSM139569	1666	1666	2607	359249	9116	67	GPL1352	GSE4779		NA		er_neg										stage_t3		n0		pr_positive			drug_cyclophosphamide				pcr_no	er_neg		pr_positive		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
595	GSM139570	1667	1667	2608	359250	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0			pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
596	GSM139571	1668	1668	2609	359251	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
597	GSM139572	1669	1669	2610	359252	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3					pcr_yes		drug_cyclophosphamide		n1_brca			er_neg		pr_negative		stage_t3	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
598	GSM139573	1670	1670	2611	359253	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2			pr_positive			drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
599	GSM139574	1671	1671	2612	359254	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3							drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
600	GSM139575	1672	1672	2613	359255	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0					drug_cyclophosphamide				pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
601	GSM139576	1673	1673	2614	359256	9116	67	GPL1352	GSE4779		NA		er_neg										stage_t3		n0		pr_positive			drug_cyclophosphamide				pcr_no	er_neg		pr_positive		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
602	GSM139577	1674	1674	2615	359257	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2			pr_positive			drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
603	GSM139578	1675	1675	2616	359258	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0			pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
604	GSM139579	1676	1676	2617	359259	9116	67	GPL1352	GSE4779		NA	er_pos											stage_t3				pr_positive	pcr_yes		drug_cyclophosphamide		n1_brca			er_pos		pr_positive		stage_t3	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
605	GSM139580	1677	1677	2618	359260	9116	67	GPL1352	GSE4779		NA	er_pos									pr_negative			stage_t2				pcr_yes		drug_cyclophosphamide		n1_brca			er_pos		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
606	GSM139581	1678	1678	2619	359261	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2	n0		pr_positive			drug_cyclophosphamide				pcr_no	er_pos		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
607	GSM139582	1679	1679	2620	359262	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2	n0		pr_positive	pcr_yes		drug_cyclophosphamide					er_pos		pr_positive		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
608	GSM139583	1680	1680	2621	359263	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2			pr_positive			drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
609	GSM139584	1681	1681	2622	359264	9116	67	GPL1352	GSE4779		NA	er_pos									pr_negative			stage_t2	n0					drug_cyclophosphamide				pcr_no	er_pos		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
610	GSM139585	1682	1682	2623	359265	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2			pr_positive			drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
611	GSM139586	1683	1683	2624	359266	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0					drug_cyclophosphamide				pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
612	GSM139587	1684	1684	2625	359267	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
613	GSM139588	1685	1685	2626	359268	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2			pr_positive			drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
614	GSM139589	1686	1686	2627	359269	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3					pcr_yes		drug_cyclophosphamide		n1_brca			er_neg		pr_negative		stage_t3	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
615	GSM139590	1687	1687	2628	359270	9116	67	GPL1352	GSE4779		NA	er_pos									pr_negative		stage_t3							drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
616	GSM139591	1688	1688	2629	359271	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2				pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
617	GSM139592	1689	1689	2630	359272	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3							drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
618	GSM139593	1690	1690	2631	359273	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3					pcr_yes		drug_cyclophosphamide		n1_brca			er_neg		pr_negative		stage_t3	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
619	GSM139594	1691	1691	2632	359274	9116	67	GPL1352	GSE4779		NA	er_pos									pr_negative		stage_t3		n0					drug_cyclophosphamide				pcr_no	er_pos		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
620	GSM139595	1692	1692	2633	359275	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0			pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
621	GSM139596	1693	1693	2634	359276	9116	67	GPL1352	GSE4779		NA	er_pos									pr_negative			stage_t2	n0					drug_cyclophosphamide				pcr_no	er_pos		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
622	GSM139597	1694	1694	2635	359277	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
623	GSM139598	1695	1695	2636	359278	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2	n0		pr_positive			drug_cyclophosphamide				pcr_no	er_pos		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
624	GSM139599	1696	1696	2637	359279	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2			pr_positive			drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
625	GSM139600	1697	1697	2638	359280	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2				pcr_yes		drug_cyclophosphamide		n1_brca			er_neg		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
626	GSM139601	1698	1698	2639	359281	9116	67	GPL1352	GSE4779		NA	er_pos									pr_negative			stage_t2				pcr_yes		drug_cyclophosphamide		n1_brca			er_pos		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
627	GSM139602	1699	1699	2640	359282	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3					pcr_yes		drug_cyclophosphamide		n1_brca			er_neg		pr_negative		stage_t3	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
628	GSM139603	1700	1700	2641	359283	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2			pr_positive			drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
629	GSM139604	1701	1701	2642	359284	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
630	GSM139605	1702	1702	2643	359285	9116	67	GPL1352	GSE4779		NA	er_pos									pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
631	GSM139606	1703	1703	2644	359286	9116	67	GPL1352	GSE4779		NA	er_pos												stage_t2			pr_positive			drug_cyclophosphamide		n1_brca		pcr_no	er_pos		pr_positive		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
632	GSM139607	1704	1704	2645	359287	9116	67	GPL1352	GSE4779		NA	er_pos											stage_t3				pr_positive	pcr_yes		drug_cyclophosphamide		n1_brca			er_pos		pr_positive		stage_t3	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
633	GSM139608	1705	1705	2646	359288	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3		n0			pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t3	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
634	GSM139609	1706	1706	2647	359289	9116	67	GPL1352	GSE4779		NA	er_pos									pr_negative			stage_t2	n0			pcr_yes		drug_cyclophosphamide					er_pos		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
635	GSM139610	1707	1707	2648	359290	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0			pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
636	GSM139611	1708	1708	2649	359291	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
637	GSM139612	1709	1709	2650	359292	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0					drug_cyclophosphamide				pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
638	GSM139613	1710	1710	2651	359293	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3		n0					drug_cyclophosphamide				pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
639	GSM139614	1711	1711	2652	359294	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
640	GSM139615	1712	1712	2653	359295	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3							drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
641	GSM139616	1713	1713	2654	359296	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative	stage_t1						pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t1	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
642	GSM139617	1714	1714	2655	359297	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2				pcr_yes		drug_cyclophosphamide		n1_brca			er_neg		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
643	GSM139618	1715	1715	2656	359298	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3							drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
644	GSM139619	1716	1716	2657	359299	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3					pcr_yes		drug_cyclophosphamide		n1_brca			er_neg		pr_negative		stage_t3	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
645	GSM139620	1717	1717	2658	359300	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0					drug_cyclophosphamide				pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
646	GSM139621	1718	1718	2659	359301	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3		n0					drug_cyclophosphamide				pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
647	GSM139622	1719	1719	2660	359302	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3					pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t3	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
648	GSM139623	1720	1720	2661	359303	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative							pcr_yes		drug_cyclophosphamide					er_neg		pr_negative			pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
649	GSM139624	1721	1721	2662	359304	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0			pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
650	GSM139625	1722	1722	2663	359305	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3					pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t3	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
651	GSM139626	1723	1723	2664	359306	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0			pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
652	GSM139627	1724	1724	2665	359307	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3							drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
653	GSM139628	1725	1725	2666	359308	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3							drug_cyclophosphamide				pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
654	GSM139629	1726	1726	2667	359309	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0			pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
655	GSM139630	1727	1727	2668	359310	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0					drug_cyclophosphamide				pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
656	GSM139631	1728	1728	2669	359311	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
657	GSM139632	1729	1729	2670	359312	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3							drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
658	GSM139633	1730	1730	2671	359313	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2						drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
659	GSM139634	1731	1731	2672	359314	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2	n0			pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
660	GSM139635	1732	1732	2673	359315	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative			stage_t2				pcr_yes		drug_cyclophosphamide		n1_brca			er_neg		pr_negative		stage_t2	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
661	GSM139636	1733	1733	2674	359316	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative							pcr_yes		drug_cyclophosphamide					er_neg		pr_negative			pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
662	GSM139637	1734	1734	2675	359317	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative									drug_cyclophosphamide				pcr_no	er_neg		pr_negative			pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
663	GSM139638	1735	1735	2676	359318	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3		n0			pcr_yes		drug_cyclophosphamide					er_neg		pr_negative		stage_t3	pcr_yes	1	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
664	GSM139639	1736	1736	2677	359319	9116	67	GPL1352	GSE4779		NA		er_neg								pr_negative		stage_t3							drug_cyclophosphamide		n1_brca		pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL1352_GSE4779	GEO	drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
665	GSM1438585	1975	1975	3539	550393	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	NA
666	GSM1438586	1976	1976	3540	550394	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
667	GSM1438587	1977	1977	3541	550395	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
668	GSM1438588	1978	1978	3542	550396	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
669	GSM1438589	1979	1979	3543	550397	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
670	GSM1438590	1980	1980	3544	550398	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
671	GSM1438591	1981	1981	3545	550399	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
672	GSM1438592	1982	1982	3546	550400	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
673	GSM1438593	1983	1983	3547	550401	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
674	GSM1438594	1984	1984	3548	550402	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	NA
675	GSM1438595	1985	1985	3549	550403	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
676	GSM1438596	1986	1986	3550	550404	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
677	GSM1438597	1987	1987	3551	550405	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	NA
678	GSM1438598	1988	1988	3552	550406	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
679	GSM1438599	1989	1989	3553	550407	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
680	GSM1438600	1990	1990	3554	550408	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	NA
681	GSM1438601	1991	1991	3555	550409	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
682	GSM1438602	1992	1992	3556	550410	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
683	GSM1438603	1993	1993	3557	550411	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
684	GSM1438604	1994	1994	3558	550412	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
685	GSM1438605	1995	1995	3559	550413	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
686	GSM1438606	1996	1996	3560	550414	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
687	GSM1438607	1997	1997	3561	550415	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
688	GSM1438608	1998	1998	3562	550416	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
689	GSM1438609	1999	1999	3563	550417	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
690	GSM1438610	2000	2000	3564	550418	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
691	GSM1438611	2001	2001	3565	550419	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
692	GSM1438612	2002	2002	3566	550420	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
693	GSM1438613	2003	2003	3567	550421	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
694	GSM1438614	2004	2004	3568	550422	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
695	GSM1438615	2005	2005	3569	550423	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
696	GSM1438616	2006	2006	3570	550424	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
697	GSM1438617	2007	2007	3571	550425	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
698	GSM1438618	2008	2008	3572	550426	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
699	GSM1438619	2009	2009	3573	550427	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
700	GSM1438620	2010	2010	3574	550428	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
701	GSM1438621	2011	2011	3575	550429	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
702	GSM1438622	2012	2012	3576	550430	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
703	GSM1438623	2013	2013	3577	550431	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
704	GSM1438624	2014	2014	3578	550432	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	NA
705	GSM1438625	2015	2015	3579	550433	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
706	GSM1438626	2016	2016	3580	550434	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
707	GSM1438627	2017	2017	3581	550435	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
708	GSM1438628	2018	2018	3582	550436	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
709	GSM1438629	2019	2019	3583	550437	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
710	GSM1438630	2020	2020	3584	550438	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
711	GSM1438631	2021	2021	3585	550439	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
712	GSM1438632	2022	2022	3586	550440	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
713	GSM1438633	2023	2023	3587	550441	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
714	GSM1438634	2024	2024	3588	550442	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
715	GSM1438635	2025	2025	3589	550443	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
716	GSM1438636	2026	2026	3590	550444	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
717	GSM1438637	2027	2027	3591	550445	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
718	GSM1438638	2028	2028	3592	550446	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
719	GSM1438639	2029	2029	3593	550447	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
720	GSM1438640	2030	2030	3594	550448	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
721	GSM1438641	2031	2031	3595	550449	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
722	GSM1438642	2032	2032	3596	550450	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
723	GSM1438643	2033	2033	3597	550451	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
724	GSM1438644	2034	2034	3598	550452	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
725	GSM1438645	2035	2035	3599	550453	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	NA
726	GSM1438646	2036	2036	3600	550454	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
727	GSM1438647	2037	2037	3601	550455	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
728	GSM1438648	2038	2038	3602	550456	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	NA
729	GSM1438649	2039	2039	3603	550457	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
730	GSM1438650	2040	2040	3604	550458	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
731	GSM1438651	2041	2041	3605	550459	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	NA
732	GSM1438652	2042	2042	3606	550460	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
733	GSM1438653	2043	2043	3607	550461	13942	674	GPL10558	GSE59515		NA	er_pos																						pcr_no	er_pos					pcr_no	2	GPL10558_GSE59515	GEO	drug_letrozole
734	GSM1438654	2044	2044	3608	550462	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
735	GSM1438655	2045	2045	3609	550463	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
736	GSM1438656	2046	2046	3610	550464	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
737	GSM1438657	2047	2047	3611	550465	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	NA
738	GSM1438658	2048	2048	3612	550466	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
739	GSM1438659	2049	2049	3613	550467	13942	674	GPL10558	GSE59515		NA	er_pos																pcr_yes							er_pos					pcr_yes	1	GPL10558_GSE59515	GEO	drug_letrozole
740	GSM1619387	2824	775	4486	584874	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
741	GSM1619388	2825	776	4487	584877	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
742	GSM1619389	2826	777	4488	584880	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
743	GSM1619390	2827	778	4489	584883	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
744	GSM1619391	2828	779	4490	584886	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
745	GSM1619392	2829	780	4491	584889	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
746	GSM1619393	2830	781	4492	584892	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
747	GSM1619394	2831	782	4493	584895	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
748	GSM1619395	2832	783	4494	584898	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
749	GSM1619396	2833	784	4495	584903	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
750	GSM1619397	2834	785	4496	584908	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
751	GSM1619398	2835	786	4497	584913	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
752	GSM1619399	2836	787	4498	584918	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
753	GSM1619400	2837	788	4499	584922	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
754	GSM1619401	2838	789	4500	584926	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
755	GSM1619402	2839	790	4501	584930	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
756	GSM1619403	2840	791	4502	584934	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
757	GSM1619404	2841	792	4503	584938	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
758	GSM1619405	2842	793	4504	584942	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
759	GSM1619406	2843	794	4505	584946	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
760	GSM1619407	2844	795	4506	584950	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
761	GSM1619408	2845	796	4507	584954	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
762	GSM1619409	2846	797	4508	584958	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
763	GSM1619410	2847	798	4509	584962	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
764	GSM1619411	2848	799	4510	584966	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
765	GSM1619412	2849	800	4511	584967	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
766	GSM1619413	2850	801	4512	584969	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
767	GSM1619414	2851	802	4513	584970	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
768	GSM1619415	2852	803	4514	584972	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
769	GSM1619416	2853	804	4515	584974	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
770	GSM1619417	2854	805	4516	584977	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
771	GSM1619418	2855	806	4517	584979	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
772	GSM1619419	2856	807	4518	584981	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
773	GSM1619420	2857	808	4519	584983	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
774	GSM1619421	2858	809	4520	584985	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
775	GSM1619422	2859	810	4521	584987	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
776	GSM1619423	2860	811	4522	584990	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
777	GSM1619424	2861	812	4523	584992	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
778	GSM1619425	2862	813	4524	584995	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
779	GSM1619426	2863	814	4525	584997	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
780	GSM1619427	2864	815	4526	584999	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
781	GSM1619428	2865	816	4527	585001	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
782	GSM1619429	2866	817	4528	585003	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
783	GSM1619430	2867	818	4529	585005	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
784	GSM1619431	2868	819	4530	585007	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
785	GSM1619432	2869	820	4531	585009	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
786	GSM1619433	2870	821	4532	585010	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
787	GSM1619434	2871	822	4533	585012	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
788	GSM1619435	2872	823	4534	585014	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
789	GSM1619436	2873	824	4535	585016	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
790	GSM1619437	2874	825	4536	585018	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
791	GSM1619438	2875	826	4537	585020	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
792	GSM1619439	2876	827	4538	585022	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
793	GSM1619440	2877	828	4539	585024	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
794	GSM1619441	2878	829	4540	585026	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
795	GSM1619442	2879	830	4541	585028	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
796	GSM1619443	2880	831	4542	585031	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
797	GSM1619444	2881	832	4543	585034	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
798	GSM1619445	2882	833	4544	585037	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
799	GSM1619446	2883	834	4545	585038	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
800	GSM1619447	2884	835	4546	585041	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
801	GSM1619448	2885	836	4547	585043	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
802	GSM1619449	2886	837	4548	585045	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
803	GSM1619450	2887	838	4549	585046	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
804	GSM1619451	2888	839	4550	585048	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
805	GSM1619452	2889	840	4551	585051	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
806	GSM1619453	2890	841	4552	585052	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
807	GSM1619454	2891	842	4553	585054	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
808	GSM1619455	2892	843	4554	585056	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
809	GSM1619456	2893	844	4555	585058	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
810	GSM1619457	2894	845	4556	585060	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
811	GSM1619458	2895	846	4557	585062	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
812	GSM1619459	2896	847	4558	585065	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
813	GSM1619460	2897	848	4559	585070	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
814	GSM1619461	2898	849	4560	585074	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
815	GSM1619462	2899	850	4561	585076	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
816	GSM1619463	2900	851	4562	585079	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
817	GSM1619464	2901	852	4563	585082	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
818	GSM1619465	2902	853	4564	585086	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
819	GSM1619466	2903	854	4565	585090	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
820	GSM1619467	2904	855	4566	585094	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
821	GSM1619468	2905	856	4567	585099	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
822	GSM1619469	2906	857	4568	585104	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
823	GSM1619470	2907	858	4569	585109	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
824	GSM1619471	2908	859	4570	585114	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_trastuzumab;drug_chemo
825	GSM1619472	2909	860	4571	585118	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
826	GSM1619473	2910	861	4572	585121	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_trastuzumab;drug_chemo
827	GSM1619474	2911	862	4573	585125	14768	4	GPL570	GSE66305	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive				pcr_no	2	GPL570_GSE66305	GEO	drug_lapatinib;drug_chemo
828	GSM1982110	2912	863	4585	645100	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
829	GSM1982111	2913	864	4586	645110	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
830	GSM1982112	2914	865	4587	645122	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
831	GSM1982113	2915	866	4588	645137	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive					NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
832	GSM1982114	2916	867	4589	645152	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
833	GSM1982115	2917	868	4590	645164	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
834	GSM1982116	2918	869	4591	645173	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
835	GSM1982117	2919	870	4592	645189	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive					NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
836	GSM1982118	2920	871	4593	645203	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
837	GSM1982119	2921	872	4594	645216	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive					NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
838	GSM1982120	2922	873	4595	645229	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
839	GSM1982121	2923	874	4596	645237	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
840	GSM1982122	2924	875	4597	645256	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
841	GSM1982123	2925	876	4598	645268	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
842	GSM1982124	2926	877	4599	645279	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
843	GSM1982125	2927	878	4600	645292	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
844	GSM1982126	2928	879	4601	645306	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
845	GSM1982127	2929	880	4602	645318	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive					NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
846	GSM1982128	2930	881	4603	645332	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
847	GSM1982129	2931	882	4604	645347	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
848	GSM1982130	2932	883	4605	645361	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
849	GSM1982131	2933	884	4606	645376	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
850	GSM1982132	2934	885	4607	645388	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
851	GSM1982133	2935	886	4608	645402	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
852	GSM1982134	2936	887	4609	645412	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment			NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
853	GSM1982135	2937	888	4610	645429	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes				NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
854	GSM1982136	2938	889	4611	645443	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive		er_neg	her2_positive	pr_positive				NA	GPL6947_GSE76360	GEO	drug_trastuzumab
855	GSM1982137	2939	890	4612	645459	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA						NA		pr_positive					NA	her2_positive		er_neg	her2_positive	pr_positive				NA	GPL6947_GSE76360	GEO	drug_trastuzumab
856	GSM1982138	2940	891	4613	645472	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
857	GSM1982139	2941	892	4614	645484	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
858	GSM1982140	2942	893	4615	645497	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
859	GSM1982141	2943	894	4616	645507	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
860	GSM1982142	2944	895	4617	645521	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
861	GSM1982143	2945	896	4618	645535	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
862	GSM1982144	2946	897	4619	645552	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
863	GSM1982145	2947	898	4620	645569	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive					NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
864	GSM1982146	2948	899	4621	645583	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive	pcr_yes	pre_treatment			NA	her2_positive		er_pos	her2_positive	pr_positive			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
865	GSM1982147	2949	900	4622	645596	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive	pcr_yes				NA	her2_positive		er_pos	her2_positive	pr_positive			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
866	GSM1982148	2950	901	4623	645603	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
867	GSM1982149	2951	902	4624	645616	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
868	GSM1982150	2952	903	4625	645627	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
869	GSM1982151	2953	904	4626	645637	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
870	GSM1982152	2954	905	4627	645648	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
871	GSM1982153	2955	906	4628	645658	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
872	GSM1982154	2956	907	4629	645665	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
873	GSM1982155	2957	908	4630	645675	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
874	GSM1982156	2958	909	4631	645688	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
875	GSM1982157	2959	910	4632	645702	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
876	GSM1982158	2960	911	4633	645715	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
877	GSM1982159	2961	912	4634	645727	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
878	GSM1982160	2962	913	4635	645739	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
879	GSM1982161	2963	914	4636	645752	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
880	GSM1982162	2964	915	4637	645763	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment			NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
881	GSM1982163	2965	916	4638	645773	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes				NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
882	GSM1982164	2966	917	4639	645785	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
883	GSM1982165	2967	918	4640	645795	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive					NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
884	GSM1982166	2968	919	4641	645810	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
885	GSM1982167	2969	920	4642	645820	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive					NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
886	GSM1982168	2970	921	4643	645836	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
887	GSM1982169	2971	922	4644	645846	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
888	GSM1982170	2972	923	4645	645858	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
889	GSM1982171	2973	924	4646	645872	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
890	GSM1982172	2974	925	4647	645887	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment			NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
891	GSM1982173	2975	926	4648	645899	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes				NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
892	GSM1982174	2976	927	4649	645914	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
893	GSM1982175	2977	928	4650	645927	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
894	GSM1982176	2978	929	4651	645943	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment			NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
895	GSM1982177	2979	930	4652	645953	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes				NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
896	GSM1982178	2980	931	4653	645965	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
897	GSM1982179	2981	932	4654	645978	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive					NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
898	GSM1982180	2982	933	4655	645990	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
899	GSM1982181	2983	934	4656	646001	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
900	GSM1982182	2984	935	4657	646017	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
901	GSM1982183	2985	936	4658	646031	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
902	GSM1982184	2986	937	4659	646041	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive	pcr_yes	pre_treatment			NA	her2_positive		er_pos	her2_positive	pr_positive			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
903	GSM1982185	2987	938	4660	646051	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive	pcr_yes				NA	her2_positive		er_pos	her2_positive	pr_positive			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
904	GSM1982186	2988	939	4661	646069	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
905	GSM1982187	2989	940	4662	646077	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
906	GSM1982188	2990	941	4663	646091	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
907	GSM1982189	2991	942	4664	646103	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
908	GSM1982190	2992	943	4665	646117	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA						NA		pr_positive	pcr_yes	pre_treatment			NA	her2_positive		er_neg	her2_positive	pr_positive			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
909	GSM1982191	2993	944	4666	646133	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA						NA		pr_positive	pcr_yes				NA	her2_positive		er_neg	her2_positive	pr_positive			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
910	GSM1982192	2994	945	4667	646144	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment			NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
911	GSM1982193	2995	946	4668	646157	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes				NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
912	GSM1982194	2996	947	4669	646170	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
913	GSM1982195	2997	948	4670	646188	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
914	GSM1982196	2998	949	4671	646205	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
915	GSM1982197	2999	950	4672	646217	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
916	GSM1982198	3000	951	4673	646229	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
917	GSM1982199	3001	952	4674	646243	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
918	GSM1982200	3002	953	4675	646251	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive		er_neg	her2_positive	pr_negative				NA	GPL6947_GSE76360	GEO	drug_trastuzumab
919	GSM1982201	3003	954	4676	646261	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive		er_neg	her2_positive	pr_negative				NA	GPL6947_GSE76360	GEO	drug_trastuzumab
920	GSM1982202	3004	955	4677	646273	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
921	GSM1982203	3005	956	4678	646287	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive					NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
922	GSM1982204	3006	957	4679	646298	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment			NA	her2_positive		er_pos	her2_positive	pr_negative			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
923	GSM1982205	3007	958	4680	646310	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA		pr_negative				NA			pcr_yes				NA	her2_positive		er_pos	her2_positive	pr_negative			pcr_yes	1	GPL6947_GSE76360	GEO	drug_trastuzumab
924	GSM1982206	3008	959	4681	646322	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
925	GSM1982207	3009	960	4682	646335	15702	389	GPL6947	GSE76360	NA	NA		er_neg			NA	NA		NA		pr_negative				NA							NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
926	GSM1982208	3010	961	4683	646349	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
927	GSM1982209	3011	962	4684	646357	15702	389	GPL6947	GSE76360	NA	NA	er_pos				NA	NA		NA						NA		pr_positive					NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL6947_GSE76360	GEO	drug_trastuzumab
928	GSM210025	1931	1931	3074	451453	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg					her2_negative			pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
929	GSM210026	1929	1929	3072	451451	11482	83	GPL1390	GSE8465	drug_cisplatin	NA	er_pos											stage_t3		n0		pr_positive		pre_treatment				her2_positive	pcr_no	er_pos	her2_positive	pr_positive		stage_t3	pcr_no	2	GPL1390_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
930	GSM210027	1932	1932	3075	451454	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg								pr_negative		stage_t3						pre_treatment			n1_brca	her2_positive	pcr_no	er_neg	her2_positive	pr_negative		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
931	GSM210028	1933	1933	3076	451455	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos						her2_negative		stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive		stage_t4	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
932	GSM210029	1934	1934	3077	451456	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg								pr_negative		stage_t3		n0				pre_treatment				her2_positive	pcr_no	er_neg	her2_positive	pr_negative		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
933	GSM210030	1935	1935	3078	451457	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos						her2_negative					stage_t3		n0		pr_positive		pre_treatment						er_pos	her2_negative	pr_positive		stage_t3		NA	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
934	GSM210031	1936	1936	3079	451458	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos											stage_t3		n0		pr_positive		pre_treatment				her2_positive	pcr_no	er_pos	her2_positive	pr_positive		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
935	GSM210032	1937	1937	3080	451459	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg					her2_negative		stage_t4	pr_negative				n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t4	pcr_yes	1	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
936	GSM210033	1938	1938	3081	451460	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg								pr_negative		stage_t3						pre_treatment			n1_brca	her2_positive	pcr_no	er_neg	her2_positive	pr_negative		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
937	GSM210034	1939	1939	3082	451461	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg					her2_negative		stage_t4	pr_negative							pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative		stage_t4	pcr_yes	1	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
938	GSM210035	1940	1940	3083	451462	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg								pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
939	GSM210036	1941	1941	3084	451463	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg								pr_negative			stage_t2					pre_treatment			n1_brca	her2_positive	pcr_no	er_neg	her2_positive	pr_negative		stage_t2	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
940	GSM210037	1942	1942	3085	451464	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg					her2_negative			pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t3	pcr_yes	1	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
941	GSM210038	1943	1943	3086	451465	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos						her2_negative		stage_t4							pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive		stage_t4	pcr_yes	1	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
942	GSM210039	1944	1944	3087	451466	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg					her2_negative			pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
943	GSM210040	1945	1945	3088	451467	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos											stage_t3		n0		pr_positive		pre_treatment				her2_positive	pcr_no	er_pos	her2_positive	pr_positive		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
944	GSM210041	1946	1946	3089	451468	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos						her2_negative					stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
945	GSM210042	1947	1947	3090	451469	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos						her2_negative		stage_t4							pr_positive		pre_treatment			n1_brca			er_pos	her2_negative	pr_positive		stage_t4		NA	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
946	GSM210043	1948	1948	3091	451470	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
947	GSM210044	1949	1949	3092	451471	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg								pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
948	GSM210045	1950	1950	3093	451472	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos								stage_t4							pr_positive		pre_treatment					pcr_no	er_pos		pr_positive		stage_t4	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
949	GSM210046	1951	1951	3094	451473	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg								pr_negative			stage_t2	n0			pcr_yes	pre_treatment				her2_positive		er_neg	her2_positive	pr_negative		stage_t2	pcr_yes	1	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
950	GSM210047	1952	1952	3095	451474	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos									pr_negative		stage_t3		n0				pre_treatment				her2_positive		er_pos	her2_positive	pr_negative		stage_t3		NA	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
951	GSM210048	1953	1953	3096	451475	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg								pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca	her2_positive		er_neg	her2_positive	pr_negative		stage_t2	pcr_yes	1	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
952	GSM210049	1954	1954	3097	451476	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos								stage_t4	pr_negative				n0			pcr_yes	pre_treatment				her2_positive		er_pos	her2_positive	pr_negative		stage_t4	pcr_yes	1	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
953	GSM210050	1955	1955	3098	451477	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos									pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca	her2_positive		er_pos	her2_positive	pr_negative		stage_t3	pcr_yes	1	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
954	GSM210051	1956	1956	3099	451478	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg					her2_negative			pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
955	GSM210052	1957	1957	3100	451479	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos											stage_t3				pr_positive		pre_treatment			n1_brca	her2_positive		er_pos	her2_positive	pr_positive		stage_t3		NA	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
956	GSM210053	1958	1958	3101	451480	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos						her2_negative		stage_t4							pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive		stage_t4	pcr_yes	1	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
957	GSM210054	1959	1959	3102	451481	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos						her2_negative						stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive		stage_t2	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
958	GSM210055	1960	1960	3103	451482	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg								pr_negative		stage_t3		n0				pre_treatment				her2_positive	pcr_no	er_neg	her2_positive	pr_negative		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
959	GSM210056	1961	1961	3104	451483	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos											stage_t3				pr_positive		pre_treatment			n1_brca	her2_positive	pcr_no	er_pos	her2_positive	pr_positive		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
960	GSM210057	1962	1962	3105	451484	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg								pr_negative		stage_t3		n0				pre_treatment				her2_positive		er_neg	her2_positive	pr_negative		stage_t3		NA	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
961	GSM210058	1963	1963	3106	451485	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos						her2_negative					stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
962	GSM210059	1964	1964	3107	451486	11482	49	GPL887	GSE8465	drug_cisplatin	NA												stage_t3					pcr_yes	pre_treatment			n1_brca							stage_t3	pcr_yes	1	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
963	GSM210060	1965	1965	3108	451487	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos						her2_negative		stage_t4					n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive		stage_t4	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
964	GSM210061	1966	1966	3109	451488	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg										stage_t3		n0		pr_positive	pcr_yes	pre_treatment						er_neg		pr_positive		stage_t3	pcr_yes	1	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
965	GSM210062	1967	1967	3110	451489	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos								stage_t4	pr_negative				n0				pre_treatment						er_pos		pr_negative		stage_t4		NA	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
966	GSM210063	1930	1930	3073	451452	11482	83	GPL1390	GSE8465	drug_cisplatin	NA	er_pos											stage_t3		n0		pr_positive		pre_treatment						er_pos		pr_positive		stage_t3		NA	GPL1390_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
967	GSM210064	1968	1968	3111	451490	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg								pr_negative		stage_t3		n0				pre_treatment				her2_positive	pcr_no	er_neg	her2_positive	pr_negative		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
968	GSM210065	1969	1969	3112	451491	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos						her2_negative		stage_t4					n0		pr_positive		pre_treatment						er_pos	her2_negative	pr_positive		stage_t4		NA	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
969	GSM210066	1970	1970	3113	451492	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos											stage_t3		n0		pr_positive		pre_treatment				her2_positive	pcr_no	er_pos	her2_positive	pr_positive		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
970	GSM210067	1971	1971	3114	451493	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg							stage_t4					n0		pr_positive		pre_treatment				her2_positive		er_neg	her2_positive	pr_positive		stage_t4		NA	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
971	GSM210068	1972	1972	3115	451494	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos									pr_negative		stage_t3		n0				pre_treatment				her2_positive	pcr_no	er_pos	her2_positive	pr_negative		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
972	GSM210069	1973	1973	3116	451495	11482	49	GPL887	GSE8465	drug_cisplatin	NA		er_neg					her2_negative					stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_neg	her2_negative	pr_positive		stage_t3	pcr_no	2	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
973	GSM210070	1974	1974	3117	451496	11482	49	GPL887	GSE8465	drug_cisplatin	NA	er_pos						her2_negative					stage_t3		n0		pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive		stage_t3	pcr_yes	1	GPL887_GSE8465	GEO	drug_cisplatin;drug_doxorubicin;drug_gemcitabine
974	GSM411290	2050	1	152	73755	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA				her2_negative		grade_3_brca			NA	GPL570_GSE16446	GEO	drug_epirubicin
975	GSM411291	2051	2	153	73756	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA				her2_negative		grade_3_brca			NA	GPL570_GSE16446	GEO	drug_epirubicin
976	GSM411292	2052	3	154	73757	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
977	GSM411293	2053	4	155	73758	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
978	GSM411294	2054	5	156	73759	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
979	GSM411295	2055	6	157	73760	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
980	GSM411296	2056	7	158	73761	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA				her2_negative		grade_3_brca			NA	GPL570_GSE16446	GEO	drug_epirubicin
981	GSM411297	2057	8	159	73762	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
982	GSM411298	2058	9	160	73763	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
983	GSM411299	2059	10	161	73764	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
984	GSM411300	2060	11	162	73765	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
985	GSM411301	2061	12	163	73766	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
986	GSM411302	2062	13	164	73767	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
987	GSM411303	2063	14	165	73768	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
988	GSM411304	2064	15	166	73769	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
989	GSM411305	2065	16	167	73770	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
990	GSM411306	2066	17	168	73771	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
991	GSM411307	2067	18	169	73772	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
992	GSM411308	2068	19	170	73773	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
993	GSM411309	2069	20	171	73774	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
994	GSM411310	2070	21	172	73775	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
995	GSM411311	2071	22	173	73776	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
996	GSM411312	2072	23	174	73777	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
997	GSM411313	2073	24	175	73778	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
998	GSM411314	2074	25	176	73779	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
999	GSM411315	2075	26	177	73780	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1000	GSM411316	2076	27	178	73781	1680	4	GPL570	GSE16446	NA	NA					NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative				pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1001	GSM411317	2077	28	179	73782	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1002	GSM411318	2078	29	180	73783	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1003	GSM411319	2079	30	181	73784	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1004	GSM411320	2080	31	182	73785	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1005	GSM411321	2081	32	183	73786	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1006	GSM411322	2082	33	184	73787	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1007	GSM411323	2083	34	185	73788	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1008	GSM411324	2084	35	186	73789	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1009	GSM411325	2085	36	187	73790	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1010	GSM411326	2086	37	188	73791	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1011	GSM411327	2087	38	189	73792	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1012	GSM411328	2088	39	190	73793	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1013	GSM411329	2089	40	191	73794	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1014	GSM411330	2090	41	192	73795	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1015	GSM411331	2091	42	193	73796	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1016	GSM411332	2092	43	194	73797	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1017	GSM411333	2093	44	195	73798	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1018	GSM411334	2094	45	196	73799	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1019	GSM411335	2095	46	197	73800	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1020	GSM411336	2096	47	198	73801	1680	4	GPL570	GSE16446	NA	NA					NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative				pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1021	GSM411337	2097	48	199	73802	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1022	GSM411338	2098	49	200	73803	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1023	GSM411339	2099	50	201	73804	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1024	GSM411340	2100	51	202	73805	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1025	GSM411341	2101	52	203	73806	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1026	GSM411342	2102	53	204	73807	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1027	GSM411343	2103	54	205	73808	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1028	GSM411344	2104	55	206	73809	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1029	GSM411345	2105	56	207	73810	1680	4	GPL570	GSE16446	NA	NA					NA	NA	her2_negative	NA						NA	grade_1_brca			pre_treatment			NA		pcr_no		her2_negative		grade_1_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1030	GSM411346	2106	57	208	73811	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1031	GSM411347	2107	58	209	73812	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1032	GSM411348	2108	59	210	73813	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1033	GSM411349	2109	60	211	73814	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1034	GSM411350	2110	61	212	73815	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1035	GSM411351	2111	62	213	73816	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1036	GSM411352	2112	63	214	73817	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1037	GSM411353	2113	64	215	73818	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1038	GSM411354	2114	65	216	73819	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1039	GSM411355	2115	66	217	73820	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1040	GSM411356	2116	67	218	73821	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1041	GSM411357	2117	68	219	73822	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1042	GSM411358	2118	69	220	73823	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1043	GSM411359	2119	70	221	73824	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1044	GSM411360	2120	71	222	73825	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1045	GSM411361	2121	72	223	73826	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1046	GSM411362	2122	73	224	73827	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1047	GSM411363	2123	74	225	73828	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1048	GSM411364	2124	75	226	73829	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive			her2_positive		grade_3_brca			NA	GPL570_GSE16446	GEO	drug_epirubicin
1049	GSM411365	2125	76	227	73830	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1050	GSM411366	2126	77	228	73831	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA				pre_treatment			NA	her2_positive	pcr_no		her2_positive		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1051	GSM411367	2127	78	229	73832	1680	4	GPL570	GSE16446	NA	NA					NA	NA		NA						NA				pre_treatment			NA	her2_positive			her2_positive					NA	GPL570_GSE16446	GEO	drug_epirubicin
1052	GSM411368	2128	79	230	73833	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1053	GSM411369	2129	80	231	73834	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1054	GSM411370	2130	81	232	73835	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1055	GSM411371	2131	82	233	73836	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1056	GSM411372	2132	83	234	73837	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1057	GSM411373	2133	84	235	73838	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1058	GSM411374	2134	85	236	73839	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1059	GSM411375	2135	86	237	73840	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1060	GSM411376	2136	87	238	73841	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1061	GSM411377	2137	88	239	73842	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1062	GSM411378	2138	89	240	73843	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1063	GSM411379	2139	90	241	73844	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1064	GSM411380	2140	91	242	73845	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1065	GSM411381	2141	92	243	73846	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1066	GSM411382	2142	93	244	73847	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1067	GSM411383	2143	94	245	73848	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1068	GSM411384	2144	95	246	73849	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1069	GSM411385	2145	96	247	73850	1680	4	GPL570	GSE16446	NA	NA					NA	NA	her2_negative	NA						NA	grade_1_brca			pre_treatment			NA		pcr_no		her2_negative		grade_1_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1070	GSM411386	2146	97	248	73851	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1071	GSM411387	2147	98	249	73852	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1072	GSM411388	2148	99	250	73853	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_2_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1073	GSM411389	2149	100	251	73854	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1074	GSM411390	2150	101	252	73855	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative		grade_3_brca		pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1075	GSM411391	2151	102	253	73856	1680	4	GPL570	GSE16446	NA	NA					NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative				pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1076	GSM411392	2152	103	254	73857	1680	4	GPL570	GSE16446	NA	NA					NA	NA	her2_negative	NA						NA				pre_treatment			NA		pcr_no		her2_negative				pcr_no	2	GPL570_GSE16446	GEO	drug_epirubicin
1077	GSM411393	2153	104	255	73858	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive		grade_2_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1078	GSM411394	2154	105	256	73859	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA			pcr_yes	pre_treatment			NA				her2_negative		grade_3_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1079	GSM411395	2155	106	257	73860	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive		grade_2_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1080	GSM411396	2156	107	258	73861	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA			pcr_yes	pre_treatment			NA				her2_negative		grade_3_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1081	GSM411397	2157	108	259	73862	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA			pcr_yes	pre_treatment			NA				her2_negative		grade_3_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1082	GSM411398	2158	109	260	73863	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA			pcr_yes	pre_treatment			NA				her2_negative		grade_3_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1083	GSM411399	2159	110	261	73864	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA				pre_treatment			NA				her2_negative		grade_3_brca			NA	GPL570_GSE16446	GEO	drug_epirubicin
1084	GSM411400	2160	111	262	73865	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA			pcr_yes	pre_treatment			NA				her2_negative		grade_3_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1085	GSM411401	2161	112	263	73866	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA			pcr_yes	pre_treatment			NA				her2_negative		grade_3_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1086	GSM411402	2162	113	264	73867	1680	4	GPL570	GSE16446	NA	NA				grade_2_brca	NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive		grade_2_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1087	GSM411403	2163	114	265	73868	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive		grade_3_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1088	GSM411404	2164	115	266	73869	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive		grade_3_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1089	GSM411405	2165	116	267	73870	1680	4	GPL570	GSE16446	NA	NA					NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive				pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1090	GSM411406	2166	117	268	73871	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive		grade_3_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1091	GSM411407	2167	118	269	73872	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA		NA						NA			pcr_yes	pre_treatment			NA	her2_positive			her2_positive		grade_3_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1092	GSM411408	2168	119	270	73873	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA			pcr_yes	pre_treatment			NA				her2_negative		grade_3_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1093	GSM411409	2169	120	271	73874	1680	4	GPL570	GSE16446	NA	NA			grade_3_brca		NA	NA	her2_negative	NA						NA			pcr_yes	pre_treatment			NA				her2_negative		grade_3_brca		pcr_yes	1	GPL570_GSE16446	GEO	drug_epirubicin
1094	GSM465183	1	1	152	92559	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine					pr_negative							pcr_yes					her2_positive		er_pos	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1095	GSM465184	2	2	153	92560	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine					pr_negative							pcr_yes	pre_treatment				her2_positive		er_pos	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1096	GSM465185	3	3	154	92561	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine					pr_negative							pcr_yes					her2_positive		er_pos	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1097	GSM465186	4	4	155	92562	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative			pr_negative								pre_treatment					pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1098	GSM465187	5	5	156	92563	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine					pr_negative												her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1099	GSM465188	6	6	157	92564	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative									pr_positive	pcr_yes							er_pos	her2_negative	pr_positive			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1100	GSM465189	7	7	158	92565	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative									pr_positive	pcr_yes							er_pos	her2_negative	pr_positive			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1101	GSM465190	8	8	159	92566	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative									pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1102	GSM465191	9	9	160	92567	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative			pr_negative								pre_treatment					pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1103	GSM465192	10	10	161	92568	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative			pr_negative													pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1104	GSM465193	11	11	162	92569	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative													pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1105	GSM465194	12	12	163	92570	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1106	GSM465195	13	13	164	92571	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative													pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1107	GSM465196	14	14	165	92572	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative									pr_positive							pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1108	GSM465197	15	15	166	92573	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine											pr_positive						her2_positive	pcr_no	er_neg	her2_positive	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1109	GSM465198	16	16	167	92574	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative										pcr_yes	pre_treatment						er_pos	her2_negative				pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1110	GSM465199	17	17	168	92575	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative										pcr_yes							er_pos	her2_negative				pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1111	GSM465200	18	18	169	92576	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative									pr_positive							pcr_no	er_neg	her2_negative	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1112	GSM465201	19	19	170	92577	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative									pr_positive		pre_treatment					pcr_no	er_neg	her2_negative	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1113	GSM465202	20	20	171	92578	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative									pr_positive							pcr_no	er_neg	her2_negative	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1114	GSM465203	21	21	172	92579	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine					pr_negative							pcr_yes	pre_treatment				her2_positive		er_pos	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1115	GSM465204	22	22	173	92580	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine					pr_negative							pcr_yes					her2_positive		er_pos	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1116	GSM465205	23	23	174	92581	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine											pr_positive						her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1117	GSM465206	24	24	175	92582	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine					pr_negative								pre_treatment				her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1118	GSM465207	25	25	176	92583	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine					pr_negative												her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1119	GSM465208	26	26	177	92584	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative													pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1120	GSM465209	27	27	178	92585	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1121	GSM465210	28	28	179	92586	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1122	GSM465211	29	29	180	92587	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative													pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1123	GSM465212	30	30	181	92588	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative													pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1124	GSM465213	31	31	182	92589	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative							pcr_yes							er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1125	GSM465214	32	32	183	92590	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative							pcr_yes							er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1126	GSM465215	33	33	184	92591	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative							pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1127	GSM465216	34	34	185	92592	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1128	GSM465217	35	35	186	92593	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative													pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1129	GSM465218	36	36	187	92594	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative													pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1130	GSM465219	37	37	188	92595	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative													pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1131	GSM465220	38	38	189	92596	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative													pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1132	GSM465221	39	39	190	92597	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1133	GSM465222	40	40	191	92598	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative										pcr_yes							er_pos	her2_negative				pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1134	GSM465223	41	41	192	92599	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative							pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1135	GSM465224	42	42	193	92600	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine					pr_negative							pcr_yes					her2_positive		er_pos	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1136	GSM465225	43	43	194	92601	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine					pr_negative							pcr_yes					her2_positive		er_pos	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1137	GSM465226	44	44	195	92602	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative									pr_positive							pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1138	GSM465227	45	45	196	92603	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative									pr_positive							pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1139	GSM465228	46	46	197	92604	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1140	GSM465229	47	47	198	92605	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative													pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1141	GSM465230	48	48	199	92606	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative									pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1142	GSM465231	49	49	200	92607	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative									pr_positive	pcr_yes							er_pos	her2_negative	pr_positive			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1143	GSM465232	50	50	201	92608	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative									pr_positive							pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1144	GSM465233	51	51	202	92609	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative									pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1145	GSM465234	52	52	203	92610	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative									pr_positive							pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1146	GSM465235	53	53	204	92611	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine					pr_negative							pcr_yes	pre_treatment				her2_positive		er_pos	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1147	GSM465236	54	54	205	92612	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine											pr_positive	pcr_yes					her2_positive		er_pos	her2_positive	pr_positive			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1148	GSM465237	55	55	206	92613	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative									pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1149	GSM465238	56	56	207	92614	2268	4	GPL570	GSE18728		NA	er_pos				drug_capecitabine		her2_negative									pr_positive							pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1150	GSM465239	57	57	208	92615	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine											pr_positive						her2_positive	pcr_no	er_neg	her2_positive	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1151	GSM465240	58	58	209	92616	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine											pr_positive		pre_treatment				her2_positive	pcr_no	er_neg	her2_positive	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1152	GSM465241	59	59	210	92617	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine											pr_positive						her2_positive	pcr_no	er_neg	her2_positive	pr_positive			pcr_no	2	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1153	GSM465242	60	60	211	92618	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative							pcr_yes							er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1154	GSM465243	61	61	212	92619	2268	4	GPL570	GSE18728		NA		er_neg			drug_capecitabine		her2_negative			pr_negative							pcr_yes							er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE18728	GEO	drug_docetaxel;drug_capecitabine
1155	GSM467523	62	62	213	93330	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1156	GSM467524	63	63	214	93331	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1157	GSM467525	64	64	215	93332	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE18864	GEO	drug_cisplatin
1158	GSM467526	65	65	216	93333	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1159	GSM467527	66	66	217	93334	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE18864	GEO	drug_cisplatin
1160	GSM467528	67	67	218	93335	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1161	GSM467529	68	68	219	93336	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1162	GSM467530	69	69	220	93337	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1163	GSM467531	70	70	221	93338	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1164	GSM467532	71	71	222	93339	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1165	GSM467533	72	72	223	93340	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1166	GSM467534	73	73	224	93341	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1167	GSM467535	74	74	225	93342	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1168	GSM467536	75	75	226	93343	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1169	GSM467537	76	76	227	93344	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE18864	GEO	drug_cisplatin
1170	GSM467538	77	77	228	93345	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1171	GSM467539	78	78	229	93346	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1172	GSM467540	79	79	230	93347	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1173	GSM467541	80	80	231	93348	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1174	GSM467542	81	81	232	93349	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1175	GSM467543	82	82	233	93350	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1176	GSM467544	83	83	234	93351	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1177	GSM467545	84	84	235	93352	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE18864	GEO	drug_cisplatin
1178	GSM467546	85	85	236	93353	2297	4	GPL570	GSE18864	drug_cisplatin	NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE18864	GEO	drug_cisplatin
1179	GSM491610	86	86	297	101170	2500	4	GPL570	GSE19697		NA		er_neg								pr_negative			stage_t2				pcr_yes	pre_treatment				her2_positive		er_neg	her2_positive	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1180	GSM491611	87	87	298	101171	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative		stage_t2	pcr_no	2	GPL570_GSE19697	GEO	NA
1181	GSM491612	88	88	299	101172	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative		stage_t2	pcr_no	2	GPL570_GSE19697	GEO	NA
1182	GSM491613	89	89	300	101173	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1183	GSM491614	90	90	301	101174	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative		stage_t3					pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t3	pcr_yes	1	GPL570_GSE19697	GEO	NA
1184	GSM491615	91	91	302	101175	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1185	GSM491616	92	92	303	101176	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1186	GSM491617	93	93	304	101177	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1187	GSM491618	94	94	305	101178	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1188	GSM491619	95	95	306	101179	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative		stage_t2	pcr_no	2	GPL570_GSE19697	GEO	NA
1189	GSM491620	96	96	307	101180	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative	stage_t1						pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t1	pcr_yes	1	GPL570_GSE19697	GEO	NA
1190	GSM491621	97	97	308	101181	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1191	GSM491622	98	98	309	101182	2500	4	GPL570	GSE19697		NA		er_neg								pr_negative			stage_t2					pre_treatment				her2_positive	pcr_no	er_neg	her2_positive	pr_negative		stage_t2	pcr_no	2	GPL570_GSE19697	GEO	NA
1192	GSM491623	99	99	310	101183	2500	4	GPL570	GSE19697		NA	er_pos						her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1193	GSM491624	100	100	311	101184	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL570_GSE19697	GEO	NA
1194	GSM491625	101	101	312	101185	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1195	GSM491626	102	102	313	101186	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL570_GSE19697	GEO	NA
1196	GSM491627	103	103	314	101187	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1197	GSM491628	104	104	315	101188	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1198	GSM491629	105	105	316	101189	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1199	GSM491630	106	106	317	101190	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1200	GSM491631	107	107	318	101191	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1201	GSM491632	108	108	319	101192	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1202	GSM491633	109	109	320	101193	2500	4	GPL570	GSE19697		NA		er_neg					her2_negative			pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL570_GSE19697	GEO	NA
1203	GSM505327	2170	121	441	107989	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1204	GSM505328	2171	122	442	107990	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1205	GSM505329	2172	123	443	107991	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1206	GSM505330	2173	124	444	107992	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1207	GSM505331	2174	125	445	107993	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1208	GSM505333	2175	126	446	107994	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1209	GSM505334	2176	127	447	107995	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1210	GSM505335	2177	128	448	107996	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1211	GSM505336	2178	129	449	107997	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA						NA		pr_positive	pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_positive			pcr_yes	1	GPL96_GSE20194	GEO	NA
1212	GSM505337	2179	130	450	107998	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1213	GSM505338	2180	131	451	107999	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1214	GSM505339	2181	132	452	108000	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_pos	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1215	GSM505340	2182	133	453	108001	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1216	GSM505341	2183	134	454	108002	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA						NA		pr_positive	pcr_yes	pre_treatment	tfac		NA	her2_positive		er_neg	her2_positive	pr_positive			pcr_yes	1	GPL96_GSE20194	GEO	NA
1217	GSM505342	2184	135	455	108003	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1218	GSM505343	2185	136	456	108004	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1219	GSM505344	2186	137	457	108005	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1220	GSM505345	2187	138	458	108006	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1221	GSM505346	2188	139	459	108007	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1222	GSM505347	2189	140	460	108008	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1223	GSM505348	2190	141	461	108009	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1224	GSM505349	2191	142	462	108010	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1225	GSM505350	2192	143	463	108011	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1226	GSM505351	2193	144	464	108012	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1227	GSM505352	2194	145	465	108013	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1228	GSM505353	2195	146	466	108014	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1229	GSM505354	2196	147	467	108015	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1230	GSM505355	2197	148	468	108016	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1231	GSM505356	2198	149	469	108017	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1232	GSM505357	2199	150	470	108018	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1233	GSM505358	2200	151	471	108019	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA						NA		pr_positive	pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_positive			pcr_yes	1	GPL96_GSE20194	GEO	NA
1234	GSM505359	2201	152	472	108020	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1235	GSM505360	2202	153	473	108021	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1236	GSM505361	2203	154	474	108022	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1237	GSM505362	2204	155	475	108023	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1238	GSM505363	2205	156	476	108024	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1239	GSM505364	2206	157	477	108025	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1240	GSM505365	2207	158	478	108026	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1241	GSM505366	2208	159	479	108027	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1242	GSM505367	2209	160	480	108028	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1243	GSM505368	2210	161	481	108029	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_pos	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1244	GSM505369	2211	162	482	108030	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1245	GSM505370	2212	163	483	108031	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1246	GSM505371	2213	164	484	108032	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1247	GSM505372	2214	165	485	108033	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1248	GSM505373	2215	166	486	108034	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1249	GSM505374	2216	167	487	108035	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1250	GSM505375	2217	168	488	108036	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1251	GSM505376	2218	169	489	108037	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1252	GSM505377	2219	170	490	108038	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1253	GSM505378	2220	171	491	108039	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1254	GSM505379	2221	172	492	108040	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1255	GSM505380	2222	173	493	108041	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	fac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1256	GSM505381	2223	174	494	108042	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	fac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1257	GSM505382	2224	175	495	108043	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1258	GSM505383	2225	176	496	108044	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1259	GSM505384	2226	177	497	108045	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1260	GSM505385	2227	178	498	108046	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1261	GSM505386	2228	179	499	108047	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1262	GSM505387	2229	180	500	108048	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1263	GSM505388	2230	181	501	108049	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1264	GSM505389	2231	182	502	108050	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1265	GSM505390	2232	183	503	108051	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive	pcr_yes	pre_treatment	tfac		NA	her2_positive		er_pos	her2_positive	pr_positive			pcr_yes	1	GPL96_GSE20194	GEO	NA
1266	GSM505391	2233	184	504	108052	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive	pcr_yes	pre_treatment	tfac		NA	her2_positive		er_pos	her2_positive	pr_positive			pcr_yes	1	GPL96_GSE20194	GEO	NA
1267	GSM505392	2234	185	505	108053	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1268	GSM505393	2235	186	506	108054	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1269	GSM505394	2236	187	507	108055	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment	fac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1270	GSM505395	2237	188	508	108056	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment	fac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1271	GSM505396	2238	189	509	108057	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1272	GSM505397	2239	190	510	108058	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1273	GSM505398	2240	191	511	108059	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1274	GSM505399	2241	192	512	108060	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1275	GSM505400	2242	193	513	108061	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1276	GSM505401	2243	194	514	108062	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1277	GSM505402	2244	195	515	108063	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1278	GSM505403	2245	196	516	108064	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1279	GSM505404	2246	197	517	108065	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1280	GSM505405	2247	198	518	108066	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1281	GSM505406	2248	199	519	108067	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1282	GSM505407	2249	200	520	108068	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1283	GSM505408	2250	201	521	108069	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1284	GSM505409	2251	202	522	108070	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1285	GSM505410	2252	203	523	108071	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1286	GSM505411	2253	204	524	108072	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1287	GSM505412	2254	205	525	108073	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1288	GSM505413	2255	206	526	108074	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1289	GSM505414	2256	207	527	108075	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1290	GSM505415	2257	208	528	108076	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1291	GSM505416	2258	209	529	108077	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1292	GSM505417	2259	210	530	108078	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1293	GSM505418	2260	211	531	108079	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1294	GSM505419	2261	212	532	108080	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1295	GSM505420	2262	213	533	108081	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1296	GSM505421	2263	214	534	108082	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1297	GSM505422	2264	215	535	108083	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1298	GSM505423	2265	216	536	108084	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1299	GSM505424	2266	217	537	108085	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1300	GSM505425	2267	218	538	108086	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA						NA		pr_positive		pre_treatment	tfac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1301	GSM505426	2268	219	539	108087	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1302	GSM505427	2269	220	540	108088	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1303	GSM505428	2270	221	541	108089	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1304	GSM505429	2271	222	542	108090	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1305	GSM505430	2272	223	543	108091	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1306	GSM505431	2273	224	544	108092	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1307	GSM505432	2274	225	545	108093	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1308	GSM505433	2275	226	546	108094	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1309	GSM505434	2276	227	547	108095	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	fec		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1310	GSM505435	2277	228	548	108096	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1311	GSM505436	2278	229	549	108097	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive	pcr_yes	pre_treatment	tfac		NA			er_pos	her2_negative	pr_positive			pcr_yes	1	GPL96_GSE20194	GEO	NA
1312	GSM505437	2279	230	550	108098	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	fac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1313	GSM505438	2280	231	551	108099	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1314	GSM505439	2281	232	552	108100	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1315	GSM505440	2282	233	553	108101	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1316	GSM505441	2283	234	554	108102	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1317	GSM505442	2284	235	555	108103	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1318	GSM505443	2285	236	556	108104	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1319	GSM505444	2286	237	557	108105	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1320	GSM505445	2287	238	558	108106	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	fec		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1321	GSM505446	2288	239	559	108107	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1322	GSM505447	2289	240	560	108108	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	fac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1323	GSM505448	2290	241	561	108109	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1324	GSM505449	2291	242	562	108110	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive	pcr_yes	pre_treatment	tfac		NA			er_pos	her2_negative	pr_positive			pcr_yes	1	GPL96_GSE20194	GEO	NA
1325	GSM505450	2292	243	563	108111	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1326	GSM505451	2293	244	564	108112	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1327	GSM505452	2294	245	565	108113	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1328	GSM505453	2295	246	566	108114	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1329	GSM505454	2296	247	567	108115	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1330	GSM505455	2297	248	568	108116	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_pos	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1331	GSM505456	2298	249	569	108117	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1332	GSM505457	2299	250	570	108118	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1333	GSM505458	2300	251	571	108119	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1334	GSM505459	2301	252	572	108120	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1335	GSM505460	2302	253	573	108121	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1336	GSM505461	2303	254	574	108122	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1337	GSM505462	2304	255	575	108123	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1338	GSM505463	2305	256	576	108124	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA	her2_positive		er_pos	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1339	GSM505464	2306	257	577	108125	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1340	GSM505465	2307	258	578	108126	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1341	GSM505466	2308	259	579	108127	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1342	GSM505467	2309	260	580	108128	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1343	GSM505468	2310	261	581	108129	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1344	GSM505469	2311	262	582	108130	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1345	GSM505470	2312	263	583	108131	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1346	GSM505471	2313	264	584	108132	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1347	GSM505472	2314	265	585	108133	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1348	GSM505473	2315	266	586	108134	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1349	GSM505474	2316	267	587	108135	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1350	GSM505475	2317	268	588	108136	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1351	GSM505476	2318	269	589	108137	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1352	GSM505477	2319	270	590	108138	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1353	GSM505478	2320	271	591	108139	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1354	GSM505479	2321	272	592	108140	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1355	GSM505480	2322	273	593	108141	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1356	GSM505481	2323	274	594	108142	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1357	GSM505482	2324	275	595	108143	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment	tfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1358	GSM505483	2325	276	596	108144	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1359	GSM505484	2326	277	597	108145	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1360	GSM505485	2327	278	598	108146	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1361	GSM505486	2328	279	599	108147	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1362	GSM505487	2329	280	600	108148	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1363	GSM505488	2330	281	601	108149	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1364	GSM505489	2331	282	602	108150	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1365	GSM505490	2332	283	603	108151	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1366	GSM505491	2333	284	604	108152	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fec		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1367	GSM505492	2334	285	605	108153	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	txfac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1368	GSM505493	2335	286	606	108154	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1369	GSM505494	2336	287	607	108155	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment	txfac		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1370	GSM505495	2337	288	608	108156	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	txfac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1371	GSM505496	2338	289	609	108157	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	txfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1372	GSM505497	2339	290	610	108158	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	txfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1373	GSM505498	2340	291	611	108159	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	txfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1374	GSM505499	2341	292	612	108160	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	txfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1375	GSM505500	2342	293	613	108161	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1376	GSM505501	2343	294	614	108162	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	txfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1377	GSM505502	2344	295	615	108163	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	txfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1378	GSM505503	2345	296	616	108164	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1379	GSM505504	2346	297	617	108165	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	tfac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1380	GSM505505	2347	298	618	108166	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA						NA		pr_positive		pre_treatment	tfac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1381	GSM505506	2348	299	619	108167	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1382	GSM505507	2349	300	620	108168	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	fac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1383	GSM505508	2350	301	621	108169	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1384	GSM505509	2351	302	622	108170	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1385	GSM505510	2352	303	623	108171	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1386	GSM505511	2353	304	624	108172	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	fac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1387	GSM505512	2354	305	625	108173	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1388	GSM505513	2355	306	626	108174	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1389	GSM505514	2356	307	627	108175	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1390	GSM505515	2357	308	628	108176	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1391	GSM505516	2358	309	629	108177	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1392	GSM505517	2359	310	630	108178	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1393	GSM505518	2360	311	631	108179	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1394	GSM505519	2361	312	632	108180	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1395	GSM505520	2362	313	633	108181	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1396	GSM505521	2363	314	634	108182	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	fac		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1397	GSM505522	2364	315	635	108183	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment	fec		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1398	GSM505523	2365	316	636	108184	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1399	GSM505524	2366	317	637	108185	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1400	GSM505525	2367	318	638	108186	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1401	GSM505526	2368	319	639	108187	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1402	GSM505527	2369	320	640	108188	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1403	GSM505528	2370	321	641	108189	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1404	GSM505529	2371	322	642	108190	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1405	GSM505530	2372	323	643	108191	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1406	GSM505531	2373	324	644	108192	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	fec		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1407	GSM505532	2374	325	645	108193	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1408	GSM505533	2375	326	646	108194	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fec		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1409	GSM505534	2376	327	647	108195	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1410	GSM505535	2377	328	648	108196	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1411	GSM505536	2378	329	649	108197	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1412	GSM505537	2379	330	650	108198	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1413	GSM505538	2380	331	651	108199	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1414	GSM505539	2381	332	652	108200	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac	drug_anastrozole	NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	tfac;tfac;tfac;tfac;drug_anastrozole
1415	GSM505540	2382	333	653	108201	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1416	GSM505541	2383	334	654	108202	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1417	GSM505542	2384	335	655	108203	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1418	GSM505543	2385	336	656	108204	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1419	GSM505544	2386	337	657	108205	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1420	GSM505545	2387	338	658	108206	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	fac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1421	GSM505546	2388	339	659	108207	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	fac		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1422	GSM505547	2389	340	660	108208	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1423	GSM505548	2390	341	661	108209	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1424	GSM505549	2391	342	662	108210	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1425	GSM505550	2392	343	663	108211	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1426	GSM505551	2393	344	664	108212	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1427	GSM505552	2394	345	665	108213	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1428	GSM505553	2395	346	666	108214	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fec		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1429	GSM505554	2396	347	667	108215	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1430	GSM505555	2397	348	668	108216	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	fec		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1431	GSM505556	2398	349	669	108217	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1432	GSM505557	2399	350	670	108218	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1433	GSM505558	2400	351	671	108219	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1434	GSM505559	2401	352	672	108220	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive	pcr_yes	pre_treatment	tfac		NA			er_pos	her2_negative	pr_positive			pcr_yes	1	GPL96_GSE20194	GEO	NA
1435	GSM505560	2402	353	673	108221	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1436	GSM505561	2403	354	674	108222	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1437	GSM505562	2404	355	675	108223	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1438	GSM505563	2405	356	676	108224	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1439	GSM505564	2406	357	677	108225	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1440	GSM505565	2407	358	678	108226	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1441	GSM505566	2408	359	679	108227	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1442	GSM505567	2409	360	680	108228	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1443	GSM505568	2410	361	681	108229	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1444	GSM505569	2411	362	682	108230	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1445	GSM505570	2412	363	683	108231	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fec		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1446	GSM505571	2413	364	684	108232	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1447	GSM505572	2414	365	685	108233	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fec		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1448	GSM505573	2415	366	686	108234	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1449	GSM505574	2416	367	687	108235	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1450	GSM505575	2417	368	688	108236	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fec		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1451	GSM505576	2418	369	689	108237	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1452	GSM505577	2419	370	690	108238	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_neg	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1453	GSM505578	2420	371	691	108239	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1454	GSM505579	2421	372	692	108240	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1455	GSM505580	2422	373	693	108241	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	fec		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1456	GSM505581	2423	374	694	108242	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1457	GSM505582	2424	375	695	108243	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1458	GSM505583	2425	376	696	108244	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1459	GSM505584	2426	377	697	108245	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	tfac		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20194	GEO	NA
1460	GSM505585	2427	378	698	108246	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1461	GSM505586	2428	379	699	108247	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1462	GSM505587	2429	380	700	108248	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1463	GSM505588	2430	381	701	108249	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fec		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1464	GSM505589	2431	382	702	108250	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1465	GSM505590	2432	383	703	108251	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1466	GSM505591	2433	384	704	108252	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1467	GSM505592	2434	385	705	108253	2639	2	GPL96	GSE20194	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fec		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1468	GSM505593	2435	386	706	108254	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1469	GSM505594	2436	387	707	108255	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1470	GSM505595	2437	388	708	108256	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1471	GSM505596	2438	389	709	108257	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1472	GSM505597	2439	390	710	108258	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1473	GSM505598	2440	391	711	108259	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive	pcr_yes	pre_treatment	tfac		NA			er_pos	her2_negative	pr_positive			pcr_yes	1	GPL96_GSE20194	GEO	NA
1474	GSM505599	2441	392	712	108260	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1475	GSM505600	2442	393	713	108261	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1476	GSM505601	2443	394	714	108262	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1477	GSM505602	2444	395	715	108263	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1478	GSM505603	2445	396	716	108264	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1479	GSM505604	2446	397	717	108265	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	fec		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20194	GEO	NA
1480	GSM505605	2447	398	718	108266	2639	2	GPL96	GSE20194	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	tfac		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20194	GEO	NA
1481	GSM508011	204	204	609	128950	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca												pr_positive	pcr_yes		drug_cyclophosphamide					er_pos		pr_positive	grade_2_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1482	GSM508012	2448	399	719	109187	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_chemo
1483	GSM508013	2449	400	720	109188	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1484	GSM508014	2450	401	721	109189	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1485	GSM508015	2451	402	722	109190	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1486	GSM508016	2452	403	723	109191	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1487	GSM508017	2453	404	724	109192	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1488	GSM508018	2454	405	725	109193	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1489	GSM508019	2455	406	726	109194	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1490	GSM508020	2456	407	727	109195	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1491	GSM508021	2457	408	728	109196	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1492	GSM508022	2458	409	729	109197	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1493	GSM508023	2459	410	730	109198	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1494	GSM508024	2460	411	731	109199	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1495	GSM508025	2461	412	732	109200	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1496	GSM508026	2462	413	733	109201	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1497	GSM508027	2463	414	734	109202	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1498	GSM508028	2464	415	735	109203	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1499	GSM508029	2465	416	736	109204	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1500	GSM508030	2466	417	737	109205	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1501	GSM508031	2467	418	738	109206	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1502	GSM508032	2468	419	739	109207	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1503	GSM508033	2469	420	740	109208	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1504	GSM508034	2470	421	741	109209	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1505	GSM508035	2471	422	742	109210	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	drug_cyclophosphamide		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1506	GSM508036	2472	423	743	109211	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	drug_cyclophosphamide		NA			er_pos	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1507	GSM508037	2473	424	744	109212	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide		NA			er_pos	her2_negative	pr_positive			pcr_yes	1	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1508	GSM508038	2474	425	745	109213	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide		NA			er_pos	her2_negative	pr_positive			pcr_yes	1	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1509	GSM508039	2475	426	746	109214	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1510	GSM508040	2476	427	747	109215	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1511	GSM508041	2477	428	748	109216	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1512	GSM508042	2478	429	749	109217	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1513	GSM508043	2479	430	750	109218	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1514	GSM508044	2480	431	751	109219	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1515	GSM508045	2481	432	752	109220	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1516	GSM508046	2482	433	753	109221	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1517	GSM508047	2483	434	754	109222	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1518	GSM508048	2484	435	755	109223	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1519	GSM508049	2485	436	756	109224	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1520	GSM508050	2486	437	757	109225	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1521	GSM508051	2487	438	758	109226	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1522	GSM508052	2488	439	759	109227	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1523	GSM508053	2489	440	760	109228	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1524	GSM508054	2490	441	761	109229	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1525	GSM508055	2491	442	762	109230	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1526	GSM508056	2492	443	763	109231	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1527	GSM508057	2493	444	764	109232	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1528	GSM508058	2494	445	765	109233	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1529	GSM508059	2495	446	766	109234	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1530	GSM508060	2496	447	767	109235	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1531	GSM508061	2497	448	768	109236	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1532	GSM508062	2498	449	769	109237	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1533	GSM508063	2499	450	770	109238	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1534	GSM508064	2500	451	771	109239	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1535	GSM508065	2501	452	772	109240	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1536	GSM508066	2502	453	773	109241	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1537	GSM508067	2503	454	774	109242	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1538	GSM508068	2504	455	775	109243	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1539	GSM508069	2505	456	776	109244	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1540	GSM508070	2506	457	777	109245	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1541	GSM508071	2507	458	778	109246	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_chemo
1542	GSM508072	2508	459	779	109247	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1543	GSM508073	2509	460	780	109248	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1544	GSM508074	2510	461	781	109249	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1545	GSM508075	2511	462	782	109250	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1546	GSM508076	2512	463	783	109251	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1547	GSM508077	2513	464	784	109252	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1548	GSM508078	2514	465	785	109253	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1549	GSM508079	2515	466	786	109254	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1550	GSM508080	2516	467	787	109255	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1551	GSM508081	2517	468	788	109256	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1552	GSM508082	2518	469	789	109257	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1553	GSM508083	2519	470	790	109258	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1554	GSM508084	2520	471	791	109259	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1555	GSM508085	2521	472	792	109260	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1556	GSM508086	2522	473	793	109261	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1557	GSM508087	2523	474	794	109262	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	drug_cyclophosphamide		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1558	GSM508088	2524	475	795	109263	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1559	GSM508089	2525	476	796	109264	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1560	GSM508090	2526	477	797	109265	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1561	GSM508091	2527	478	798	109266	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1562	GSM508092	2528	479	799	109267	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1563	GSM508093	2529	480	800	109268	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1564	GSM508094	2530	481	801	109269	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1565	GSM508095	2531	482	802	109270	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1566	GSM508096	2532	483	803	109271	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1567	GSM508097	2533	484	804	109272	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1568	GSM508098	2534	485	805	109273	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_chemo
1569	GSM508099	2535	486	806	109274	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment			NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1570	GSM508100	2536	487	807	109275	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1571	GSM508101	2537	488	808	109276	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1572	GSM508102	2538	489	809	109277	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1573	GSM508103	2539	490	810	109278	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1574	GSM508104	2540	491	811	109279	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1575	GSM508105	2541	492	812	109280	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1576	GSM508106	2542	493	813	109281	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1577	GSM508107	2543	494	814	109282	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1578	GSM508108	2544	495	815	109283	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1579	GSM508109	2545	496	816	109284	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1580	GSM508110	2546	497	817	109285	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1581	GSM508111	2547	498	818	109286	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1582	GSM508112	2548	499	819	109287	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1583	GSM508113	2549	500	820	109288	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1584	GSM508114	2550	501	821	109289	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment			NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1585	GSM508115	2551	502	822	109290	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	drug_cyclophosphamide		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1586	GSM508116	2552	503	823	109291	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	drug_cyclophosphamide		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1587	GSM508117	2553	504	824	109292	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1588	GSM508118	2554	505	825	109293	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1589	GSM508119	2555	506	826	109294	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1590	GSM508120	2556	507	827	109295	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1591	GSM508121	2557	508	828	109296	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1592	GSM508122	2558	509	829	109297	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1593	GSM508123	2559	510	830	109298	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1594	GSM508124	2560	511	831	109299	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1595	GSM508125	2561	512	832	109300	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1596	GSM508126	2562	513	833	109301	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA		NA						NA		pr_positive		pre_treatment			NA	her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1597	GSM508127	2563	514	834	109302	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1598	GSM508128	2564	515	835	109303	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1599	GSM508129	2565	516	836	109304	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1600	GSM508130	2566	517	837	109305	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1601	GSM508131	2567	518	838	109306	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel
1602	GSM508132	2568	519	839	109307	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1603	GSM508133	2569	520	840	109308	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1604	GSM508134	2570	521	841	109309	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1605	GSM508135	2571	522	842	109310	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA		NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA	her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1606	GSM508136	2572	523	843	109311	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1607	GSM508137	2573	524	844	109312	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	drug_cyclophosphamide		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1608	GSM508138	2574	525	845	109313	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	drug_cyclophosphamide		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1609	GSM508139	2575	526	846	109314	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1610	GSM508140	2576	527	847	109315	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1611	GSM508141	2577	528	848	109316	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1612	GSM508142	2578	529	849	109317	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1613	GSM508143	2579	530	850	109318	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1614	GSM508144	2580	531	851	109319	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1615	GSM508145	2581	532	852	109320	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1616	GSM508146	2582	533	853	109321	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1617	GSM508147	2583	534	854	109322	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1618	GSM508148	2584	535	855	109323	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1619	GSM508149	2585	536	856	109324	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide		NA			er_pos	her2_negative	pr_positive			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1620	GSM508150	2586	537	857	109325	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1621	GSM508151	2587	538	858	109326	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment			NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1622	GSM508152	2588	539	859	109327	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1623	GSM508153	2589	540	860	109328	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1624	GSM508154	2590	541	861	109329	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1625	GSM508155	2591	542	862	109330	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1626	GSM508156	2592	543	863	109331	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1627	GSM508157	2593	544	864	109332	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1628	GSM508158	2594	545	865	109333	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1629	GSM508159	2595	546	866	109334	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1630	GSM508160	2596	547	867	109335	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel
1631	GSM508161	2597	548	868	109336	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel
1632	GSM508162	2598	549	869	109337	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1633	GSM508163	2599	550	870	109338	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1634	GSM508164	2600	551	871	109339	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA		NA						NA		pr_positive	pcr_yes	pre_treatment			NA	her2_positive		er_pos	her2_positive	pr_positive			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1635	GSM508165	2601	552	872	109340	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment			NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1636	GSM508166	2602	553	873	109341	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1637	GSM508167	2603	554	874	109342	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1638	GSM508168	2604	555	875	109343	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1639	GSM508169	2605	556	876	109344	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1640	GSM508170	2606	557	877	109345	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1641	GSM508171	2607	558	878	109346	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA		NA		pr_negative				NA			pcr_yes	pre_treatment	drug_cyclophosphamide		NA	her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1642	GSM508172	2608	559	879	109347	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1643	GSM508173	2609	560	880	109348	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	drug_cyclophosphamide		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1644	GSM508174	2610	561	881	109349	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1645	GSM508175	2611	562	882	109350	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1646	GSM508176	2612	563	883	109351	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1647	GSM508177	2613	564	884	109352	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1648	GSM508178	2614	565	885	109353	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1649	GSM508179	2615	566	886	109354	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment	drug_cyclophosphamide		NA			er_neg	her2_negative	pr_negative			pcr_yes	1	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1650	GSM508180	2616	567	887	109355	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1651	GSM508181	2617	568	888	109356	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1652	GSM508182	2618	569	889	109357	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1653	GSM508183	2619	570	890	109358	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_neg	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1654	GSM508184	2620	571	891	109359	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1655	GSM508185	2621	572	892	109360	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1656	GSM508186	2622	573	893	109361	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1657	GSM508187	2623	574	894	109362	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1658	GSM508188	2624	575	895	109363	2654	2	GPL96	GSE20271	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_chemo
1659	GSM508189	2625	576	896	109364	2654	2	GPL96	GSE20271	NA	NA	er_pos				NA	NA	her2_negative	NA						NA		pr_positive		pre_treatment	drug_cyclophosphamide		NA		pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL96_GSE20271	GEO	drug_paclitaxel;drug_adriamycin;drug_fluorouracil;drug_cyclophosphamide
1660	GSM508190	205	205	610	128951	3135	26	GPL1708	GSE22226		NA		er_neg		grade_2_brca			her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1661	GSM508191	206	206	611	128952	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca													pr_positive			drug_cyclophosphamide				pcr_no	er_neg		pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1662	GSM508192	207	207	612	128953	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_cyclophosphamide
1663	GSM508193	208	208	613	128954	3135	26	GPL1708	GSE22226		NA			grade_3_brca														pcr_yes		drug_cyclophosphamide								grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1664	GSM508194	209	209	614	128955	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1665	GSM508195	210	210	615	128956	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1666	GSM508196	211	211	616	128957	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1667	GSM508197	212	212	617	128958	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca				her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1668	GSM508198	213	213	618	128959	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca							pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_herceptin;drug_cyclophosphamide
1669	GSM508199	214	214	619	128960	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca							pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1670	GSM508200	215	215	620	128961	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1671	GSM508201	216	216	621	128962	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1672	GSM508202	217	217	622	128963	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative							pcr_yes		drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1673	GSM508203	218	218	623	128964	3135	26	GPL1708	GSE22226		NA		er_neg		grade_2_brca						pr_negative									drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1674	GSM508204	219	219	624	128965	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca												pr_positive	pcr_yes		drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive	grade_2_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1675	GSM508205	220	220	625	128966	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca							pr_negative									drug_cyclophosphamide				pcr_no	er_pos		pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1676	GSM508206	221	221	626	128967	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca							pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1677	GSM508207	222	222	627	128968	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1678	GSM508208	223	223	628	128969	3135	26	GPL1708	GSE22226		NA				grade_2_brca															drug_cyclophosphamide				pcr_no				grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1679	GSM508209	224	224	629	128970	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca				her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1680	GSM508210	225	225	630	128971	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1681	GSM508211	226	226	631	128972	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca				her2_negative			pr_negative							pcr_yes		drug_cyclophosphamide					er_pos	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1682	GSM508212	227	227	632	128973	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca				her2_negative			pr_negative							pcr_yes		drug_cyclophosphamide					er_pos	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1683	GSM508213	228	228	633	128974	3135	26	GPL1708	GSE22226		NA		er_neg		grade_2_brca			her2_negative			pr_negative							pcr_yes		drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_2_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1684	GSM508214	229	229	634	128975	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca							pr_negative									drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1685	GSM508215	230	230	635	128976	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca												pr_positive			drug_cyclophosphamide				pcr_no	er_pos		pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1686	GSM508216	231	231	636	128977	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca						pr_negative									drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1687	GSM508217	232	232	637	128978	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca						pr_negative									drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1688	GSM508218	233	233	638	128979	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca							pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1689	GSM508219	234	234	639	128980	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca							pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1690	GSM508220	235	235	640	128981	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca						pr_negative									drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1691	GSM508221	236	236	641	128982	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca				her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1692	GSM508222	237	237	642	128983	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca							pr_negative							pcr_yes		drug_cyclophosphamide					er_neg		pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1693	GSM508223	238	238	643	128984	3135	26	GPL1708	GSE22226		NA			grade_3_brca																drug_cyclophosphamide				pcr_no				grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1694	GSM508224	239	239	644	128985	3135	26	GPL1708	GSE22226		NA		er_neg		grade_2_brca						pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1695	GSM508225	240	240	645	128986	3135	26	GPL1708	GSE22226		NA	er_pos						her2_negative								grade_1_brca	pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1696	GSM508226	241	241	646	128987	3135	26	GPL1708	GSE22226		NA		er_neg		grade_2_brca						pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1697	GSM508227	242	242	647	128988	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca													pr_positive			drug_cyclophosphamide				pcr_no	er_neg		pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1698	GSM508228	243	243	648	128989	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1699	GSM508229	244	244	649	128990	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1700	GSM508230	245	245	650	128991	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1701	GSM508231	246	246	651	128992	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca													pr_positive			drug_cyclophosphamide				pcr_no	er_neg		pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1702	GSM508232	247	247	652	128993	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca													pr_positive			drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1703	GSM508233	248	248	653	128994	3135	26	GPL1708	GSE22226		NA	er_pos						her2_negative								grade_1_brca	pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1704	GSM508234	249	249	654	128995	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca							pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1705	GSM508235	250	250	655	128996	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca							pr_negative									drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1706	GSM508236	251	251	656	128997	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative										pcr_yes		drug_cyclophosphamide					er_neg	her2_negative		grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1707	GSM508237	252	252	657	128998	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca				her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1708	GSM508238	253	253	658	128999	3135	26	GPL1708	GSE22226		NA	er_pos						her2_negative								grade_1_brca	pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1709	GSM508239	254	254	659	129000	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca				her2_negative			pr_negative							pcr_yes		drug_cyclophosphamide					er_pos	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1710	GSM508240	255	255	660	129001	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca												pr_positive			drug_cyclophosphamide				pcr_no	er_pos		pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_cyclophosphamide
1711	GSM508241	256	256	661	129002	3135	26	GPL1708	GSE22226		NA				grade_2_brca			her2_negative												drug_cyclophosphamide				pcr_no		her2_negative		grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1712	GSM508242	257	257	662	129003	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1713	GSM508243	258	258	663	129004	3135	26	GPL1708	GSE22226		NA		er_neg		grade_2_brca						pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_herceptin;drug_cyclophosphamide
1714	GSM508244	259	259	664	129005	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative							pcr_yes		drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1715	GSM508245	260	260	665	129006	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca							pr_negative									drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_herceptin;drug_cyclophosphamide
1716	GSM508246	261	261	666	129007	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1717	GSM508247	262	262	667	129008	3135	26	GPL1708	GSE22226		NA		er_neg								pr_negative							pcr_yes		drug_cyclophosphamide					er_neg		pr_negative			pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1718	GSM508248	263	263	668	129009	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1719	GSM508249	264	264	669	129010	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative							pcr_yes		drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1720	GSM508250	265	265	670	129011	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1721	GSM508251	266	266	671	129012	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca				her2_negative									pr_positive			drug_cyclophosphamide					er_pos	her2_negative	pr_positive	grade_3_brca			NA	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1722	GSM508252	267	267	672	129013	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca												pr_positive	pcr_yes		drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive	grade_2_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_herceptin;drug_cyclophosphamide
1723	GSM508253	268	268	673	129014	3135	26	GPL1708	GSE22226		NA		er_neg		grade_2_brca			her2_negative			pr_negative							pcr_yes		drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_2_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1724	GSM508254	269	269	674	129015	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1725	GSM508255	270	270	675	129016	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca													pr_positive			drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_herceptin;drug_cyclophosphamide
1726	GSM508256	271	271	676	129017	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1727	GSM508257	272	272	677	129018	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1728	GSM508258	273	273	678	129019	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1729	GSM508259	274	274	679	129020	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca													pr_positive			drug_cyclophosphamide				pcr_no	er_pos		pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1730	GSM508260	275	275	680	129021	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca							pr_negative									drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1731	GSM508261	276	276	681	129022	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1732	GSM508262	277	277	682	129023	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1733	GSM508263	278	278	683	129024	3135	26	GPL1708	GSE22226		NA		er_neg		grade_2_brca						pr_negative									drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1734	GSM508264	279	279	684	129025	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_3_brca			NA	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1735	GSM508265	280	280	685	129026	3135	26	GPL1708	GSE22226		NA	er_pos						her2_negative								grade_1_brca	pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1736	GSM508266	281	281	686	129027	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_3_brca			NA	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1737	GSM508267	282	282	687	129028	3135	26	GPL1708	GSE22226		NA		er_neg		grade_2_brca						pr_negative									drug_cyclophosphamide				pcr_no	er_neg		pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1738	GSM508268	283	283	688	129029	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca				her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_cyclophosphamide
1739	GSM508269	284	284	689	129030	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca							pr_negative									drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1740	GSM508270	285	285	690	129031	3135	26	GPL1708	GSE22226		NA		er_neg		grade_2_brca			her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1741	GSM508271	286	286	691	129032	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca												pr_positive			drug_cyclophosphamide				pcr_no	er_pos		pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1742	GSM508272	287	287	692	129033	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca							pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_herceptin;drug_cyclophosphamide
1743	GSM508273	288	288	693	129034	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca													pr_positive			drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_herceptin;drug_cyclophosphamide
1744	GSM508274	289	289	694	129035	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1745	GSM508275	290	290	695	129036	3135	26	GPL1708	GSE22226		NA		er_neg								pr_negative					grade_1_brca				drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_1_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_herceptin;drug_cyclophosphamide
1746	GSM508276	291	291	696	129037	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1747	GSM508277	292	292	697	129038	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_cyclophosphamide
1748	GSM508278	293	293	698	129039	3135	26	GPL1708	GSE22226		NA		er_neg		grade_2_brca						pr_negative									drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1749	GSM508279	294	294	699	129040	3135	26	GPL1708	GSE22226		NA		er_neg		grade_2_brca			her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1750	GSM508280	295	295	700	129041	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca							pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_herceptin;drug_cyclophosphamide
1751	GSM508281	296	296	701	129042	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1752	GSM508282	297	297	702	129043	3135	26	GPL1708	GSE22226		NA		er_neg		grade_2_brca						pr_negative									drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_herceptin;drug_cyclophosphamide
1753	GSM508283	298	298	703	129044	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca				her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1754	GSM508284	299	299	704	129045	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative												drug_cyclophosphamide				pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1755	GSM508285	300	300	705	129046	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca				her2_negative									pr_positive	pcr_yes		drug_cyclophosphamide					er_pos	her2_negative	pr_positive	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1756	GSM508286	301	301	706	129047	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca							pr_negative									drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1757	GSM508287	302	302	707	129048	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca													pr_positive			drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_herceptin;drug_cyclophosphamide
1758	GSM508288	303	303	708	129049	3135	26	GPL1708	GSE22226		NA				grade_2_brca															drug_cyclophosphamide			her2_positive	pcr_no		her2_positive		grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1759	GSM508289	304	304	709	129050	3135	26	GPL1708	GSE22226		NA	er_pos						her2_negative								grade_1_brca	pr_positive			drug_cyclophosphamide					er_pos	her2_negative	pr_positive	grade_1_brca			NA	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1760	GSM508290	333	333	739	129080	3135	10	GPL4133	GSE22226		NA	er_pos		grade_3_brca				her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1761	GSM508297	334	334	740	129081	3135	10	GPL4133	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1762	GSM508298	335	335	741	129082	3135	10	GPL4133	GSE22226		NA	er_pos						her2_negative								grade_1_brca	pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1763	GSM508299	336	336	742	129083	3135	10	GPL4133	GSE22226		NA	er_pos						her2_negative								grade_1_brca	pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1764	GSM508300	337	337	743	129084	3135	10	GPL4133	GSE22226		NA	er_pos			grade_2_brca												pr_positive			drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_2_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_herceptin;drug_cyclophosphamide
1765	GSM508301	338	338	744	129085	3135	10	GPL4133	GSE22226		NA	er_pos			grade_2_brca			her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1766	GSM508302	339	339	745	129086	3135	10	GPL4133	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative							pcr_yes		drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1767	GSM508303	340	340	746	129087	3135	10	GPL4133	GSE22226		NA			grade_3_brca																drug_cyclophosphamide				pcr_no				grade_3_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1768	GSM508304	341	341	747	129088	3135	10	GPL4133	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1769	GSM508305	342	342	748	129089	3135	10	GPL4133	GSE22226		NA	er_pos		grade_3_brca				her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1770	GSM508306	343	343	749	129090	3135	10	GPL4133	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1771	GSM508307	344	344	750	129091	3135	10	GPL4133	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1772	GSM508308	345	345	751	129092	3135	10	GPL4133	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1773	GSM508309	346	346	752	129093	3135	10	GPL4133	GSE22226		NA		er_neg	grade_3_brca							pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_herceptin;drug_cyclophosphamide
1774	GSM508310	347	347	753	129094	3135	10	GPL4133	GSE22226		NA		er_neg		grade_2_brca						pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_herceptin;drug_cyclophosphamide
1775	GSM508311	348	348	754	129095	3135	10	GPL4133	GSE22226		NA		er_neg		grade_2_brca						pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca		pcr_yes	1	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1776	GSM508312	349	349	755	129096	3135	10	GPL4133	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1777	GSM508313	350	350	756	129097	3135	10	GPL4133	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1778	GSM508314	351	351	757	129098	3135	10	GPL4133	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1779	GSM508315	352	352	758	129099	3135	10	GPL4133	GSE22226		NA	er_pos						her2_negative								grade_1_brca	pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca		pcr_no	2	GPL4133_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1780	GSM508316	305	305	710	129051	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1781	GSM508317	306	306	711	129052	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative							pcr_yes		drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1782	GSM508318	307	307	712	129053	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1783	GSM508319	308	308	713	129054	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1784	GSM508320	309	309	714	129055	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1785	GSM508321	310	310	715	129056	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1786	GSM508322	311	311	716	129057	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1787	GSM508323	312	312	717	129058	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1788	GSM508324	313	313	718	129059	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1789	GSM508325	314	314	719	129060	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1790	GSM508326	315	315	720	129061	3135	26	GPL1708	GSE22226		NA	er_pos						her2_negative								grade_1_brca	pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_cyclophosphamide
1791	GSM508327	316	316	721	129062	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca												pr_positive	pcr_yes		drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive	grade_2_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1792	GSM508328	317	317	722	129063	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca													pr_positive			drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1793	GSM508329	318	318	723	129064	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca							pr_negative									drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1794	GSM508330	319	319	724	129065	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca													pr_positive	pcr_yes		drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1795	GSM508331	320	320	725	129066	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1796	GSM508332	321	321	726	129067	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca							pr_negative							pcr_yes		drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1797	GSM508333	322	322	727	129068	3135	26	GPL1708	GSE22226		NA	er_pos		grade_3_brca													pr_positive			drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1798	GSM508334	323	323	728	129069	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1799	GSM508335	324	324	729	129070	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca			her2_negative									pr_positive			drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1800	GSM508336	325	325	730	129071	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1801	GSM508337	326	326	731	129072	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative							pcr_yes		drug_cyclophosphamide					er_neg	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1802	GSM508338	327	327	732	129073	3135	26	GPL1708	GSE22226		NA		er_neg		grade_2_brca			her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1803	GSM508339	328	328	733	129074	3135	26	GPL1708	GSE22226		NA	er_pos			grade_2_brca												pr_positive			drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive	grade_2_brca			NA	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1804	GSM508340	329	329	734	129075	3135	26	GPL1708	GSE22226		NA				grade_2_brca															drug_cyclophosphamide				pcr_no				grade_2_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1805	GSM508341	330	330	735	129076	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1806	GSM508342	331	331	736	129077	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca							pr_negative									drug_cyclophosphamide				pcr_no	er_neg		pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_cyclophosphamide
1807	GSM508343	332	332	737	129078	3135	26	GPL1708	GSE22226		NA		er_neg	grade_3_brca				her2_negative			pr_negative									drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca		pcr_no	2	GPL1708_GSE22226	GEO	drug_doxorubicin;drug_taxane;drug_cyclophosphamide
1808	GSM508344	110	110	408	126371	3066	83	GPL1390	GSE21997		NA		er_neg		grade_2_brca			her2_negative										pcr_yes	pre_treatment						er_neg	her2_negative		grade_2_brca		pcr_yes	1	GPL1390_GSE21997	GEO	drug_doxorubicin
1809	GSM508345	111	111	409	126372	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca														pre_treatment				her2_positive	pcr_no	er_pos	her2_positive		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1810	GSM508346	112	112	410	126373	3066	83	GPL1390	GSE21997		NA		er_neg		grade_2_brca														pre_treatment				her2_positive	pcr_no	er_neg	her2_positive		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1811	GSM508347	113	113	411	126374	3066	83	GPL1390	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1812	GSM508360	114	114	412	126375	3066	83	GPL1390	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1813	GSM508361	115	115	413	126376	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_taxane
1814	GSM508362	116	116	414	126377	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1815	GSM508363	117	117	415	126378	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1816	GSM508364	118	118	416	126379	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca														pre_treatment				her2_positive	pcr_no	er_pos	her2_positive		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1817	GSM508365	119	119	417	126380	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca														pre_treatment				her2_positive	pcr_no	er_pos	her2_positive		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1818	GSM508366	120	120	418	126381	3066	83	GPL1390	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1819	GSM508367	121	121	419	126382	3066	83	GPL1390	GSE21997		NA		er_neg		grade_2_brca													pcr_yes	pre_treatment				her2_positive		er_neg	her2_positive		grade_2_brca		pcr_yes	1	GPL1390_GSE21997	GEO	drug_doxorubicin
1820	GSM508368	122	122	420	126383	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_taxane
1821	GSM508369	123	123	421	126384	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1822	GSM508370	124	124	422	126385	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca			her2_negative										pcr_yes	pre_treatment						er_pos	her2_negative		grade_2_brca		pcr_yes	1	GPL1390_GSE21997	GEO	drug_doxorubicin
1823	GSM508371	125	125	423	126386	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_taxane
1824	GSM508372	126	126	424	126387	3066	83	GPL1390	GSE21997		NA	er_pos						her2_negative								grade_1_brca			pre_treatment					pcr_no	er_pos	her2_negative		grade_1_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1825	GSM508373	127	127	425	126388	3066	83	GPL1390	GSE21997		NA		er_neg		grade_2_brca														pre_treatment				her2_positive	pcr_no	er_neg	her2_positive		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_taxane
1826	GSM508374	128	128	426	126389	3066	83	GPL1390	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1827	GSM508375	129	129	427	126390	3066	83	GPL1390	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1828	GSM508376	130	130	428	126391	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_taxane
1829	GSM508377	131	131	429	126392	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1830	GSM508378	132	132	430	126393	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1831	GSM508379	133	133	431	126394	3066	83	GPL1390	GSE21997		NA		er_neg	grade_3_brca															pre_treatment				her2_positive	pcr_no	er_neg	her2_positive		grade_3_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_taxane
1832	GSM508380	134	134	432	126395	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1833	GSM508381	135	135	433	126396	3066	83	GPL1390	GSE21997		NA		er_neg	grade_3_brca														pcr_yes	pre_treatment				her2_positive		er_neg	her2_positive		grade_3_brca		pcr_yes	1	GPL1390_GSE21997	GEO	drug_taxane
1834	GSM508382	136	136	434	126397	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_taxane
1835	GSM508383	137	137	435	126398	3066	83	GPL1390	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1836	GSM508384	138	138	436	126399	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1837	GSM508385	139	139	437	126400	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca														pre_treatment				her2_positive	pcr_no	er_pos	her2_positive		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_doxorubicin
1838	GSM508386	140	140	438	126401	3066	83	GPL1390	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_taxane
1839	GSM508387	141	141	439	126402	3066	83	GPL1390	GSE21997		NA		er_neg		grade_2_brca			her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_taxane
1840	GSM508388	142	142	440	126403	3066	83	GPL1390	GSE21997		NA		er_neg		grade_2_brca			her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_2_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_taxane
1841	GSM508389	143	143	441	126404	3066	83	GPL1390	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL1390_GSE21997	GEO	drug_taxane
1842	GSM508390	144	144	442	126405	3066	83	GPL1390	GSE21997		NA	er_pos						her2_negative								grade_1_brca		pcr_yes	pre_treatment						er_pos	her2_negative		grade_1_brca		pcr_yes	1	GPL1390_GSE21997	GEO	drug_doxorubicin
1843	GSM508391	145	145	443	126406	3066	84	GPL5325	GSE21997		NA		er_neg		grade_2_brca														pre_treatment				her2_positive	pcr_no	er_neg	her2_positive		grade_2_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_taxane
1844	GSM508392	146	146	444	126407	3066	84	GPL5325	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_taxane
1845	GSM508393	147	147	445	126408	3066	84	GPL5325	GSE21997		NA		er_neg		grade_2_brca			her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_2_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_taxane
1846	GSM508394	148	148	446	126409	3066	84	GPL5325	GSE21997		NA	er_pos						her2_negative								grade_1_brca			pre_treatment					pcr_no	er_pos	her2_negative		grade_1_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_doxorubicin
1847	GSM508395	149	149	447	126410	3066	84	GPL5325	GSE21997		NA	er_pos		grade_3_brca															pre_treatment				her2_positive	pcr_no	er_pos	her2_positive		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_taxane
1848	GSM508396	150	150	448	126411	3066	84	GPL5325	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_taxane
1849	GSM508397	151	151	449	126412	3066	84	GPL5325	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_doxorubicin
1850	GSM508398	152	152	450	126413	3066	84	GPL5325	GSE21997		NA		er_neg	grade_3_brca															pre_treatment				her2_positive	pcr_no	er_neg	her2_positive		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_doxorubicin
1851	GSM508399	153	153	451	126414	3066	84	GPL5325	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_taxane
1852	GSM508400	154	154	452	126415	3066	84	GPL5325	GSE21997		NA	er_pos		grade_3_brca				her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_doxorubicin
1853	GSM508401	155	155	453	126416	3066	84	GPL5325	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_doxorubicin
1854	GSM508402	156	156	454	126417	3066	84	GPL5325	GSE21997		NA	er_pos		grade_3_brca															pre_treatment				her2_positive	pcr_no	er_pos	her2_positive		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_doxorubicin
1855	GSM508403	157	157	455	126418	3066	84	GPL5325	GSE21997		NA		er_neg	grade_3_brca															pre_treatment				her2_positive	pcr_no	er_neg	her2_positive		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_doxorubicin
1856	GSM508404	158	158	456	126419	3066	84	GPL5325	GSE21997		NA		er_neg		grade_2_brca			her2_negative										pcr_yes	pre_treatment						er_neg	her2_negative		grade_2_brca		pcr_yes	1	GPL5325_GSE21997	GEO	drug_taxane
1857	GSM508405	159	159	457	126420	3066	84	GPL5325	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_taxane
1858	GSM508406	160	160	458	126421	3066	84	GPL5325	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_doxorubicin
1859	GSM508407	161	161	459	126422	3066	84	GPL5325	GSE21997		NA		er_neg	grade_3_brca															pre_treatment				her2_positive	pcr_no	er_neg	her2_positive		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_taxane
1860	GSM508408	162	162	460	126423	3066	84	GPL5325	GSE21997		NA		er_neg		grade_2_brca			her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_2_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_taxane
1861	GSM508409	163	163	461	126424	3066	84	GPL5325	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_doxorubicin
1862	GSM508410	164	164	462	126425	3066	84	GPL5325	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_doxorubicin
1863	GSM508477	165	165	463	126426	3066	84	GPL5325	GSE21997		NA		er_neg		grade_2_brca			her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_2_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_taxane
1864	GSM508478	166	166	464	126427	3066	84	GPL5325	GSE21997		NA	er_pos		grade_3_brca															pre_treatment				her2_positive	pcr_no	er_pos	her2_positive		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_doxorubicin
1865	GSM508479	167	167	465	126428	3066	84	GPL5325	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_taxane
1866	GSM508480	168	168	466	126429	3066	84	GPL5325	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_taxane
1867	GSM508481	169	169	467	126430	3066	84	GPL5325	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_taxane
1868	GSM508482	170	170	468	126431	3066	84	GPL5325	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_doxorubicin
1869	GSM508483	171	171	469	126432	3066	84	GPL5325	GSE21997		NA	er_pos		grade_3_brca				her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_doxorubicin
1870	GSM508484	172	172	470	126433	3066	84	GPL5325	GSE21997		NA	er_pos		grade_3_brca				her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_3_brca		pcr_no	2	GPL5325_GSE21997	GEO	drug_doxorubicin
1871	GSM508485	173	173	475	126438	3066	607	GPL7504	GSE21997		NA	er_pos			grade_2_brca			her2_negative										pcr_yes	pre_treatment						er_pos	her2_negative		grade_2_brca		pcr_yes	1	GPL7504_GSE21997	GEO	drug_doxorubicin
1872	GSM508486	174	174	476	126439	3066	607	GPL7504	GSE21997		NA		er_neg	grade_3_brca				her2_negative										pcr_yes	pre_treatment						er_neg	her2_negative		grade_3_brca		pcr_yes	1	GPL7504_GSE21997	GEO	drug_taxane
1873	GSM508487	175	175	477	126440	3066	607	GPL7504	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1874	GSM508488	176	176	478	126441	3066	607	GPL7504	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_taxane
1875	GSM508489	177	177	479	126442	3066	607	GPL7504	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_taxane
1876	GSM508490	178	178	480	126443	3066	607	GPL7504	GSE21997		NA		er_neg	grade_3_brca														pcr_yes	pre_treatment				her2_positive		er_neg	her2_positive		grade_3_brca		pcr_yes	1	GPL7504_GSE21997	GEO	drug_taxane
1877	GSM508491	179	179	481	126444	3066	607	GPL7504	GSE21997		NA		er_neg	grade_3_brca				her2_negative										pcr_yes	pre_treatment						er_neg	her2_negative		grade_3_brca		pcr_yes	1	GPL7504_GSE21997	GEO	drug_taxane
1878	GSM508492	180	180	482	126445	3066	607	GPL7504	GSE21997		NA		er_neg		grade_2_brca			her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1879	GSM508493	181	181	483	126446	3066	607	GPL7504	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1880	GSM508494	182	182	484	126447	3066	607	GPL7504	GSE21997		NA	er_pos		grade_3_brca				her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_3_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1881	GSM508495	183	183	485	126448	3066	607	GPL7504	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1882	GSM508496	184	184	486	126449	3066	607	GPL7504	GSE21997		NA	er_pos		grade_3_brca				her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_3_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1883	GSM508497	185	185	487	126450	3066	607	GPL7504	GSE21997		NA	er_pos			grade_2_brca														pre_treatment				her2_positive	pcr_no	er_pos	her2_positive		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1884	GSM508498	186	186	488	126451	3066	607	GPL7504	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_taxane
1885	GSM508499	187	187	489	126452	3066	607	GPL7504	GSE21997		NA	er_pos		grade_3_brca															pre_treatment				her2_positive	pcr_no	er_pos	her2_positive		grade_3_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_taxane
1886	GSM508500	188	188	490	126453	3066	607	GPL7504	GSE21997		NA	er_pos		grade_3_brca				her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_3_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1887	GSM508501	189	189	491	126454	3066	607	GPL7504	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1888	GSM508502	190	190	492	126455	3066	607	GPL7504	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1889	GSM508503	191	191	493	126456	3066	607	GPL7504	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_taxane
1890	GSM508504	192	192	494	126457	3066	607	GPL7504	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1891	GSM508505	193	193	495	126458	3066	607	GPL7504	GSE21997		NA		er_neg		grade_2_brca														pre_treatment				her2_positive	pcr_no	er_neg	her2_positive		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1892	GSM508506	194	194	496	126459	3066	607	GPL7504	GSE21997		NA		er_neg	grade_3_brca														pcr_yes	pre_treatment				her2_positive		er_neg	her2_positive		grade_3_brca		pcr_yes	1	GPL7504_GSE21997	GEO	drug_doxorubicin
1893	GSM508507	195	195	497	126460	3066	607	GPL7504	GSE21997		NA	er_pos			grade_2_brca														pre_treatment				her2_positive	pcr_no	er_pos	her2_positive		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1894	GSM508508	196	196	498	126461	3066	607	GPL7504	GSE21997		NA	er_pos		grade_3_brca															pre_treatment				her2_positive	pcr_no	er_pos	her2_positive		grade_3_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1895	GSM508509	197	197	499	126462	3066	607	GPL7504	GSE21997		NA	er_pos			grade_2_brca														pre_treatment				her2_positive	pcr_no	er_pos	her2_positive		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_doxorubicin
1896	GSM508510	198	198	500	126463	3066	607	GPL7504	GSE21997		NA	er_pos		grade_3_brca															pre_treatment				her2_positive	pcr_no	er_pos	her2_positive		grade_3_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_taxane
1897	GSM508511	199	199	501	126464	3066	607	GPL7504	GSE21997		NA	er_pos		grade_3_brca															pre_treatment				her2_positive	pcr_no	er_pos	her2_positive		grade_3_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_taxane
1898	GSM508512	200	200	502	126465	3066	607	GPL7504	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_taxane
1899	GSM508513	201	201	503	126466	3066	607	GPL7504	GSE21997		NA	er_pos			grade_2_brca			her2_negative											pre_treatment					pcr_no	er_pos	her2_negative		grade_2_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_taxane
1900	GSM508514	202	202	504	126467	3066	607	GPL7504	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_taxane
1901	GSM508515	203	203	505	126468	3066	607	GPL7504	GSE21997		NA		er_neg	grade_3_brca				her2_negative											pre_treatment					pcr_no	er_neg	her2_negative		grade_3_brca		pcr_no	2	GPL7504_GSE21997	GEO	drug_taxane
1902	GSM559042	353	353	759	131523	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1903	GSM559043	354	354	760	131524	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1904	GSM559044	355	355	761	131525	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1905	GSM559045	356	356	762	131526	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1906	GSM559046	357	357	763	131527	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1907	GSM559047	358	358	764	131528	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1908	GSM559048	359	359	765	131529	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1909	GSM559049	360	360	766	131530	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1910	GSM559050	361	361	767	131531	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1911	GSM559051	362	362	768	131532	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1912	GSM559052	363	363	769	131533	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1913	GSM559053	364	364	770	131534	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1914	GSM559054	365	365	771	131535	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1915	GSM559055	366	366	772	131536	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1916	GSM559056	367	367	773	131537	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1917	GSM559057	368	368	774	131538	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1918	GSM559058	369	369	775	131539	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1919	GSM559059	370	370	776	131540	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1920	GSM559060	371	371	777	131541	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1921	GSM559061	372	372	778	131542	3222	4	GPL570	GSE22513		NA																		pre_treatment					pcr_no						pcr_no	2	GPL570_GSE22513	GEO	drug_paclitaxel
1922	GSM559062	373	373	779	131543	3222	4	GPL570	GSE22513		NA																	pcr_yes	pre_treatment											pcr_yes	1	GPL570_GSE22513	GEO	drug_paclitaxel
1923	GSM559063	374	374	780	131544	3222	4	GPL570	GSE22513		NA																	pcr_yes	pre_treatment											pcr_yes	1	GPL570_GSE22513	GEO	drug_paclitaxel
1924	GSM559064	375	375	781	131545	3222	4	GPL570	GSE22513		NA																	pcr_yes	pre_treatment											pcr_yes	1	GPL570_GSE22513	GEO	drug_paclitaxel
1925	GSM559065	376	376	782	131546	3222	4	GPL570	GSE22513		NA																	pcr_yes	pre_treatment											pcr_yes	1	GPL570_GSE22513	GEO	drug_paclitaxel
1926	GSM559066	377	377	783	131547	3222	4	GPL570	GSE22513		NA																	pcr_yes	pre_treatment											pcr_yes	1	GPL570_GSE22513	GEO	drug_paclitaxel
1927	GSM559067	378	378	784	131548	3222	4	GPL570	GSE22513		NA																	pcr_yes	pre_treatment											pcr_yes	1	GPL570_GSE22513	GEO	drug_paclitaxel
1928	GSM559068	379	379	785	131549	3222	4	GPL570	GSE22513		NA																	pcr_yes	pre_treatment											pcr_yes	1	GPL570_GSE22513	GEO	drug_paclitaxel
1929	GSM559069	380	380	786	131550	3222	4	GPL570	GSE22513		NA																	pcr_yes	pre_treatment											pcr_yes	1	GPL570_GSE22513	GEO	drug_paclitaxel
1930	GSM590840	381	381	787	145793	3605	2	GPL96	GSE23988		NA		er_neg			drug_capecitabine		her2_negative					stage_t3		n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative			stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1931	GSM590841	382	382	788	145794	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative						stage_t2	n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative		grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1932	GSM590842	383	383	789	145795	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2				pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_neg	her2_negative		grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1933	GSM590843	384	384	790	145796	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative						stage_t2					pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1934	GSM590844	385	385	791	145797	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative						stage_t2	n0			pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative		grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1935	GSM590845	386	386	792	145798	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine	n3_brca	her2_negative					stage_t3					pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1936	GSM590846	387	387	793	145799	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3					pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_pos	her2_negative		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1937	GSM590847	388	388	794	145800	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1938	GSM590848	389	389	795	145801	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0			pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1939	GSM590849	390	390	796	145802	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative						stage_t2					pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1940	GSM590850	391	391	797	145803	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3					pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_neg	her2_negative		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1941	GSM590851	392	392	798	145804	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2					pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg	her2_negative		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1942	GSM590852	393	393	799	145805	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1943	GSM590853	394	394	800	145806	3605	2	GPL96	GSE23988		NA		er_neg		grade_2_brca	drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg	her2_negative		grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1944	GSM590854	395	395	801	145807	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1945	GSM590855	396	396	802	145808	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3					pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_neg	her2_negative		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1946	GSM590856	397	397	803	145809	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1947	GSM590857	398	398	804	145810	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative					stage_t3		n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative		grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1948	GSM590858	399	399	805	145811	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1949	GSM590859	400	400	806	145812	3605	2	GPL96	GSE23988		NA	er_pos				drug_capecitabine		her2_negative						stage_t2	n0	grade_1_brca			pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative		grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1950	GSM590860	401	401	807	145813	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3					pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_neg	her2_negative		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1951	GSM590861	402	402	808	145814	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1952	GSM590862	403	403	809	145815	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1953	GSM590863	404	404	810	145816	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1954	GSM590864	405	405	811	145817	3605	2	GPL96	GSE23988		NA		er_neg		grade_2_brca	drug_capecitabine		her2_negative						stage_t2					pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg	her2_negative		grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1955	GSM590865	406	406	812	145818	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1956	GSM590866	407	407	813	145819	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1957	GSM590867	408	408	814	145820	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1958	GSM590868	409	409	815	145821	3605	2	GPL96	GSE23988		NA	er_pos				drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative			stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1959	GSM590869	410	410	816	145822	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2				pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_neg	her2_negative		grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1960	GSM590870	411	411	817	145823	3605	2	GPL96	GSE23988		NA		er_neg		grade_2_brca	drug_capecitabine		her2_negative					stage_t3		n0			pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative		grade_2_brca	stage_t3	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1961	GSM590871	412	412	818	145824	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1962	GSM590872	413	413	819	145825	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1963	GSM590873	414	414	820	145826	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2					pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg	her2_negative		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1964	GSM590874	415	415	821	145827	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine	n3_brca	her2_negative						stage_t2				pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative		grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1965	GSM590875	416	416	822	145828	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3					pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_pos	her2_negative		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1966	GSM590876	417	417	823	145829	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1967	GSM590877	418	418	824	145830	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1968	GSM590878	419	419	825	145831	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative						stage_t2				pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_pos	her2_negative		grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1969	GSM590879	420	420	826	145832	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1970	GSM590880	421	421	827	145833	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1971	GSM590881	422	422	828	145834	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0			pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1972	GSM590882	423	423	829	145835	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative						stage_t2				pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative		grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1973	GSM590883	424	424	830	145836	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative					stage_t3		n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative		grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1974	GSM590884	425	425	831	145837	3605	2	GPL96	GSE23988		NA		er_neg		grade_2_brca	drug_capecitabine		her2_negative					stage_t3		n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative		grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1975	GSM590885	426	426	832	145838	3605	2	GPL96	GSE23988		NA		er_neg			drug_capecitabine		her2_negative					stage_t3		n0			pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative			stage_t3	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1976	GSM590886	427	427	833	145839	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative				stage_t1							pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_neg	her2_negative		grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1977	GSM590887	428	428	834	145840	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1978	GSM590888	429	429	835	145841	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative					stage_t3		n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative		grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1979	GSM590889	430	430	836	145842	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2				pcr_yes	pre_treatment	drug_cyclophosphamide		n1_brca			er_neg	her2_negative		grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1980	GSM590890	431	431	837	145843	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0			pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1981	GSM590891	432	432	838	145844	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1982	GSM590892	433	433	839	145845	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative						stage_t2	n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1983	GSM590893	434	434	840	145846	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative					stage_t3		n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative		grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1984	GSM590894	435	435	841	145847	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine	n3_brca	her2_negative					stage_t3					pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative		grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1985	GSM590895	436	436	842	145848	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative						stage_t2					pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1986	GSM590896	437	437	843	145849	3605	2	GPL96	GSE23988		NA		er_neg			drug_capecitabine		her2_negative						stage_t2	n0			pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative			stage_t2	pcr_yes	1	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1987	GSM590897	438	438	844	145850	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative						stage_t2					pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1988	GSM590898	439	439	845	145851	3605	2	GPL96	GSE23988		NA		er_neg	grade_3_brca		drug_capecitabine		her2_negative						stage_t2	n0				pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1989	GSM590899	440	440	846	145852	3605	2	GPL96	GSE23988		NA	er_pos			grade_2_brca	drug_capecitabine		her2_negative					stage_t3						pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative		grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1990	GSM590900	441	441	847	145853	3605	2	GPL96	GSE23988		NA	er_pos		grade_3_brca		drug_capecitabine		her2_negative						stage_t2					pre_treatment	drug_cyclophosphamide		n1_brca		pcr_no	er_pos	her2_negative		grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE23988	GEO	drug_doxorubicin;drug_docetaxel;drug_capecitabine;drug_fluorouracil;drug_cyclophosphamide
1991	GSM615096	442	442	1158	159742	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
1992	GSM615096	442	442	1158	159742	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
1993	GSM615097	443	443	1159	159743	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
1994	GSM615097	443	443	1159	159743	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
1995	GSM615098	444	444	1160	159744	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
1996	GSM615098	444	444	1160	159744	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
1997	GSM615099	445	445	1161	159745	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
1998	GSM615099	445	445	1161	159745	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
1999	GSM615100	446	446	1162	159746	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2000	GSM615100	446	446	1162	159746	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2001	GSM615101	447	447	1163	159747	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative				n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2002	GSM615101	447	447	1163	159747	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative				n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2003	GSM615102	448	448	1164	159748	3888	2	GPL96	GSE25066		NA		er_neg						drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2004	GSM615102	448	448	1164	159748	3888	2	GPL96	GSE25066		NA		er_neg						drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg		pr_negative		stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2005	GSM615103	449	449	1165	159749	3888	2	GPL96	GSE25066		NA								drug_anthracycline				stage_t3						pre_treatment			n1_brca		pcr_no					stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2006	GSM615103	449	449	1165	159749	3888	2	GPL96	GSE25066		NA								drug_anthracycline				stage_t3						pre_treatment			n1_brca		pcr_no					stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2007	GSM615104	450	450	1166	159750	3888	2	GPL96	GSE25066		NA		er_neg				n3_brca	her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2008	GSM615104	450	450	1166	159750	3888	2	GPL96	GSE25066		NA		er_neg				n3_brca	her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2009	GSM615105	451	451	1167	159751	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca		drug_anthracycline	stage_t4							pr_positive		pre_treatment				her2_positive		er_pos	her2_positive	pr_positive	grade_2_brca	stage_t4		NA	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2010	GSM615105	451	451	1167	159751	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca		drug_anthracycline	stage_t4							pr_positive		pre_treatment				her2_positive		er_pos	her2_positive	pr_positive	grade_2_brca	stage_t4		NA	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2011	GSM615106	452	452	1168	159752	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2012	GSM615106	452	452	1168	159752	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2013	GSM615107	453	453	1169	159753	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2014	GSM615107	453	453	1169	159753	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2015	GSM615108	454	454	1170	159754	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca			n3_brca		drug_anthracycline				stage_t3				pr_positive		pre_treatment				her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2016	GSM615108	454	454	1170	159754	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca			n3_brca		drug_anthracycline				stage_t3				pr_positive		pre_treatment				her2_positive	pcr_no	er_pos	her2_positive	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2017	GSM615109	455	455	1171	159755	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2018	GSM615109	455	455	1171	159755	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2019	GSM615110	456	456	1172	159756	3888	2	GPL96	GSE25066		NA			grade_3_brca					drug_anthracycline				stage_t3					pcr_yes	pre_treatment			n1_brca						grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2020	GSM615110	456	456	1172	159756	3888	2	GPL96	GSE25066		NA			grade_3_brca					drug_anthracycline				stage_t3					pcr_yes	pre_treatment			n1_brca						grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2021	GSM615111	457	457	1173	159757	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2022	GSM615111	457	457	1173	159757	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2023	GSM615112	458	458	1174	159758	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2024	GSM615112	458	458	1174	159758	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2025	GSM615113	459	459	1175	159759	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2026	GSM615113	459	459	1175	159759	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2027	GSM615114	460	460	1176	159760	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2028	GSM615114	460	460	1176	159760	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2029	GSM615115	461	461	1177	159761	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2030	GSM615115	461	461	1177	159761	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2031	GSM615116	462	462	1178	159762	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca					drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca	her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2032	GSM615116	462	462	1178	159762	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca					drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca	her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2033	GSM615117	463	463	1179	159763	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2034	GSM615117	463	463	1179	159763	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2035	GSM615118	464	464	1180	159764	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2036	GSM615118	464	464	1180	159764	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2037	GSM615119	465	465	1181	159765	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2038	GSM615119	465	465	1181	159765	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2039	GSM615120	466	466	1182	159766	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3		n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2040	GSM615120	466	466	1182	159766	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3		n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2041	GSM615121	467	467	1183	159767	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca					drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_pos		pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2042	GSM615121	467	467	1183	159767	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca					drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_pos		pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2043	GSM615122	468	468	1184	159768	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2044	GSM615122	468	468	1184	159768	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2045	GSM615123	469	469	1185	159769	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2046	GSM615123	469	469	1185	159769	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2047	GSM615124	470	470	1186	159770	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2048	GSM615124	470	470	1186	159770	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2049	GSM615125	471	471	1187	159771	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2050	GSM615125	471	471	1187	159771	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2051	GSM615126	472	472	1188	159772	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4					n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2052	GSM615126	472	472	1188	159772	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4					n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2053	GSM615127	473	473	1189	159773	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2054	GSM615127	473	473	1189	159773	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2055	GSM615128	474	474	1190	159774	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive		stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2056	GSM615128	474	474	1190	159774	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive		stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2057	GSM615129	475	475	1191	159775	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive		stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2058	GSM615129	475	475	1191	159775	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive		stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2059	GSM615130	476	476	1192	159776	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2060	GSM615130	476	476	1192	159776	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2061	GSM615131	477	477	1193	159777	3888	2	GPL96	GSE25066		NA	er_pos							drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos		pr_positive		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2062	GSM615131	477	477	1193	159777	3888	2	GPL96	GSE25066		NA	er_pos							drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos		pr_positive		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2063	GSM615132	478	478	1194	159778	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca				drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos		pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2064	GSM615132	478	478	1194	159778	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca				drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos		pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2065	GSM615133	479	479	1195	159779	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2	n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2066	GSM615133	479	479	1195	159779	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2	n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2067	GSM615134	480	480	1196	159780	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2068	GSM615134	480	480	1196	159780	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2069	GSM615135	481	481	1197	159781	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2070	GSM615135	481	481	1197	159781	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2071	GSM615136	482	482	1198	159782	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2072	GSM615136	482	482	1198	159782	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2073	GSM615137	483	483	1199	159783	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_negative		stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2074	GSM615137	483	483	1199	159783	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_negative		stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2075	GSM615138	484	484	1200	159784	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2076	GSM615138	484	484	1200	159784	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2077	GSM615139	485	485	1201	159785	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca					drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg		pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2078	GSM615139	485	485	1201	159785	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca					drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg		pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2079	GSM615140	486	486	1202	159786	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca				drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca	her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2080	GSM615140	486	486	1202	159786	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca				drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca	her2_positive		er_neg	her2_positive	pr_negative	grade_2_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2081	GSM615141	487	487	1203	159787	3888	2	GPL96	GSE25066		NA								drug_anthracycline				stage_t3						pre_treatment			n1_brca		pcr_no					stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2082	GSM615141	487	487	1203	159787	3888	2	GPL96	GSE25066		NA								drug_anthracycline				stage_t3						pre_treatment			n1_brca		pcr_no					stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2083	GSM615142	488	488	1204	159788	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2084	GSM615142	488	488	1204	159788	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2085	GSM615143	489	489	1205	159789	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca					drug_anthracycline					stage_t2	n0		pr_positive	pcr_yes	pre_treatment						er_neg		pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2086	GSM615143	489	489	1205	159789	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca					drug_anthracycline					stage_t2	n0		pr_positive	pcr_yes	pre_treatment						er_neg		pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2087	GSM615144	490	490	1206	159790	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2088	GSM615144	490	490	1206	159790	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2089	GSM615145	491	491	1207	159791	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2090	GSM615145	491	491	1207	159791	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2091	GSM615146	492	492	1208	159792	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2092	GSM615146	492	492	1208	159792	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2093	GSM615147	493	493	1209	159793	3888	2	GPL96	GSE25066		NA	er_pos							drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos		pr_positive		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2094	GSM615147	493	493	1209	159793	3888	2	GPL96	GSE25066		NA	er_pos							drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos		pr_positive		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2095	GSM615148	494	494	1210	159794	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2096	GSM615148	494	494	1210	159794	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2097	GSM615149	495	495	1211	159795	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2098	GSM615149	495	495	1211	159795	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2099	GSM615150	496	496	1212	159796	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2100	GSM615150	496	496	1212	159796	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2101	GSM615151	497	497	1213	159797	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2102	GSM615151	497	497	1213	159797	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2103	GSM615152	498	498	1214	159798	3888	2	GPL96	GSE25066		NA			grade_3_brca					drug_anthracycline					stage_t2					pre_treatment					pcr_no				grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2104	GSM615152	498	498	1214	159798	3888	2	GPL96	GSE25066		NA			grade_3_brca					drug_anthracycline					stage_t2					pre_treatment					pcr_no				grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2105	GSM615153	499	499	1215	159799	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2106	GSM615153	499	499	1215	159799	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2107	GSM615154	500	500	1216	159800	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2108	GSM615154	500	500	1216	159800	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2109	GSM615155	501	501	1217	159801	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2110	GSM615155	501	501	1217	159801	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2111	GSM615156	502	502	1218	159802	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2112	GSM615156	502	502	1218	159802	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2113	GSM615157	503	503	1219	159803	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative		grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2114	GSM615157	503	503	1219	159803	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative		grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2115	GSM615158	504	504	1220	159804	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2	n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2116	GSM615158	504	504	1220	159804	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2	n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2117	GSM615159	505	505	1221	159805	3888	2	GPL96	GSE25066		NA		er_neg						drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_neg		pr_positive		stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2118	GSM615159	505	505	1221	159805	3888	2	GPL96	GSE25066		NA		er_neg						drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_neg		pr_positive		stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2119	GSM615160	506	506	1222	159806	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2120	GSM615160	506	506	1222	159806	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2121	GSM615161	507	507	1223	159807	3888	2	GPL96	GSE25066		NA				grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0				pre_treatment					pcr_no		her2_negative		grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2122	GSM615161	507	507	1223	159807	3888	2	GPL96	GSE25066		NA				grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0				pre_treatment					pcr_no		her2_negative		grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2123	GSM615162	508	508	1224	159808	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3			grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2124	GSM615162	508	508	1224	159808	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3			grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2125	GSM615163	509	509	1225	159809	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca			er_pos	her2_negative	pr_positive		stage_t3		NA	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2126	GSM615163	509	509	1225	159809	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca			er_pos	her2_negative	pr_positive		stage_t3		NA	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2127	GSM615164	510	510	1226	159810	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2128	GSM615164	510	510	1226	159810	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2129	GSM615165	511	511	1227	159811	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2130	GSM615165	511	511	1227	159811	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2131	GSM615166	512	512	1228	159812	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca				drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos		pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2132	GSM615166	512	512	1228	159812	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca				drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos		pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2133	GSM615167	513	513	1229	159813	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2134	GSM615167	513	513	1229	159813	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2135	GSM615168	514	514	1230	159814	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive		stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2136	GSM615168	514	514	1230	159814	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive		stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2137	GSM615169	515	515	1231	159815	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2138	GSM615169	515	515	1231	159815	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2139	GSM615170	516	516	1232	159816	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca				drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos		pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2140	GSM615170	516	516	1232	159816	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca				drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos		pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2141	GSM615171	517	517	1233	159817	3888	2	GPL96	GSE25066		NA		er_neg						drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg		pr_negative		stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2142	GSM615171	517	517	1233	159817	3888	2	GPL96	GSE25066		NA		er_neg						drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg		pr_negative		stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2143	GSM615172	518	518	1234	159818	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2144	GSM615172	518	518	1234	159818	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2145	GSM615173	519	519	1235	159819	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive		stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2146	GSM615173	519	519	1235	159819	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive		stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2147	GSM615174	520	520	1236	159820	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2148	GSM615174	520	520	1236	159820	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2149	GSM615175	521	521	1237	159821	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2150	GSM615175	521	521	1237	159821	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2151	GSM615176	522	522	1238	159822	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3		n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2152	GSM615176	522	522	1238	159822	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3		n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2153	GSM615177	523	523	1239	159823	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2154	GSM615177	523	523	1239	159823	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2155	GSM615178	524	524	1240	159824	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2156	GSM615178	524	524	1240	159824	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2157	GSM615179	525	525	1241	159825	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2158	GSM615179	525	525	1241	159825	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2159	GSM615180	526	526	1242	159826	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2160	GSM615180	526	526	1242	159826	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2161	GSM615181	527	527	1243	159827	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2162	GSM615181	527	527	1243	159827	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2163	GSM615182	528	528	1244	159828	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2164	GSM615182	528	528	1244	159828	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2165	GSM615183	529	529	1245	159829	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2166	GSM615183	529	529	1245	159829	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2167	GSM615184	530	530	1246	159830	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2168	GSM615184	530	530	1246	159830	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2169	GSM615185	531	531	1247	159831	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1			n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2170	GSM615185	531	531	1247	159831	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1			n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2171	GSM615186	532	532	1248	159832	3888	2	GPL96	GSE25066		NA	er_pos					n3_brca	her2_negative	drug_anthracycline		pr_negative		stage_t3			grade_1_brca		pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_1_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2172	GSM615186	532	532	1248	159832	3888	2	GPL96	GSE25066		NA	er_pos					n3_brca	her2_negative	drug_anthracycline		pr_negative		stage_t3			grade_1_brca		pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_1_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2173	GSM615187	533	533	1249	159833	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2174	GSM615187	533	533	1249	159833	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2175	GSM615188	534	534	1250	159834	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2176	GSM615188	534	534	1250	159834	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2177	GSM615189	535	535	1251	159835	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2178	GSM615189	535	535	1251	159835	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2179	GSM615190	536	536	1252	159836	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2180	GSM615190	536	536	1252	159836	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2181	GSM615191	537	537	1253	159837	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline			stage_t1			n0		pr_positive	pcr_yes	pre_treatment						er_neg	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2182	GSM615191	537	537	1253	159837	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline			stage_t1			n0		pr_positive	pcr_yes	pre_treatment						er_neg	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2183	GSM615192	538	538	1254	159838	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2184	GSM615192	538	538	1254	159838	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2185	GSM615193	539	539	1255	159839	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1			n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2186	GSM615193	539	539	1255	159839	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1			n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2187	GSM615194	540	540	1256	159840	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline			stage_t1					pr_positive	pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2188	GSM615194	540	540	1256	159840	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline			stage_t1					pr_positive	pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2189	GSM615195	541	541	1257	159841	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2190	GSM615195	541	541	1257	159841	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2191	GSM615196	542	542	1258	159842	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2192	GSM615196	542	542	1258	159842	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2193	GSM615197	543	543	1259	159843	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2194	GSM615197	543	543	1259	159843	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2195	GSM615198	544	544	1260	159844	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2196	GSM615198	544	544	1260	159844	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2197	GSM615199	545	545	1261	159845	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2198	GSM615199	545	545	1261	159845	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2199	GSM615200	546	546	1262	159846	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2200	GSM615200	546	546	1262	159846	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2201	GSM615201	547	547	1263	159847	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2202	GSM615201	547	547	1263	159847	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2203	GSM615202	548	548	1264	159848	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive	pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2204	GSM615202	548	548	1264	159848	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive	pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2205	GSM615203	549	549	1265	159849	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2206	GSM615203	549	549	1265	159849	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2207	GSM615204	550	550	1266	159850	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline			stage_t1			n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2208	GSM615204	550	550	1266	159850	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline			stage_t1			n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2209	GSM615205	551	551	1267	159851	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2210	GSM615205	551	551	1267	159851	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2211	GSM615206	552	552	1268	159852	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2212	GSM615206	552	552	1268	159852	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2213	GSM615207	553	553	1269	159853	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2214	GSM615207	553	553	1269	159853	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2215	GSM615208	554	554	1270	159854	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2216	GSM615208	554	554	1270	159854	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2217	GSM615209	555	555	1271	159855	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2218	GSM615209	555	555	1271	159855	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2219	GSM615210	556	556	1272	159856	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2220	GSM615210	556	556	1272	159856	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2221	GSM615211	557	557	1273	159857	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2222	GSM615211	557	557	1273	159857	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2223	GSM615212	558	558	1274	159858	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2224	GSM615212	558	558	1274	159858	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2225	GSM615213	559	559	1275	159859	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2226	GSM615213	559	559	1275	159859	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2227	GSM615214	560	560	1276	159860	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2228	GSM615214	560	560	1276	159860	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2229	GSM615215	561	561	1277	159861	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2230	GSM615215	561	561	1277	159861	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2231	GSM615216	562	562	1278	159862	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2232	GSM615216	562	562	1278	159862	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2233	GSM615217	563	563	1279	159863	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2234	GSM615217	563	563	1279	159863	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2235	GSM615218	564	564	1280	159864	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2236	GSM615218	564	564	1280	159864	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2237	GSM615219	565	565	1281	159865	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2238	GSM615219	565	565	1281	159865	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2239	GSM615220	566	566	1282	159866	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2240	GSM615220	566	566	1282	159866	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2241	GSM615221	567	567	1283	159867	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2242	GSM615221	567	567	1283	159867	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2243	GSM615222	568	568	1284	159868	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2244	GSM615222	568	568	1284	159868	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2245	GSM615223	569	569	1285	159869	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2246	GSM615223	569	569	1285	159869	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2247	GSM615224	570	570	1286	159870	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2248	GSM615224	570	570	1286	159870	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2249	GSM615225	571	571	1287	159871	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2250	GSM615225	571	571	1287	159871	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2251	GSM615226	572	572	1288	159872	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline		pr_negative		stage_t3		n0	grade_1_brca			pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2252	GSM615226	572	572	1288	159872	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline		pr_negative		stage_t3		n0	grade_1_brca			pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2253	GSM615227	573	573	1289	159873	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2254	GSM615227	573	573	1289	159873	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2255	GSM615228	574	574	1290	159874	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1							pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2256	GSM615228	574	574	1290	159874	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1							pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2257	GSM615229	575	575	1291	159875	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca		n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2258	GSM615229	575	575	1291	159875	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca		n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2259	GSM615230	576	576	1292	159876	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2260	GSM615230	576	576	1292	159876	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2261	GSM615231	577	577	1293	159877	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2262	GSM615231	577	577	1293	159877	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2263	GSM615232	578	578	1294	159878	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2264	GSM615232	578	578	1294	159878	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2265	GSM615233	579	579	1295	159879	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2266	GSM615233	579	579	1295	159879	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2267	GSM615234	580	580	1296	159880	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2268	GSM615234	580	580	1296	159880	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2269	GSM615235	581	581	1297	159881	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative				n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2270	GSM615235	581	581	1297	159881	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative				n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2271	GSM615236	582	582	1298	159882	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca			n3_brca	her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2272	GSM615236	582	582	1298	159882	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca			n3_brca	her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2273	GSM615237	583	583	1299	159883	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2274	GSM615237	583	583	1299	159883	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2275	GSM615238	584	584	1300	159884	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2276	GSM615238	584	584	1300	159884	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2277	GSM615239	585	585	1301	159885	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2278	GSM615239	585	585	1301	159885	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2279	GSM615240	586	586	1302	159886	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2280	GSM615240	586	586	1302	159886	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2281	GSM615241	587	587	1303	159887	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2282	GSM615241	587	587	1303	159887	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2283	GSM615242	588	588	1304	159888	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2284	GSM615242	588	588	1304	159888	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2285	GSM615243	589	589	1305	159889	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2286	GSM615243	589	589	1305	159889	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2287	GSM615244	590	590	1306	159890	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1							pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2288	GSM615244	590	590	1306	159890	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1							pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2289	GSM615245	591	591	1307	159891	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2290	GSM615245	591	591	1307	159891	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2291	GSM615246	592	592	1308	159892	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2292	GSM615246	592	592	1308	159892	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2293	GSM615247	593	593	1309	159893	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2294	GSM615247	593	593	1309	159893	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2295	GSM615248	594	594	1310	159894	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2296	GSM615248	594	594	1310	159894	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2297	GSM615249	595	595	1311	159895	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2298	GSM615249	595	595	1311	159895	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2299	GSM615250	596	596	1312	159896	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1							pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2300	GSM615250	596	596	1312	159896	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1							pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2301	GSM615251	597	597	1313	159897	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2302	GSM615251	597	597	1313	159897	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2303	GSM615252	598	598	1314	159898	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2304	GSM615252	598	598	1314	159898	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2305	GSM615253	599	599	1315	159899	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2306	GSM615253	599	599	1315	159899	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2307	GSM615254	600	600	1316	159900	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca	her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2308	GSM615254	600	600	1316	159900	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca	her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2309	GSM615255	601	601	1317	159901	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2310	GSM615255	601	601	1317	159901	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2311	GSM615256	602	602	1318	159902	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2312	GSM615256	602	602	1318	159902	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2313	GSM615257	603	603	1319	159903	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3			grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2314	GSM615257	603	603	1319	159903	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3			grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2315	GSM615258	604	604	1320	159904	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2316	GSM615258	604	604	1320	159904	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2317	GSM615259	605	605	1321	159905	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2318	GSM615259	605	605	1321	159905	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2319	GSM615260	606	606	1322	159906	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca			n3_brca	her2_negative	drug_anthracycline								pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2320	GSM615260	606	606	1322	159906	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca			n3_brca	her2_negative	drug_anthracycline								pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca		pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2321	GSM615261	607	607	1323	159907	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2322	GSM615261	607	607	1323	159907	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2323	GSM615262	608	608	1324	159908	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2324	GSM615262	608	608	1324	159908	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2325	GSM615263	609	609	1325	159909	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative							pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2326	GSM615263	609	609	1325	159909	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative							pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2327	GSM615264	610	610	1326	159910	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2328	GSM615264	610	610	1326	159910	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2329	GSM615265	611	611	1327	159911	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2330	GSM615265	611	611	1327	159911	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2331	GSM615266	612	612	1328	159912	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2332	GSM615266	612	612	1328	159912	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2333	GSM615267	613	613	1329	159913	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2334	GSM615267	613	613	1329	159913	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2335	GSM615268	614	614	1330	159914	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline		pr_negative			stage_t2		grade_1_brca			pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2336	GSM615268	614	614	1330	159914	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline		pr_negative			stage_t2		grade_1_brca			pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2337	GSM615269	615	615	1331	159915	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2338	GSM615269	615	615	1331	159915	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2339	GSM615270	616	616	1332	159916	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative							pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2340	GSM615270	616	616	1332	159916	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative							pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2341	GSM615271	617	617	1333	159917	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2342	GSM615271	617	617	1333	159917	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2343	GSM615272	618	618	1334	159918	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2344	GSM615272	618	618	1334	159918	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2345	GSM615273	619	619	1335	159919	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2346	GSM615273	619	619	1335	159919	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2347	GSM615274	620	620	1336	159920	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca	her2_negative	drug_anthracycline								pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2348	GSM615274	620	620	1336	159920	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca	her2_negative	drug_anthracycline								pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca		pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2349	GSM615275	621	621	1337	159921	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2350	GSM615275	621	621	1337	159921	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2351	GSM615276	622	622	1338	159922	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2352	GSM615276	622	622	1338	159922	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2353	GSM615277	623	623	1339	159923	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2354	GSM615277	623	623	1339	159923	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2355	GSM615278	624	624	1340	159924	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2356	GSM615278	624	624	1340	159924	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2357	GSM615279	625	625	1341	159925	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2358	GSM615279	625	625	1341	159925	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2359	GSM615280	626	626	1342	159926	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2360	GSM615280	626	626	1342	159926	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2361	GSM615281	627	627	1343	159927	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2362	GSM615281	627	627	1343	159927	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2363	GSM615282	628	628	1344	159928	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2364	GSM615282	628	628	1344	159928	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2365	GSM615283	629	629	1345	159929	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2366	GSM615283	629	629	1345	159929	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2367	GSM615284	630	630	1346	159930	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative							pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2368	GSM615284	630	630	1346	159930	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative							pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2369	GSM615285	631	631	1347	159931	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2370	GSM615285	631	631	1347	159931	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2371	GSM615286	632	632	1348	159932	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2372	GSM615286	632	632	1348	159932	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2373	GSM615287	633	633	1349	159933	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2374	GSM615287	633	633	1349	159933	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2375	GSM615288	634	634	1350	159934	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1			n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2376	GSM615288	634	634	1350	159934	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1			n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2377	GSM615289	635	635	1351	159935	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2378	GSM615289	635	635	1351	159935	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2379	GSM615290	636	636	1352	159936	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2380	GSM615290	636	636	1352	159936	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2381	GSM615291	637	637	1353	159937	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2382	GSM615291	637	637	1353	159937	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2383	GSM615292	638	638	1354	159938	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2384	GSM615292	638	638	1354	159938	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2385	GSM615293	639	639	1355	159939	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2386	GSM615293	639	639	1355	159939	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2387	GSM615294	640	640	1356	159940	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2388	GSM615294	640	640	1356	159940	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2389	GSM615295	641	641	1357	159941	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2390	GSM615295	641	641	1357	159941	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2391	GSM615296	642	642	1358	159942	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca	her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2392	GSM615296	642	642	1358	159942	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca	her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2393	GSM615297	643	643	1359	159943	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2394	GSM615297	643	643	1359	159943	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2395	GSM615298	644	644	1360	159944	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2396	GSM615298	644	644	1360	159944	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2397	GSM615299	645	645	1361	159945	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2398	GSM615299	645	645	1361	159945	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2399	GSM615300	646	646	1362	159946	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2400	GSM615300	646	646	1362	159946	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2401	GSM615301	647	647	1363	159947	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2402	GSM615301	647	647	1363	159947	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2403	GSM615302	648	648	1364	159948	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2404	GSM615302	648	648	1364	159948	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2405	GSM615303	649	649	1365	159949	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2406	GSM615303	649	649	1365	159949	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2407	GSM615304	650	650	1366	159950	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2408	GSM615304	650	650	1366	159950	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2409	GSM615305	651	651	1367	159951	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2410	GSM615305	651	651	1367	159951	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2411	GSM615306	652	652	1368	159952	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2412	GSM615306	652	652	1368	159952	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2413	GSM615307	653	653	1369	159953	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2414	GSM615307	653	653	1369	159953	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2415	GSM615308	654	654	1370	159954	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2416	GSM615308	654	654	1370	159954	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2417	GSM615309	655	655	1371	159955	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2418	GSM615309	655	655	1371	159955	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2419	GSM615310	656	656	1372	159956	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2420	GSM615310	656	656	1372	159956	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2421	GSM615311	657	657	1373	159957	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2422	GSM615311	657	657	1373	159957	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2423	GSM615312	658	658	1374	159958	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca		n3_brca	her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_neg	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2424	GSM615312	658	658	1374	159958	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca		n3_brca	her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_neg	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2425	GSM615313	659	659	1375	159959	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline			stage_t1				grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2426	GSM615313	659	659	1375	159959	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline			stage_t1				grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2427	GSM615314	660	660	1376	159960	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2428	GSM615314	660	660	1376	159960	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2429	GSM615315	661	661	1377	159961	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2430	GSM615315	661	661	1377	159961	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2431	GSM615316	662	662	1378	159962	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative	stage_t1							pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2432	GSM615316	662	662	1378	159962	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative	stage_t1							pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2433	GSM615317	663	663	1379	159963	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2434	GSM615317	663	663	1379	159963	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2435	GSM615318	664	664	1380	159964	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2436	GSM615318	664	664	1380	159964	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2437	GSM615319	665	665	1381	159965	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2438	GSM615319	665	665	1381	159965	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2439	GSM615320	666	666	1382	159966	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2440	GSM615320	666	666	1382	159966	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2441	GSM615321	667	667	1383	159967	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2442	GSM615321	667	667	1383	159967	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2443	GSM615322	668	668	1384	159968	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2444	GSM615322	668	668	1384	159968	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2445	GSM615323	669	669	1385	159969	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2446	GSM615323	669	669	1385	159969	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2447	GSM615324	670	670	1386	159970	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1						pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2448	GSM615324	670	670	1386	159970	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1						pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2449	GSM615325	671	671	1387	159971	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative	stage_t1						pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2450	GSM615325	671	671	1387	159971	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative	stage_t1						pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2451	GSM615326	672	672	1388	159972	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2452	GSM615326	672	672	1388	159972	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2453	GSM615327	673	673	1389	159973	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2454	GSM615327	673	673	1389	159973	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2455	GSM615328	674	674	1390	159974	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2456	GSM615328	674	674	1390	159974	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2457	GSM615329	675	675	1391	159975	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2458	GSM615329	675	675	1391	159975	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2459	GSM615330	676	676	1392	159976	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2460	GSM615330	676	676	1392	159976	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2461	GSM615331	677	677	1393	159977	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2462	GSM615331	677	677	1393	159977	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2463	GSM615332	678	678	1394	159978	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2464	GSM615332	678	678	1394	159978	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2465	GSM615333	679	679	1395	159979	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline			stage_t1			n0		pr_positive		pre_treatment					pcr_no	er_neg	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2466	GSM615333	679	679	1395	159979	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline			stage_t1			n0		pr_positive		pre_treatment					pcr_no	er_neg	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2467	GSM615334	680	680	1396	159980	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2468	GSM615334	680	680	1396	159980	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2469	GSM615335	681	681	1397	159981	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2470	GSM615335	681	681	1397	159981	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2471	GSM615336	682	682	1398	159982	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2472	GSM615336	682	682	1398	159982	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2473	GSM615337	683	683	1399	159983	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2474	GSM615337	683	683	1399	159983	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2475	GSM615338	684	684	1400	159984	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2476	GSM615338	684	684	1400	159984	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2477	GSM615339	685	685	1401	159985	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2478	GSM615339	685	685	1401	159985	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2479	GSM615340	686	686	1402	159986	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2480	GSM615340	686	686	1402	159986	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2481	GSM615341	687	687	1403	159987	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2482	GSM615341	687	687	1403	159987	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2483	GSM615342	688	688	1404	159988	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2484	GSM615342	688	688	1404	159988	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2485	GSM615343	689	689	1405	159989	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2486	GSM615343	689	689	1405	159989	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2487	GSM615344	690	690	1406	159990	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2488	GSM615344	690	690	1406	159990	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2489	GSM615345	691	691	1407	159991	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2490	GSM615345	691	691	1407	159991	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2491	GSM615346	692	692	1408	159992	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2492	GSM615346	692	692	1408	159992	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2493	GSM615347	693	693	1409	159993	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2494	GSM615347	693	693	1409	159993	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2495	GSM615348	694	694	1410	159994	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2496	GSM615348	694	694	1410	159994	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2497	GSM615349	695	695	1411	159995	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2498	GSM615349	695	695	1411	159995	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2499	GSM615350	696	696	1412	159996	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2500	GSM615350	696	696	1412	159996	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2501	GSM615351	697	697	1413	159997	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2	n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2502	GSM615351	697	697	1413	159997	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2	n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2503	GSM615352	698	698	1414	159998	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2504	GSM615352	698	698	1414	159998	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2505	GSM615353	699	699	1415	159999	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline			stage_t1					pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2506	GSM615353	699	699	1415	159999	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline			stage_t1					pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2507	GSM615354	700	700	1416	160000	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca		n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2508	GSM615354	700	700	1416	160000	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca		n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2509	GSM615355	701	701	1417	160001	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2510	GSM615355	701	701	1417	160001	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2511	GSM615356	702	702	1418	160002	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2512	GSM615356	702	702	1418	160002	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2513	GSM615357	703	703	1419	160003	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2514	GSM615357	703	703	1419	160003	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2515	GSM615358	704	704	1420	160004	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative				n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2516	GSM615358	704	704	1420	160004	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative				n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2517	GSM615359	705	705	1421	160005	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative							pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2518	GSM615359	705	705	1421	160005	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative							pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2519	GSM615360	706	706	1422	160006	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2520	GSM615360	706	706	1422	160006	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2521	GSM615361	707	707	1423	160007	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2522	GSM615361	707	707	1423	160007	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2523	GSM615362	708	708	1424	160008	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2	n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2524	GSM615362	708	708	1424	160008	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2	n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2525	GSM615363	709	709	1425	160009	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2526	GSM615363	709	709	1425	160009	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2527	GSM615364	710	710	1426	160010	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2528	GSM615364	710	710	1426	160010	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2529	GSM615365	711	711	1427	160011	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2530	GSM615365	711	711	1427	160011	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2531	GSM615366	712	712	1428	160012	3888	2	GPL96	GSE25066		NA	er_pos					n3_brca	her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2532	GSM615366	712	712	1428	160012	3888	2	GPL96	GSE25066		NA	er_pos					n3_brca	her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2533	GSM615367	713	713	1429	160013	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2534	GSM615367	713	713	1429	160013	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2535	GSM615368	714	714	1430	160014	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2536	GSM615368	714	714	1430	160014	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2537	GSM615369	715	715	1431	160015	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2538	GSM615369	715	715	1431	160015	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2539	GSM615370	716	716	1432	160016	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2540	GSM615370	716	716	1432	160016	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2541	GSM615371	717	717	1433	160017	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2542	GSM615371	717	717	1433	160017	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2543	GSM615372	718	718	1434	160018	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2544	GSM615372	718	718	1434	160018	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2545	GSM615373	719	719	1435	160019	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2546	GSM615373	719	719	1435	160019	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2547	GSM615374	720	720	1436	160020	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3		n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2548	GSM615374	720	720	1436	160020	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3		n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2549	GSM615375	721	721	1437	160021	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive	pcr_yes	pre_treatment						er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2550	GSM615375	721	721	1437	160021	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive	pcr_yes	pre_treatment						er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2551	GSM615376	722	722	1438	160022	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2552	GSM615376	722	722	1438	160022	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2553	GSM615377	723	723	1439	160023	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4					n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2554	GSM615377	723	723	1439	160023	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4					n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2555	GSM615378	724	724	1440	160024	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2556	GSM615378	724	724	1440	160024	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2557	GSM615379	725	725	1441	160025	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative							pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2558	GSM615379	725	725	1441	160025	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative							pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2559	GSM615380	726	726	1442	160026	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2560	GSM615380	726	726	1442	160026	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2561	GSM615381	727	727	1443	160027	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2562	GSM615381	727	727	1443	160027	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2563	GSM615382	728	728	1444	160028	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2564	GSM615382	728	728	1444	160028	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2565	GSM615383	729	729	1445	160029	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2566	GSM615383	729	729	1445	160029	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2567	GSM615384	730	730	1446	160030	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2568	GSM615384	730	730	1446	160030	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2569	GSM615385	731	731	1447	160031	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2570	GSM615385	731	731	1447	160031	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2571	GSM615386	732	732	1448	160032	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2572	GSM615386	732	732	1448	160032	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2573	GSM615387	733	733	1449	160033	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2574	GSM615387	733	733	1449	160033	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2575	GSM615388	734	734	1450	160034	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2576	GSM615388	734	734	1450	160034	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2577	GSM615389	735	735	1451	160035	3888	2	GPL96	GSE25066		NA	er_pos					n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2		grade_1_brca			pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2578	GSM615389	735	735	1451	160035	3888	2	GPL96	GSE25066		NA	er_pos					n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2		grade_1_brca			pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2579	GSM615390	736	736	1452	160036	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2580	GSM615390	736	736	1452	160036	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2581	GSM615391	737	737	1453	160037	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4					n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2582	GSM615391	737	737	1453	160037	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4					n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2583	GSM615392	738	738	1454	160038	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2584	GSM615392	738	738	1454	160038	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2585	GSM615393	739	739	1455	160039	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2586	GSM615393	739	739	1455	160039	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2587	GSM615394	740	740	1456	160040	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2588	GSM615394	740	740	1456	160040	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2589	GSM615395	741	741	1457	160041	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2590	GSM615395	741	741	1457	160041	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2591	GSM615396	742	742	1458	160042	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2592	GSM615396	742	742	1458	160042	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2593	GSM615397	743	743	1459	160043	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2594	GSM615397	743	743	1459	160043	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2595	GSM615398	744	744	1460	160044	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2596	GSM615398	744	744	1460	160044	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2597	GSM615399	745	745	1461	160045	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2598	GSM615399	745	745	1461	160045	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2599	GSM615400	746	746	1462	160046	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2600	GSM615400	746	746	1462	160046	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2601	GSM615401	747	747	1463	160047	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2602	GSM615401	747	747	1463	160047	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2603	GSM615402	748	748	1464	160048	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2604	GSM615402	748	748	1464	160048	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2605	GSM615403	749	749	1465	160049	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2606	GSM615403	749	749	1465	160049	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2607	GSM615404	750	750	1466	160050	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_endocrine_therapy;drug_taxane
2608	GSM615404	750	750	1466	160050	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2609	GSM615405	751	751	1467	160051	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_doxorubicin;drug_taxane
2610	GSM615405	751	751	1467	160051	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2611	GSM615631	752	752	1468	160052	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2612	GSM615631	752	752	1468	160052	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2613	GSM615631	2626	577	1734	159544	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2614	GSM615631	2626	577	1734	159544	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2615	GSM615632	753	753	1469	160053	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca					drug_anthracycline					stage_t2			pr_positive	pcr_yes	pre_treatment			n1_brca	her2_positive		er_neg	her2_positive	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2616	GSM615632	753	753	1469	160053	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca					drug_anthracycline					stage_t2			pr_positive	pcr_yes	pre_treatment			n1_brca	her2_positive		er_neg	her2_positive	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2617	GSM615632	2627	578	1735	159545	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA		NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA	her2_positive		er_neg	her2_positive	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2618	GSM615632	2627	578	1735	159545	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA		NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA	her2_positive		er_neg	her2_positive	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2619	GSM615633	2628	579	1736	159546	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2620	GSM615633	2628	579	1736	159546	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2621	GSM615633	754	754	1470	160054	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2622	GSM615633	754	754	1470	160054	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2623	GSM615634	755	755	1471	160055	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2624	GSM615634	755	755	1471	160055	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2625	GSM615634	2629	580	1737	159547	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2626	GSM615634	2629	580	1737	159547	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2627	GSM615635	2630	581	1738	159548	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2628	GSM615635	2630	581	1738	159548	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2629	GSM615635	756	756	1472	160056	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca			n3_brca	her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2630	GSM615635	756	756	1472	160056	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca			n3_brca	her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2631	GSM615636	757	757	1473	160057	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2632	GSM615636	757	757	1473	160057	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2633	GSM615636	2631	582	1739	159549	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2634	GSM615636	2631	582	1739	159549	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2635	GSM615637	758	758	1474	160058	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2636	GSM615637	758	758	1474	160058	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2637	GSM615637	2632	583	1740	159550	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2638	GSM615637	2632	583	1740	159550	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2639	GSM615638	2633	584	1741	159551	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2640	GSM615638	2633	584	1741	159551	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2641	GSM615638	759	759	1475	160059	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2642	GSM615638	759	759	1475	160059	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2643	GSM615639	2634	585	1742	159552	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2644	GSM615639	2634	585	1742	159552	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2645	GSM615639	760	760	1476	160060	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2646	GSM615639	760	760	1476	160060	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2647	GSM615640	761	761	1477	160061	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2648	GSM615640	761	761	1477	160061	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2649	GSM615640	2635	586	1743	159553	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2650	GSM615640	2635	586	1743	159553	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2651	GSM615641	2636	587	1744	159554	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2652	GSM615641	2636	587	1744	159554	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2653	GSM615641	762	762	1478	160062	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2654	GSM615641	762	762	1478	160062	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2655	GSM615642	763	763	1479	160063	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2656	GSM615642	763	763	1479	160063	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2657	GSM615642	2637	588	1745	159555	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2658	GSM615642	2637	588	1745	159555	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2659	GSM615643	764	764	1480	160064	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca				drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca	her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2660	GSM615643	764	764	1480	160064	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca				drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca	her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2661	GSM615643	2638	589	1746	159556	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA		NA		pr_negative		stage_t3		NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2662	GSM615643	2638	589	1746	159556	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA		NA		pr_negative		stage_t3		NA				pre_treatment			NA	her2_positive	pcr_no	er_neg	her2_positive	pr_negative	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2663	GSM615644	2639	590	1747	159557	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2664	GSM615644	2639	590	1747	159557	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2665	GSM615644	765	765	1481	160065	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2666	GSM615644	765	765	1481	160065	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2667	GSM615645	766	766	1482	160066	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2668	GSM615645	766	766	1482	160066	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2669	GSM615645	2640	591	1748	159558	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2670	GSM615645	2640	591	1748	159558	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2671	GSM615646	2641	592	1749	159559	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2672	GSM615646	2641	592	1749	159559	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2673	GSM615646	767	767	1483	160067	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2674	GSM615646	767	767	1483	160067	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2675	GSM615647	2642	593	1750	159560	3887	2	GPL96	GSE25065	NA	NA					NA	NA		NA		pr_negative			stage_t2	NA	grade_1_brca			pre_treatment			NA		pcr_no			pr_negative	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2676	GSM615647	2642	593	1750	159560	3887	2	GPL96	GSE25065	NA	NA					NA	NA		NA		pr_negative			stage_t2	NA	grade_1_brca			pre_treatment			NA		pcr_no			pr_negative	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2677	GSM615647	768	768	1484	160068	3888	2	GPL96	GSE25066		NA								drug_anthracycline					stage_t2	n0	grade_1_brca			pre_treatment					pcr_no				grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2678	GSM615647	768	768	1484	160068	3888	2	GPL96	GSE25066		NA								drug_anthracycline					stage_t2	n0	grade_1_brca			pre_treatment					pcr_no				grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2679	GSM615648	769	769	1485	160069	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2680	GSM615648	769	769	1485	160069	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2681	GSM615648	2643	594	1751	159561	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2682	GSM615648	2643	594	1751	159561	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2683	GSM615649	770	770	1486	160070	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2684	GSM615649	770	770	1486	160070	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2685	GSM615649	2644	595	1752	159562	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2686	GSM615649	2644	595	1752	159562	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2687	GSM615650	771	771	1487	160071	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2688	GSM615650	771	771	1487	160071	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2689	GSM615650	2645	596	1753	159563	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2690	GSM615650	2645	596	1753	159563	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2691	GSM615651	772	772	1488	160072	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2692	GSM615651	772	772	1488	160072	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2693	GSM615651	2646	597	1754	159564	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2694	GSM615651	2646	597	1754	159564	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2695	GSM615652	2647	598	1755	159565	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2696	GSM615652	2647	598	1755	159565	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2697	GSM615652	773	773	1489	160073	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2698	GSM615652	773	773	1489	160073	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2699	GSM615653	774	774	1490	160074	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2700	GSM615653	774	774	1490	160074	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2701	GSM615653	2648	599	1756	159566	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2702	GSM615653	2648	599	1756	159566	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2703	GSM615654	2649	600	1757	159567	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2704	GSM615654	2649	600	1757	159567	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2705	GSM615654	775	775	1491	160075	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2706	GSM615654	775	775	1491	160075	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2707	GSM615655	776	776	1492	160076	3888	2	GPL96	GSE25066		NA		er_neg						drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2708	GSM615655	776	776	1492	160076	3888	2	GPL96	GSE25066		NA		er_neg						drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2709	GSM615655	2650	601	1758	159568	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA		NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2710	GSM615655	2650	601	1758	159568	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA		NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg		pr_negative		stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2711	GSM615656	2651	602	1759	159569	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_2_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2712	GSM615656	2651	602	1759	159569	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_2_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2713	GSM615656	777	777	1493	160077	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_2_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2714	GSM615656	777	777	1493	160077	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_2_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2715	GSM615657	2652	603	1760	159570	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2716	GSM615657	2652	603	1760	159570	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2717	GSM615657	778	778	1494	160078	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2718	GSM615657	778	778	1494	160078	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2719	GSM615658	779	779	1495	160079	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2720	GSM615658	779	779	1495	160079	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2721	GSM615658	2653	604	1761	159571	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2722	GSM615658	2653	604	1761	159571	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2723	GSM615659	2654	605	1762	159572	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2724	GSM615659	2654	605	1762	159572	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2725	GSM615659	780	780	1496	160080	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2726	GSM615659	780	780	1496	160080	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2727	GSM615660	2655	606	1763	159573	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2728	GSM615660	2655	606	1763	159573	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2729	GSM615660	781	781	1497	160081	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2730	GSM615660	781	781	1497	160081	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2731	GSM615661	782	782	1498	160082	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2732	GSM615661	782	782	1498	160082	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2733	GSM615661	2656	607	1764	159574	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2734	GSM615661	2656	607	1764	159574	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2735	GSM615662	783	783	1499	160083	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2736	GSM615662	783	783	1499	160083	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2737	GSM615662	2657	608	1765	159575	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2738	GSM615662	2657	608	1765	159575	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2739	GSM615663	2658	609	1766	159576	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2740	GSM615663	2658	609	1766	159576	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2741	GSM615663	784	784	1500	160084	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2742	GSM615663	784	784	1500	160084	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2743	GSM615664	785	785	1501	160085	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2744	GSM615664	785	785	1501	160085	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2745	GSM615664	2659	610	1767	159577	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2746	GSM615664	2659	610	1767	159577	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2747	GSM615665	2660	611	1768	159578	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2748	GSM615665	2660	611	1768	159578	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2749	GSM615665	786	786	1502	160086	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2750	GSM615665	786	786	1502	160086	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2751	GSM615666	787	787	1503	160087	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2752	GSM615666	787	787	1503	160087	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2753	GSM615666	2661	612	1769	159579	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2754	GSM615666	2661	612	1769	159579	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2755	GSM615667	2662	613	1770	159580	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2756	GSM615667	2662	613	1770	159580	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2757	GSM615667	788	788	1504	160088	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2758	GSM615667	788	788	1504	160088	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2759	GSM615668	2663	614	1771	159581	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2760	GSM615668	2663	614	1771	159581	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2761	GSM615668	789	789	1505	160089	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2762	GSM615668	789	789	1505	160089	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2763	GSM615669	2664	615	1772	159582	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2764	GSM615669	2664	615	1772	159582	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2765	GSM615669	790	790	1506	160090	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2766	GSM615669	790	790	1506	160090	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2767	GSM615670	791	791	1507	160091	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2768	GSM615670	791	791	1507	160091	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2769	GSM615670	2665	616	1773	159583	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2770	GSM615670	2665	616	1773	159583	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2771	GSM615671	2666	617	1774	159584	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2772	GSM615671	2666	617	1774	159584	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2773	GSM615671	792	792	1508	160092	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2774	GSM615671	792	792	1508	160092	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2775	GSM615672	793	793	1509	160093	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2776	GSM615672	793	793	1509	160093	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2777	GSM615672	2667	618	1775	159585	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative		stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2778	GSM615672	2667	618	1775	159585	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative		stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2779	GSM615673	2668	619	1776	159586	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2780	GSM615673	2668	619	1776	159586	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2781	GSM615673	794	794	1510	160094	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2782	GSM615673	794	794	1510	160094	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2783	GSM615674	795	795	1511	160095	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1							pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2784	GSM615674	795	795	1511	160095	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative	stage_t1							pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2785	GSM615674	2669	620	1777	159587	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative	stage_t1			NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2786	GSM615674	2669	620	1777	159587	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative	stage_t1			NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2787	GSM615675	796	796	1512	160096	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2788	GSM615675	796	796	1512	160096	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2789	GSM615675	2670	621	1778	159588	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2790	GSM615675	2670	621	1778	159588	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2791	GSM615676	2671	622	1779	159589	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2792	GSM615676	2671	622	1779	159589	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2793	GSM615676	797	797	1513	160097	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive	pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2794	GSM615676	797	797	1513	160097	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive	pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2795	GSM615677	2672	623	1780	159590	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2796	GSM615677	2672	623	1780	159590	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2797	GSM615677	798	798	1514	160098	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2798	GSM615677	798	798	1514	160098	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2799	GSM615678	799	799	1515	160099	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2800	GSM615678	799	799	1515	160099	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2801	GSM615678	2673	624	1781	159591	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2802	GSM615678	2673	624	1781	159591	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2803	GSM615679	2674	625	1782	159592	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2804	GSM615679	2674	625	1782	159592	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2805	GSM615679	800	800	1516	160100	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2806	GSM615679	800	800	1516	160100	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2807	GSM615680	2675	626	1783	159593	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2808	GSM615680	2675	626	1783	159593	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2809	GSM615680	801	801	1517	160101	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2810	GSM615680	801	801	1517	160101	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2811	GSM615681	2676	627	1784	159594	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2812	GSM615681	2676	627	1784	159594	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2813	GSM615681	802	802	1518	160102	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2814	GSM615681	802	802	1518	160102	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2815	GSM615682	803	803	1519	160103	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2816	GSM615682	803	803	1519	160103	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2817	GSM615682	2677	628	1785	159595	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2818	GSM615682	2677	628	1785	159595	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2819	GSM615683	804	804	1520	160104	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2820	GSM615683	804	804	1520	160104	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2821	GSM615683	2678	629	1786	159596	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2822	GSM615683	2678	629	1786	159596	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2823	GSM615684	805	805	1521	160105	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2824	GSM615684	805	805	1521	160105	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2825	GSM615684	2679	630	1787	159597	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2826	GSM615684	2679	630	1787	159597	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2827	GSM615685	2680	631	1788	159598	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2828	GSM615685	2680	631	1788	159598	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2829	GSM615685	806	806	1522	160106	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2830	GSM615685	806	806	1522	160106	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2831	GSM615686	2681	632	1789	159599	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2832	GSM615686	2681	632	1789	159599	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2833	GSM615686	807	807	1523	160107	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2834	GSM615686	807	807	1523	160107	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2835	GSM615687	808	808	1524	160108	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2836	GSM615687	808	808	1524	160108	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2837	GSM615687	2682	633	1790	159600	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2838	GSM615687	2682	633	1790	159600	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2839	GSM615688	2683	634	1791	159601	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2840	GSM615688	2683	634	1791	159601	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2841	GSM615688	809	809	1525	160109	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2842	GSM615688	809	809	1525	160109	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2843	GSM615689	2684	635	1792	159602	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2844	GSM615689	2684	635	1792	159602	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2845	GSM615689	810	810	1526	160110	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2846	GSM615689	810	810	1526	160110	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2847	GSM615690	2685	636	1793	159603	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2848	GSM615690	2685	636	1793	159603	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2849	GSM615690	811	811	1527	160111	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2850	GSM615690	811	811	1527	160111	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2851	GSM615691	2686	637	1794	159604	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2852	GSM615691	2686	637	1794	159604	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2853	GSM615691	812	812	1528	160112	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2854	GSM615691	812	812	1528	160112	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2855	GSM615692	813	813	1529	160113	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2856	GSM615692	813	813	1529	160113	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2857	GSM615692	2687	638	1795	159605	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2858	GSM615692	2687	638	1795	159605	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2859	GSM615693	814	814	1530	160114	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2860	GSM615693	814	814	1530	160114	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2861	GSM615693	2688	639	1796	159606	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2862	GSM615693	2688	639	1796	159606	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2863	GSM615694	815	815	1531	160115	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2864	GSM615694	815	815	1531	160115	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2865	GSM615694	2689	640	1797	159607	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2866	GSM615694	2689	640	1797	159607	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2867	GSM615695	2690	641	1798	159608	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2868	GSM615695	2690	641	1798	159608	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2869	GSM615695	816	816	1532	160116	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2870	GSM615695	816	816	1532	160116	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2871	GSM615696	817	817	1533	160117	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2872	GSM615696	817	817	1533	160117	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2873	GSM615696	2691	642	1799	159609	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2874	GSM615696	2691	642	1799	159609	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2875	GSM615697	818	818	1534	160118	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2876	GSM615697	818	818	1534	160118	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2877	GSM615697	2692	643	1800	159610	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2878	GSM615697	2692	643	1800	159610	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2879	GSM615698	2693	644	1801	159611	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2880	GSM615698	2693	644	1801	159611	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2881	GSM615698	819	819	1535	160119	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2882	GSM615698	819	819	1535	160119	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2883	GSM615699	820	820	1536	160120	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2884	GSM615699	820	820	1536	160120	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2885	GSM615699	2694	645	1802	159612	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2886	GSM615699	2694	645	1802	159612	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2887	GSM615700	821	821	1537	160121	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3		n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2888	GSM615700	821	821	1537	160121	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3		n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2889	GSM615700	2695	646	1803	159613	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA				stage_t3		NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2890	GSM615700	2695	646	1803	159613	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA				stage_t3		NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2891	GSM615701	822	822	1538	160122	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2892	GSM615701	822	822	1538	160122	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2893	GSM615701	2696	647	1804	159614	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2894	GSM615701	2696	647	1804	159614	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2895	GSM615702	2697	648	1805	159615	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2896	GSM615702	2697	648	1805	159615	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2897	GSM615702	823	823	1539	160123	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2898	GSM615702	823	823	1539	160123	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2899	GSM615703	2698	649	1806	159616	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2900	GSM615703	2698	649	1806	159616	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2901	GSM615703	824	824	1540	160124	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2902	GSM615703	824	824	1540	160124	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2903	GSM615704	825	825	1541	160125	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline			stage_t1				grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2904	GSM615704	825	825	1541	160125	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline			stage_t1				grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2905	GSM615704	2699	650	1807	159617	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA			stage_t1			NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t1	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2906	GSM615704	2699	650	1807	159617	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA			stage_t1			NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t1	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2907	GSM615705	2700	651	1808	159618	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA					stage_t2	NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2908	GSM615705	2700	651	1808	159618	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA					stage_t2	NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2909	GSM615705	826	826	1542	160126	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2910	GSM615705	826	826	1542	160126	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2911	GSM615706	2701	652	1809	159619	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive	pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
2912	GSM615706	2701	652	1809	159619	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive	pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2913	GSM615706	827	827	1543	160127	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
2914	GSM615706	827	827	1543	160127	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2915	GSM615707	2702	653	1810	159620	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2916	GSM615707	2702	653	1810	159620	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2917	GSM615707	828	828	1544	160128	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2918	GSM615707	828	828	1544	160128	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2919	GSM615708	2703	654	1811	159621	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2920	GSM615708	2703	654	1811	159621	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2921	GSM615708	829	829	1545	160129	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2922	GSM615708	829	829	1545	160129	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2923	GSM615709	830	830	1546	160130	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
2924	GSM615709	830	830	1546	160130	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2925	GSM615709	2704	655	1812	159622	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
2926	GSM615709	2704	655	1812	159622	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2927	GSM615710	2705	656	1813	159623	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2928	GSM615710	2705	656	1813	159623	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2929	GSM615710	831	831	1547	160131	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2930	GSM615710	831	831	1547	160131	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2931	GSM615711	832	832	1548	160132	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2932	GSM615711	832	832	1548	160132	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2933	GSM615711	2706	657	1814	159624	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2934	GSM615711	2706	657	1814	159624	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2935	GSM615712	2707	658	1815	159625	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2936	GSM615712	2707	658	1815	159625	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2937	GSM615712	833	833	1549	160133	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2938	GSM615712	833	833	1549	160133	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2939	GSM615713	834	834	1550	160134	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2940	GSM615713	834	834	1550	160134	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
2941	GSM615713	2708	659	1816	159626	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA			stage_t1			NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2942	GSM615713	2708	659	1816	159626	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA			stage_t1			NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
2943	GSM615714	2709	660	1817	159627	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2944	GSM615714	2709	660	1817	159627	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2945	GSM615714	835	835	1551	160135	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2946	GSM615714	835	835	1551	160135	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2947	GSM615715	836	836	1552	160136	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2948	GSM615715	836	836	1552	160136	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
2949	GSM615715	2710	661	1818	159628	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2950	GSM615715	2710	661	1818	159628	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
2951	GSM615716	837	837	1553	160137	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
2952	GSM615716	837	837	1553	160137	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2953	GSM615716	2711	662	1819	159629	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
2954	GSM615716	2711	662	1819	159629	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2955	GSM615717	2712	663	1820	159630	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2956	GSM615717	2712	663	1820	159630	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
2957	GSM615717	838	838	1554	160138	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2958	GSM615717	838	838	1554	160138	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
2959	GSM615718	839	839	1555	160139	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2960	GSM615718	839	839	1555	160139	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
2961	GSM615718	2713	664	1821	159631	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2962	GSM615718	2713	664	1821	159631	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
2963	GSM615719	840	840	1556	160140	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3		n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2964	GSM615719	840	840	1556	160140	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3		n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
2965	GSM615719	2714	665	1822	159632	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA				stage_t3		NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2966	GSM615719	2714	665	1822	159632	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA				stage_t3		NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
2967	GSM615720	2715	666	1823	159633	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2968	GSM615720	2715	666	1823	159633	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
2969	GSM615720	841	841	1557	160141	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2970	GSM615720	841	841	1557	160141	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
2971	GSM615721	2716	667	1824	159634	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2972	GSM615721	2716	667	1824	159634	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
2973	GSM615721	842	842	1558	160142	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2974	GSM615721	842	842	1558	160142	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
2975	GSM615722	843	843	1559	160143	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2976	GSM615722	843	843	1559	160143	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
2977	GSM615722	2717	668	1825	159635	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2978	GSM615722	2717	668	1825	159635	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
2979	GSM615723	2718	669	1826	159636	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
2980	GSM615723	2718	669	1826	159636	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2981	GSM615723	844	844	1560	160144	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
2982	GSM615723	844	844	1560	160144	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2983	GSM615724	2719	670	1827	159637	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2984	GSM615724	2719	670	1827	159637	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
2985	GSM615724	845	845	1561	160145	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2986	GSM615724	845	845	1561	160145	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
2987	GSM615725	2720	671	1828	159638	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
2988	GSM615725	2720	671	1828	159638	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2989	GSM615725	846	846	1562	160146	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
2990	GSM615725	846	846	1562	160146	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2991	GSM615726	847	847	1563	160147	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2992	GSM615726	847	847	1563	160147	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
2993	GSM615726	2721	672	1829	159639	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
2994	GSM615726	2721	672	1829	159639	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
2995	GSM615727	848	848	1564	160148	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
2996	GSM615727	848	848	1564	160148	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
2997	GSM615727	2722	673	1830	159640	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
2998	GSM615727	2722	673	1830	159640	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
2999	GSM615728	2723	674	1831	159641	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3000	GSM615728	2723	674	1831	159641	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3001	GSM615728	849	849	1565	160149	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3002	GSM615728	849	849	1565	160149	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3003	GSM615729	2724	675	1832	159642	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3004	GSM615729	2724	675	1832	159642	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3005	GSM615729	850	850	1566	160150	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3006	GSM615729	850	850	1566	160150	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3007	GSM615730	2725	676	1833	159643	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3008	GSM615730	2725	676	1833	159643	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3009	GSM615730	851	851	1567	160151	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative				n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3010	GSM615730	851	851	1567	160151	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative				n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3011	GSM615731	2726	677	1834	159644	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3012	GSM615731	2726	677	1834	159644	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3013	GSM615731	852	852	1568	160152	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3014	GSM615731	852	852	1568	160152	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3015	GSM615732	2727	678	1835	159645	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3016	GSM615732	2727	678	1835	159645	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3017	GSM615732	853	853	1569	160153	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3018	GSM615732	853	853	1569	160153	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3019	GSM615733	2728	679	1836	159646	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3020	GSM615733	2728	679	1836	159646	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3021	GSM615733	854	854	1570	160154	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3022	GSM615733	854	854	1570	160154	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3023	GSM615734	855	855	1571	160155	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3024	GSM615734	855	855	1571	160155	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3025	GSM615734	2729	680	1837	159647	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3026	GSM615734	2729	680	1837	159647	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3027	GSM615735	856	856	1572	160156	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3028	GSM615735	856	856	1572	160156	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3029	GSM615735	2730	681	1838	159648	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3030	GSM615735	2730	681	1838	159648	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3031	GSM615736	2731	682	1839	159649	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3032	GSM615736	2731	682	1839	159649	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative				NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3033	GSM615736	857	857	1573	160157	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative							pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3034	GSM615736	857	857	1573	160157	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative							pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_negative	grade_3_brca		pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3035	GSM615737	2732	683	1840	159650	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3036	GSM615737	2732	683	1840	159650	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3037	GSM615737	858	858	1574	160158	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3038	GSM615737	858	858	1574	160158	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3039	GSM615738	859	859	1575	160159	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4					n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3040	GSM615738	859	859	1575	160159	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4					n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3041	GSM615738	2733	684	1841	159651	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3042	GSM615738	2733	684	1841	159651	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3043	GSM615739	860	860	1576	160160	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3044	GSM615739	860	860	1576	160160	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3045	GSM615739	2734	685	1842	159652	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3046	GSM615739	2734	685	1842	159652	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3047	GSM615740	2735	686	1843	159653	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3048	GSM615740	2735	686	1843	159653	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3049	GSM615740	861	861	1577	160161	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3050	GSM615740	861	861	1577	160161	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3051	GSM615741	2736	687	1844	159654	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3052	GSM615741	2736	687	1844	159654	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3053	GSM615741	862	862	1578	160162	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3054	GSM615741	862	862	1578	160162	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3055	GSM615742	863	863	1579	160163	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3056	GSM615742	863	863	1579	160163	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3057	GSM615742	2737	688	1845	159655	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3058	GSM615742	2737	688	1845	159655	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3059	GSM615743	2738	689	1846	159656	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3060	GSM615743	2738	689	1846	159656	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
3061	GSM615743	864	864	1580	160164	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3062	GSM615743	864	864	1580	160164	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
3063	GSM615744	865	865	1581	160165	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_docetaxel
3064	GSM615744	865	865	1581	160165	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3065	GSM615744	2739	690	1847	159657	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_docetaxel
3066	GSM615744	2739	690	1847	159657	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3067	GSM615745	2740	691	1848	159658	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA			stage_t1			NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3068	GSM615745	2740	691	1848	159658	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA			stage_t1			NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
3069	GSM615745	866	866	1582	160166	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline			stage_t1			n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3070	GSM615745	866	866	1582	160166	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline			stage_t1			n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
3071	GSM615746	867	867	1583	160167	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca		n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3072	GSM615746	867	867	1583	160167	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca		n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3073	GSM615746	2741	692	1849	159659	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3074	GSM615746	2741	692	1849	159659	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3075	GSM615747	2742	693	1850	159660	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3076	GSM615747	2742	693	1850	159660	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3077	GSM615747	868	868	1584	160168	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3078	GSM615747	868	868	1584	160168	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3079	GSM615748	869	869	1585	160169	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3080	GSM615748	869	869	1585	160169	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3081	GSM615748	2743	694	1851	159661	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3082	GSM615748	2743	694	1851	159661	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3083	GSM615749	2744	695	1852	159662	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA			stage_t1			NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
3084	GSM615749	2744	695	1852	159662	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA			stage_t1			NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3085	GSM615749	870	870	1586	160170	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
3086	GSM615749	870	870	1586	160170	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3087	GSM615750	871	871	1587	160171	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3088	GSM615750	871	871	1587	160171	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
3089	GSM615750	2745	696	1853	159663	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3090	GSM615750	2745	696	1853	159663	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
3091	GSM615751	2746	697	1854	159664	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3092	GSM615751	2746	697	1854	159664	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3093	GSM615751	872	872	1588	160172	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3094	GSM615751	872	872	1588	160172	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3095	GSM615752	2747	698	1855	159665	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3096	GSM615752	2747	698	1855	159665	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3097	GSM615752	873	873	1589	160173	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3098	GSM615752	873	873	1589	160173	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3099	GSM615753	874	874	1590	160174	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca			n3_brca	her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3100	GSM615753	874	874	1590	160174	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca			n3_brca	her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3101	GSM615753	2748	699	1856	159666	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3102	GSM615753	2748	699	1856	159666	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3103	GSM615754	875	875	1591	160175	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3104	GSM615754	875	875	1591	160175	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca			n3_brca	her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3105	GSM615754	2749	700	1857	159667	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3106	GSM615754	2749	700	1857	159667	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3107	GSM615755	876	876	1592	160176	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3108	GSM615755	876	876	1592	160176	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3109	GSM615755	2750	701	1858	159668	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3110	GSM615755	2750	701	1858	159668	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3111	GSM615756	2751	702	1859	159669	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA					stage_t2	NA	grade_1_brca	pr_positive		pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_paclitaxel
3112	GSM615756	2751	702	1859	159669	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA					stage_t2	NA	grade_1_brca	pr_positive		pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3113	GSM615756	877	877	1593	160177	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment						er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_paclitaxel
3114	GSM615756	877	877	1593	160177	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment						er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3115	GSM615757	878	878	1594	160178	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative	stage_t1			n0				pre_treatment						er_neg	her2_negative	pr_negative	grade_2_brca	stage_t1		NA	GPL96_GSE25066	GEO	drug_docetaxel
3116	GSM615757	878	878	1594	160178	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative	stage_t1			n0				pre_treatment						er_neg	her2_negative	pr_negative	grade_2_brca	stage_t1		NA	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3117	GSM615757	2752	703	1860	159670	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA		pr_negative	stage_t1			NA				pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_2_brca	stage_t1		NA	GPL96_GSE25065	GEO	drug_docetaxel
3118	GSM615757	2752	703	1860	159670	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA		pr_negative	stage_t1			NA				pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_2_brca	stage_t1		NA	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3119	GSM615758	879	879	1595	160179	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1		NA	GPL96_GSE25066	GEO	drug_docetaxel
3120	GSM615758	879	879	1595	160179	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1		NA	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3121	GSM615758	2753	704	1861	159671	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA			stage_t1			NA		pr_positive		pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1		NA	GPL96_GSE25065	GEO	drug_docetaxel
3122	GSM615758	2753	704	1861	159671	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA			stage_t1			NA		pr_positive		pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1		NA	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3123	GSM615759	880	880	1596	160180	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_paclitaxel
3124	GSM615759	880	880	1596	160180	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3125	GSM615759	2754	705	1862	159672	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_paclitaxel
3126	GSM615759	2754	705	1862	159672	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3127	GSM615760	2755	706	1863	159673	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3128	GSM615760	2755	706	1863	159673	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_paclitaxel
3129	GSM615760	881	881	1597	160181	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment						er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3130	GSM615760	881	881	1597	160181	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment						er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_paclitaxel
3131	GSM615761	2756	707	1864	159674	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative		stage_t3		NA	grade_1_brca			pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_1_brca	stage_t3		NA	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3132	GSM615761	2756	707	1864	159674	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA		pr_negative		stage_t3		NA	grade_1_brca			pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_1_brca	stage_t3		NA	GPL96_GSE25065	GEO	drug_paclitaxel
3133	GSM615761	882	882	1598	160182	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline		pr_negative		stage_t3			grade_1_brca			pre_treatment			n1_brca			er_pos	her2_negative	pr_negative	grade_1_brca	stage_t3		NA	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3134	GSM615761	882	882	1598	160182	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline		pr_negative		stage_t3			grade_1_brca			pre_treatment			n1_brca			er_pos	her2_negative	pr_negative	grade_1_brca	stage_t3		NA	GPL96_GSE25066	GEO	drug_paclitaxel
3135	GSM615762	883	883	1599	160183	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3		NA	GPL96_GSE25066	GEO	drug_paclitaxel
3136	GSM615762	883	883	1599	160183	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3		NA	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3137	GSM615762	2757	708	1865	159675	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3		NA	GPL96_GSE25065	GEO	drug_paclitaxel
3138	GSM615762	2757	708	1865	159675	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3		NA	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3139	GSM615763	2758	709	1866	159676	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3140	GSM615763	2758	709	1866	159676	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_paclitaxel
3141	GSM615763	884	884	1600	160184	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3142	GSM615763	884	884	1600	160184	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_paclitaxel
3143	GSM615764	885	885	1601	160185	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3144	GSM615764	885	885	1601	160185	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0				pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_paclitaxel
3145	GSM615764	2759	710	1867	159677	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3146	GSM615764	2759	710	1867	159677	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_paclitaxel
3147	GSM615765	2760	711	1868	159678	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA				stage_t3		NA	grade_1_brca	pr_positive		pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3		NA	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3148	GSM615765	2760	711	1868	159678	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA				stage_t3		NA	grade_1_brca	pr_positive		pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3		NA	GPL96_GSE25065	GEO	drug_paclitaxel
3149	GSM615765	886	886	1602	160186	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3			grade_1_brca	pr_positive		pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3		NA	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3150	GSM615765	886	886	1602	160186	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3			grade_1_brca	pr_positive		pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3		NA	GPL96_GSE25066	GEO	drug_paclitaxel
3151	GSM615766	887	887	1603	160187	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3152	GSM615766	887	887	1603	160187	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_paclitaxel
3153	GSM615766	2761	712	1869	159679	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3154	GSM615766	2761	712	1869	159679	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_paclitaxel
3155	GSM615767	888	888	1604	160188	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative	stage_t1							pre_treatment			n1_brca			er_pos	her2_negative	pr_negative	grade_2_brca	stage_t1		NA	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3156	GSM615767	888	888	1604	160188	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative	stage_t1							pre_treatment			n1_brca			er_pos	her2_negative	pr_negative	grade_2_brca	stage_t1		NA	GPL96_GSE25066	GEO	drug_paclitaxel
3157	GSM615767	2762	713	1870	159680	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA		pr_negative	stage_t1			NA				pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_2_brca	stage_t1		NA	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3158	GSM615767	2762	713	1870	159680	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA		pr_negative	stage_t1			NA				pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_2_brca	stage_t1		NA	GPL96_GSE25065	GEO	drug_paclitaxel
3159	GSM615768	2763	714	1871	159681	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA			stage_t1			NA		pr_positive		pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1		NA	GPL96_GSE25065	GEO	drug_paclitaxel
3160	GSM615768	2763	714	1871	159681	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA			stage_t1			NA		pr_positive		pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1		NA	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3161	GSM615768	889	889	1605	160189	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1		NA	GPL96_GSE25066	GEO	drug_paclitaxel
3162	GSM615768	889	889	1605	160189	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1		NA	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3163	GSM615769	890	890	1606	160190	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_paclitaxel
3164	GSM615769	890	890	1606	160190	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3165	GSM615769	2764	715	1872	159682	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_paclitaxel
3166	GSM615769	2764	715	1872	159682	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3167	GSM615770	891	891	1607	160191	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca	her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment						er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_paclitaxel
3168	GSM615770	891	891	1607	160191	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca		n3_brca	her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment						er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2		NA	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3169	GSM615770	2765	716	1873	159683	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_paclitaxel
3170	GSM615770	2765	716	1873	159683	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2		NA	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3171	GSM615771	892	892	1608	160192	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3172	GSM615771	892	892	1608	160192	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3173	GSM615771	2766	717	1874	159684	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3174	GSM615771	2766	717	1874	159684	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3175	GSM615772	893	893	1609	160193	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
3176	GSM615772	893	893	1609	160193	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3177	GSM615772	2767	718	1875	159685	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
3178	GSM615772	2767	718	1875	159685	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3179	GSM615773	894	894	1610	160194	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3180	GSM615773	894	894	1610	160194	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2				pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3181	GSM615773	2768	719	1876	159686	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3182	GSM615773	2768	719	1876	159686	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3183	GSM615774	895	895	1611	160195	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3184	GSM615774	895	895	1611	160195	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3185	GSM615774	2769	720	1877	159687	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3186	GSM615774	2769	720	1877	159687	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3187	GSM615775	896	896	1612	160196	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3188	GSM615775	896	896	1612	160196	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2	n0		pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3189	GSM615775	2770	721	1878	159688	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3190	GSM615775	2770	721	1878	159688	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3191	GSM615776	897	897	1613	160197	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3192	GSM615776	897	897	1613	160197	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_docetaxel
3193	GSM615776	2771	722	1879	159689	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3194	GSM615776	2771	722	1879	159689	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_docetaxel
3195	GSM615777	898	898	1614	160198	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3196	GSM615777	898	898	1614	160198	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline			stage_t1					pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3197	GSM615777	2772	723	1880	159690	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA			stage_t1			NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3198	GSM615777	2772	723	1880	159690	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA			stage_t1			NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t1	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3199	GSM615778	2773	724	1881	159691	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3200	GSM615778	2773	724	1881	159691	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3201	GSM615778	899	899	1615	160199	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3202	GSM615778	899	899	1615	160199	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3203	GSM615779	2774	725	1882	159692	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3204	GSM615779	2774	725	1882	159692	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3205	GSM615779	900	900	1616	160200	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3206	GSM615779	900	900	1616	160200	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3207	GSM615780	901	901	1617	160201	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3208	GSM615780	901	901	1617	160201	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3209	GSM615780	2775	726	1883	159693	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3210	GSM615780	2775	726	1883	159693	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3211	GSM615781	2776	727	1884	159694	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3212	GSM615781	2776	727	1884	159694	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3213	GSM615781	902	902	1618	160202	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3214	GSM615781	902	902	1618	160202	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3215	GSM615782	2777	728	1885	159695	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3216	GSM615782	2777	728	1885	159695	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3217	GSM615782	903	903	1619	160203	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3218	GSM615782	903	903	1619	160203	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3					pcr_yes	pre_treatment						er_pos	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3219	GSM615783	904	904	1620	160204	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative				n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3220	GSM615783	904	904	1620	160204	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative				n0				pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3221	GSM615783	2778	729	1886	159696	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3222	GSM615783	2778	729	1886	159696	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3223	GSM615784	2779	730	1887	159697	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3224	GSM615784	2779	730	1887	159697	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3225	GSM615784	905	905	1621	160205	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3226	GSM615784	905	905	1621	160205	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3227	GSM615785	2780	731	1888	159698	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3228	GSM615785	2780	731	1888	159698	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3229	GSM615785	906	906	1622	160206	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3230	GSM615785	906	906	1622	160206	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3231	GSM615786	2781	732	1889	159699	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3232	GSM615786	2781	732	1889	159699	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3233	GSM615786	907	907	1623	160207	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3234	GSM615786	907	907	1623	160207	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3235	GSM615787	2782	733	1890	159700	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3236	GSM615787	2782	733	1890	159700	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3237	GSM615787	908	908	1624	160208	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3238	GSM615787	908	908	1624	160208	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3239	GSM615788	2783	734	1891	159701	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3240	GSM615788	2783	734	1891	159701	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3241	GSM615788	909	909	1625	160209	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3242	GSM615788	909	909	1625	160209	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3243	GSM615789	2784	735	1892	159702	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3244	GSM615789	2784	735	1892	159702	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3245	GSM615789	910	910	1626	160210	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3246	GSM615789	910	910	1626	160210	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3247	GSM615790	911	911	1627	160211	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca			er_pos	her2_negative	pr_positive		stage_t3		NA	GPL96_GSE25066	GEO	drug_paclitaxel
3248	GSM615790	911	911	1627	160211	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca			er_pos	her2_negative	pr_positive		stage_t3		NA	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3249	GSM615790	2785	736	1893	159703	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA			er_pos	her2_negative	pr_positive		stage_t3		NA	GPL96_GSE25065	GEO	drug_paclitaxel
3250	GSM615790	2785	736	1893	159703	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA			er_pos	her2_negative	pr_positive		stage_t3		NA	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3251	GSM615791	2786	737	1894	159704	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive		stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3252	GSM615791	2786	737	1894	159704	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive		stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3253	GSM615791	912	912	1628	160212	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive		stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3254	GSM615791	912	912	1628	160212	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive		stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3255	GSM615792	2787	738	1895	159705	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive		stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3256	GSM615792	2787	738	1895	159705	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive		stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3257	GSM615792	913	913	1629	160213	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3258	GSM615792	913	913	1629	160213	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3		n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive		stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3259	GSM615793	2788	739	1896	159706	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA	stage_t4	pr_negative				NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative		stage_t4	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3260	GSM615793	2788	739	1896	159706	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA	stage_t4	pr_negative				NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative		stage_t4	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3261	GSM615793	914	914	1630	160214	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline	stage_t4	pr_negative				n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3262	GSM615793	914	914	1630	160214	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline	stage_t4	pr_negative				n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative		stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3263	GSM615794	2789	740	1897	159707	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3264	GSM615794	2789	740	1897	159707	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3265	GSM615794	915	915	1631	160215	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3266	GSM615794	915	915	1631	160215	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3267	GSM615795	2790	741	1898	159708	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3268	GSM615795	2790	741	1898	159708	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3269	GSM615795	916	916	1632	160216	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3270	GSM615795	916	916	1632	160216	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3271	GSM615796	2791	742	1899	159709	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3272	GSM615796	2791	742	1899	159709	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3273	GSM615796	917	917	1633	160217	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3274	GSM615796	917	917	1633	160217	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3275	GSM615797	2792	743	1900	159710	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3276	GSM615797	2792	743	1900	159710	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3277	GSM615797	918	918	1634	160218	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3278	GSM615797	918	918	1634	160218	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3279	GSM615798	919	919	1635	160219	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3280	GSM615798	919	919	1635	160219	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive	pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3281	GSM615798	2793	744	1901	159711	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3282	GSM615798	2793	744	1901	159711	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3283	GSM615799	920	920	1636	160220	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive		stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3284	GSM615799	920	920	1636	160220	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive		stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3285	GSM615799	2794	745	1902	159712	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive		stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3286	GSM615799	2794	745	1902	159712	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive		stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3287	GSM615800	2795	746	1903	159713	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3288	GSM615800	2795	746	1903	159713	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3289	GSM615800	921	921	1637	160221	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative				n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3290	GSM615800	921	921	1637	160221	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline	stage_t4	pr_negative				n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3291	GSM615801	2796	747	1904	159714	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3292	GSM615801	2796	747	1904	159714	3887	2	GPL96	GSE25065	NA	NA		er_neg		grade_2_brca	NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3293	GSM615801	922	922	1638	160222	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca		n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3294	GSM615801	922	922	1638	160222	3888	2	GPL96	GSE25066		NA		er_neg		grade_2_brca		n3_brca	her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3295	GSM615802	2797	748	1905	159715	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive		stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3296	GSM615802	2797	748	1905	159715	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA					stage_t2	NA		pr_positive	pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_positive		stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3297	GSM615802	923	923	1639	160223	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2			pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive		stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3298	GSM615802	923	923	1639	160223	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2			pr_positive	pcr_yes	pre_treatment						er_pos	her2_negative	pr_positive		stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3299	GSM615803	2798	749	1906	159716	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA	stage_t4	pr_negative				NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative		stage_t4	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3300	GSM615803	2798	749	1906	159716	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA	stage_t4	pr_negative				NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative		stage_t4	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3301	GSM615803	924	924	1640	160224	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline	stage_t4	pr_negative							pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative		stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3302	GSM615803	924	924	1640	160224	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline	stage_t4	pr_negative							pcr_yes	pre_treatment			n1_brca			er_neg	her2_negative	pr_negative		stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3303	GSM615804	925	925	1641	160225	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3304	GSM615804	925	925	1641	160225	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3305	GSM615804	2799	750	1907	159717	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3306	GSM615804	2799	750	1907	159717	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3307	GSM615805	926	926	1642	160226	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3308	GSM615805	926	926	1642	160226	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative		stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3309	GSM615805	2800	751	1908	159718	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative		stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3310	GSM615805	2800	751	1908	159718	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative		stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3311	GSM615806	2801	752	1909	159719	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative		stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3312	GSM615806	2801	752	1909	159719	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative		stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3313	GSM615806	927	927	1643	160227	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative		stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3314	GSM615806	927	927	1643	160227	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative		stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3315	GSM615807	2802	753	1910	159720	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA					stage_t2	NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3316	GSM615807	2802	753	1910	159720	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA					stage_t2	NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3317	GSM615807	928	928	1644	160228	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3318	GSM615807	928	928	1644	160228	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2		grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3319	GSM615808	929	929	1645	160229	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3320	GSM615808	929	929	1645	160229	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3321	GSM615808	2803	754	1911	159721	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3322	GSM615808	2803	754	1911	159721	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3323	GSM615809	930	930	1646	160230	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3324	GSM615809	930	930	1646	160230	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3325	GSM615809	2804	755	1912	159722	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3326	GSM615809	2804	755	1912	159722	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3327	GSM615810	2805	756	1913	159723	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3328	GSM615810	2805	756	1913	159723	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA	stage_t4					NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3329	GSM615810	931	931	1647	160231	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3330	GSM615810	931	931	1647	160231	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline	stage_t4							pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3331	GSM615811	932	932	1648	160232	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3332	GSM615811	932	932	1648	160232	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3333	GSM615811	2806	757	1914	159724	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3334	GSM615811	2806	757	1914	159724	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3335	GSM615812	933	933	1649	160233	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative		stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3336	GSM615812	933	933	1649	160233	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline	stage_t4	pr_negative								pre_treatment					pcr_no	er_neg	her2_negative	pr_negative		stage_t4	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3337	GSM615812	2807	758	1915	159725	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative		stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3338	GSM615812	2807	758	1915	159725	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA	stage_t4	pr_negative				NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative		stage_t4	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3339	GSM615813	934	934	1650	160234	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3340	GSM615813	934	934	1650	160234	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3		n0				pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3341	GSM615813	2808	759	1916	159726	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3342	GSM615813	2808	759	1916	159726	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3343	GSM615814	935	935	1651	160235	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3344	GSM615814	935	935	1651	160235	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3345	GSM615814	2809	760	1917	159727	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3346	GSM615814	2809	760	1917	159727	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3347	GSM615815	2810	761	1918	159728	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3348	GSM615815	2810	761	1918	159728	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3349	GSM615815	936	936	1652	160236	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3350	GSM615815	936	936	1652	160236	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3351	GSM615816	937	937	1653	160237	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2	n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3352	GSM615816	937	937	1653	160237	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline					stage_t2	n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3353	GSM615816	2811	762	1919	159729	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA					stage_t2	NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3354	GSM615816	2811	762	1919	159729	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA					stage_t2	NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3355	GSM615817	938	938	1654	160238	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3		n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3356	GSM615817	938	938	1654	160238	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline				stage_t3		n0	grade_1_brca	pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3357	GSM615817	2812	763	1920	159730	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA				stage_t3		NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3358	GSM615817	2812	763	1920	159730	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA				stage_t3		NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3359	GSM615818	939	939	1655	160239	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3360	GSM615818	939	939	1655	160239	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline					stage_t2	n0		pr_positive		pre_treatment					pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3361	GSM615818	2813	764	1921	159731	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3362	GSM615818	2813	764	1921	159731	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3363	GSM615819	2814	765	1922	159732	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3364	GSM615819	2814	765	1922	159732	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3365	GSM615819	940	940	1656	160240	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3366	GSM615819	940	940	1656	160240	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment					pcr_no	er_pos	her2_negative	pr_negative	grade_2_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3367	GSM615820	2815	766	1923	159733	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3368	GSM615820	2815	766	1923	159733	3887	2	GPL96	GSE25065	NA	NA	er_pos			grade_2_brca	NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3369	GSM615820	941	941	1657	160241	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3370	GSM615820	941	941	1657	160241	3888	2	GPL96	GSE25066		NA	er_pos			grade_2_brca			her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_2_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3371	GSM615821	942	942	1658	160242	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3372	GSM615821	942	942	1658	160242	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline				stage_t3				pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3373	GSM615821	2816	767	1924	159734	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3374	GSM615821	2816	767	1924	159734	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA				stage_t3		NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3375	GSM615822	2817	768	1925	159735	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA	stage_t4	pr_negative				NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative		stage_t4	pcr_yes	1	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3376	GSM615822	2817	768	1925	159735	3887	2	GPL96	GSE25065	NA	NA	er_pos				NA	NA	her2_negative	NA	stage_t4	pr_negative				NA			pcr_yes	pre_treatment			NA			er_pos	her2_negative	pr_negative		stage_t4	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3377	GSM615822	943	943	1659	160243	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline	stage_t4	pr_negative							pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_negative		stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3378	GSM615822	943	943	1659	160243	3888	2	GPL96	GSE25066		NA	er_pos						her2_negative	drug_anthracycline	stage_t4	pr_negative							pcr_yes	pre_treatment			n1_brca			er_pos	her2_negative	pr_negative		stage_t4	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3379	GSM615823	2818	769	1926	159736	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3380	GSM615823	2818	769	1926	159736	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative		stage_t3		NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3381	GSM615823	944	944	1660	160244	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3382	GSM615823	944	944	1660	160244	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative		stage_t3						pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3383	GSM615824	945	945	1661	160245	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_paclitaxel
3384	GSM615824	945	945	1661	160245	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2	n0			pcr_yes	pre_treatment						er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3385	GSM615824	2819	770	1927	159737	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_paclitaxel
3386	GSM615824	2819	770	1927	159737	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA			pcr_yes	pre_treatment			NA			er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_yes	1	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3387	GSM615825	946	946	1662	160246	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3388	GSM615825	946	946	1662	160246	3888	2	GPL96	GSE25066		NA	er_pos		grade_3_brca				her2_negative	drug_anthracycline					stage_t2			pr_positive		pre_treatment			n1_brca		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3389	GSM615825	2820	771	1928	159738	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3390	GSM615825	2820	771	1928	159738	3887	2	GPL96	GSE25065	NA	NA	er_pos		grade_3_brca		NA	NA	her2_negative	NA					stage_t2	NA		pr_positive		pre_treatment			NA		pcr_no	er_pos	her2_negative	pr_positive	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_endocrine_therapy;drug_anthracycline;drug_taxane
3391	GSM615826	2821	772	1929	159739	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA				stage_t3		NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3392	GSM615826	2821	772	1929	159739	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA				stage_t3		NA	grade_1_brca	pr_positive		pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3393	GSM615826	947	947	1663	160247	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline				stage_t3			grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3394	GSM615826	947	947	1663	160247	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline				stage_t3			grade_1_brca	pr_positive		pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_positive	grade_1_brca	stage_t3	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3395	GSM615827	948	948	1664	160248	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3396	GSM615827	948	948	1664	160248	3888	2	GPL96	GSE25066		NA		er_neg	grade_3_brca				her2_negative	drug_anthracycline		pr_negative			stage_t2					pre_treatment			n1_brca		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3397	GSM615827	2822	773	1930	159740	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3398	GSM615827	2822	773	1930	159740	3887	2	GPL96	GSE25065	NA	NA		er_neg	grade_3_brca		NA	NA	her2_negative	NA		pr_negative			stage_t2	NA				pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_3_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3399	GSM615828	949	949	1665	160249	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative			stage_t2	n0	grade_1_brca			pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_paclitaxel
3400	GSM615828	949	949	1665	160249	3888	2	GPL96	GSE25066		NA		er_neg					her2_negative	drug_anthracycline		pr_negative			stage_t2	n0	grade_1_brca			pre_treatment					pcr_no	er_neg	her2_negative	pr_negative	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25066	GEO	drug_anthracycline;drug_taxane
3401	GSM615828	2823	774	1931	159741	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative			stage_t2	NA	grade_1_brca			pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_paclitaxel
3402	GSM615828	2823	774	1931	159741	3887	2	GPL96	GSE25065	NA	NA		er_neg			NA	NA	her2_negative	NA		pr_negative			stage_t2	NA	grade_1_brca			pre_treatment			NA		pcr_no	er_neg	her2_negative	pr_negative	grade_1_brca	stage_t2	pcr_no	2	GPL96_GSE25065	GEO	drug_anthracycline;drug_taxane
3403	GSM809184	950	950	1803	231698	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3404	GSM809185	951	951	1804	231699	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3405	GSM809186	952	952	1805	231700	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3406	GSM809187	953	953	1806	231701	5767	4	GPL570	GSE32646		NA	er_pos															pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3407	GSM809188	954	954	1807	231702	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3408	GSM809189	955	955	1808	231703	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3409	GSM809190	956	956	1809	231704	5767	4	GPL570	GSE32646		NA	er_pos									pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3410	GSM809191	957	957	1810	231705	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3411	GSM809192	958	958	1811	231706	5767	4	GPL570	GSE32646		NA	er_pos									pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3412	GSM809193	959	959	1812	231707	5767	4	GPL570	GSE32646		NA	er_pos									pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3413	GSM809194	960	960	1813	231708	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3414	GSM809195	961	961	1814	231709	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3415	GSM809196	962	962	1815	231710	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3416	GSM809197	963	963	1816	231711	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3417	GSM809198	964	964	1817	231712	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3418	GSM809199	965	965	1818	231713	5767	4	GPL570	GSE32646		NA	er_pos									pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3419	GSM809200	966	966	1819	231714	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3420	GSM809201	967	967	1820	231715	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3421	GSM809202	968	968	1821	231716	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3422	GSM809203	969	969	1822	231717	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3423	GSM809204	970	970	1823	231718	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3424	GSM809205	971	971	1824	231719	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3425	GSM809206	972	972	1825	231720	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3426	GSM809207	973	973	1826	231721	5767	4	GPL570	GSE32646		NA	er_pos															pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3427	GSM809208	974	974	1827	231722	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3428	GSM809209	975	975	1828	231723	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3429	GSM809210	976	976	1829	231724	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3430	GSM809211	977	977	1830	231725	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3431	GSM809212	978	978	1831	231726	5767	4	GPL570	GSE32646		NA	er_pos									pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3432	GSM809213	979	979	1832	231727	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3433	GSM809214	980	980	1833	231728	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3434	GSM809215	981	981	1834	231729	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3435	GSM809216	982	982	1835	231730	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3436	GSM809217	983	983	1836	231731	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3437	GSM809218	984	984	1837	231732	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3438	GSM809219	985	985	1838	231733	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3439	GSM809220	986	986	1839	231734	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3440	GSM809221	987	987	1840	231735	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3441	GSM809222	988	988	1841	231736	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3442	GSM809223	989	989	1842	231737	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3443	GSM809224	990	990	1843	231738	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3444	GSM809225	991	991	1844	231739	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3445	GSM809226	992	992	1845	231740	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3446	GSM809227	993	993	1846	231741	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3447	GSM809228	994	994	1847	231742	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3448	GSM809229	995	995	1848	231743	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3449	GSM809230	996	996	1849	231744	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3450	GSM809231	997	997	1850	231745	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3451	GSM809232	998	998	1851	231746	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3452	GSM809233	999	999	1852	231747	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3453	GSM809234	1000	1000	1853	231748	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3454	GSM809235	1001	1001	1854	231749	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3455	GSM809236	1002	1002	1855	231750	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3456	GSM809237	1003	1003	1856	231751	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3457	GSM809238	1004	1004	1857	231752	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3458	GSM809239	1005	1005	1858	231753	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3459	GSM809240	1006	1006	1859	231754	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3460	GSM809241	1007	1007	1860	231755	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3461	GSM809242	1008	1008	1861	231756	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3462	GSM809243	1009	1009	1862	231757	5767	4	GPL570	GSE32646		NA	er_pos									pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3463	GSM809244	1010	1010	1863	231758	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3464	GSM809245	1011	1011	1864	231759	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3465	GSM809246	1012	1012	1865	231760	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3466	GSM809247	1013	1013	1866	231761	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3467	GSM809248	1014	1014	1867	231762	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3468	GSM809249	1015	1015	1868	231763	5767	4	GPL570	GSE32646		NA	er_pos															pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3469	GSM809250	1016	1016	1869	231764	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3470	GSM809251	1017	1017	1870	231765	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3471	GSM809252	1018	1018	1871	231766	5767	4	GPL570	GSE32646		NA	er_pos															pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3472	GSM809253	1019	1019	1872	231767	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_positive			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3473	GSM809254	1020	1020	1873	231768	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3474	GSM809255	1021	1021	1874	231769	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3475	GSM809256	1022	1022	1875	231770	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3476	GSM809257	1023	1023	1876	231771	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3477	GSM809258	1024	1024	1877	231772	5767	4	GPL570	GSE32646		NA	er_pos															pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3478	GSM809259	1025	1025	1878	231773	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3479	GSM809260	1026	1026	1879	231774	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3480	GSM809261	1027	1027	1880	231775	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3481	GSM809262	1028	1028	1881	231776	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3482	GSM809263	1029	1029	1882	231777	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3483	GSM809264	1030	1030	1883	231778	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3484	GSM809265	1031	1031	1884	231779	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3485	GSM809266	1032	1032	1885	231780	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3486	GSM809267	1033	1033	1886	231781	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3487	GSM809268	1034	1034	1887	231782	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3488	GSM809269	1035	1035	1888	231783	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3489	GSM809270	1036	1036	1889	231784	5767	4	GPL570	GSE32646		NA	er_pos									pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3490	GSM809271	1037	1037	1890	231785	5767	4	GPL570	GSE32646		NA	er_pos									pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3491	GSM809272	1038	1038	1891	231786	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3492	GSM809273	1039	1039	1892	231787	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3493	GSM809274	1040	1040	1893	231788	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3494	GSM809275	1041	1041	1894	231789	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3495	GSM809276	1042	1042	1895	231790	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3496	GSM809277	1043	1043	1896	231791	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3497	GSM809278	1044	1044	1897	231792	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_neg	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3498	GSM809279	1045	1045	1898	231793	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3499	GSM809280	1046	1046	1899	231794	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3500	GSM809281	1047	1047	1900	231795	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3501	GSM809282	1048	1048	1901	231796	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_neg	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3502	GSM809283	1049	1049	1902	231797	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3503	GSM809284	1050	1050	1903	231798	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3504	GSM809285	1051	1051	1904	231799	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3505	GSM809286	1052	1052	1905	231800	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3506	GSM809287	1053	1053	1906	231801	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3507	GSM809288	1054	1054	1907	231802	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3508	GSM809289	1055	1055	1908	231803	5767	4	GPL570	GSE32646		NA	er_pos															pr_positive	pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_pos	her2_positive	pr_positive			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3509	GSM809290	1056	1056	1909	231804	5767	4	GPL570	GSE32646		NA	er_pos															pr_positive		pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3510	GSM809291	1057	1057	1910	231805	5767	4	GPL570	GSE32646		NA	er_pos									pr_negative								pre_treatment	drug_cyclophosphamide			her2_positive	pcr_no	er_pos	her2_positive	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3511	GSM809292	1058	1058	1911	231806	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3512	GSM809293	1059	1059	1912	231807	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3513	GSM809294	1060	1060	1913	231808	5767	4	GPL570	GSE32646		NA		er_neg								pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide			her2_positive		er_neg	her2_positive	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3514	GSM809295	1061	1061	1914	231809	5767	4	GPL570	GSE32646		NA		er_neg					her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_neg	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3515	GSM809296	1062	1062	1915	231810	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative									pr_positive		pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3516	GSM809297	1063	1063	1916	231811	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative								pre_treatment	drug_cyclophosphamide				pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3517	GSM809298	1064	1064	1917	231812	5767	4	GPL570	GSE32646		NA	er_pos						her2_negative			pr_negative							pcr_yes	pre_treatment	drug_cyclophosphamide					er_pos	her2_negative	pr_negative			pcr_yes	1	GPL570_GSE32646	GEO	drug_paclitaxel;drug_fluorouracil;drug_cyclophosphamide;drug_epirubicin
3518	GSM832390	1065	1065	1946	241629	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive		pre_treatment		drug_anastrozole			pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE33658	GEO	drug_anastrozole;drug_fulvestrant
3519	GSM832391	1066	1066	1947	241630	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive				drug_anastrozole			pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE33658	GEO	drug_anastrozole;drug_fulvestrant
3520	GSM832392	1067	1067	1948	241631	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive		pre_treatment		drug_anastrozole			pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE33658	GEO	drug_anastrozole;drug_fulvestrant
3521	GSM832393	1068	1068	1949	241632	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive				drug_anastrozole			pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE33658	GEO	drug_anastrozole;drug_fulvestrant
3522	GSM832394	1069	1069	1950	241633	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive		pre_treatment		drug_anastrozole			pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE33658	GEO	drug_anastrozole;drug_fulvestrant
3523	GSM832395	1070	1070	1951	241634	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive				drug_anastrozole			pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE33658	GEO	drug_anastrozole;drug_fulvestrant
3524	GSM832396	1071	1071	1952	241635	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive		pre_treatment		drug_anastrozole			pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE33658	GEO	drug_anastrozole;drug_fulvestrant
3525	GSM832397	1072	1072	1953	241636	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive				drug_anastrozole			pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE33658	GEO	drug_anastrozole;drug_fulvestrant
3526	GSM832398	1073	1073	1954	241637	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative			pr_negative								pre_treatment		drug_anastrozole			pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE33658	GEO	drug_anastrozole;drug_fulvestrant
3527	GSM832399	1074	1074	1955	241638	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative			pr_negative										drug_anastrozole			pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE33658	GEO	drug_anastrozole;drug_fulvestrant
3528	GSM832400	1075	1075	1956	241639	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment		drug_anastrozole				er_pos	her2_negative	pr_positive			pcr_yes	1	GPL570_GSE33658	GEO	drug_gefitinib;drug_anastrozole;drug_fulvestrant
3529	GSM832401	1076	1076	1957	241640	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive	pcr_yes			drug_anastrozole				er_pos	her2_negative	pr_positive			pcr_yes	1	GPL570_GSE33658	GEO	drug_gefitinib;drug_anastrozole;drug_fulvestrant
3530	GSM832402	1077	1077	1958	241641	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive	pcr_yes	pre_treatment		drug_anastrozole				er_pos	her2_negative	pr_positive			pcr_yes	1	GPL570_GSE33658	GEO	drug_gefitinib;drug_anastrozole;drug_fulvestrant
3531	GSM832403	1078	1078	1959	241642	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive	pcr_yes			drug_anastrozole				er_pos	her2_negative	pr_positive			pcr_yes	1	GPL570_GSE33658	GEO	drug_gefitinib;drug_anastrozole;drug_fulvestrant
3532	GSM832404	1079	1079	1960	241643	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive		pre_treatment		drug_anastrozole			pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE33658	GEO	drug_gefitinib;drug_anastrozole;drug_fulvestrant
3533	GSM832405	1080	1080	1961	241644	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive				drug_anastrozole			pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE33658	GEO	drug_gefitinib;drug_anastrozole;drug_fulvestrant
3534	GSM832406	1081	1081	1962	241645	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive		pre_treatment		drug_anastrozole			pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE33658	GEO	drug_gefitinib;drug_anastrozole;drug_fulvestrant
3535	GSM832407	1082	1082	1963	241646	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive				drug_anastrozole			pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE33658	GEO	drug_gefitinib;drug_anastrozole;drug_fulvestrant
3536	GSM832408	1083	1083	1964	241647	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative			pr_negative								pre_treatment		drug_anastrozole			pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE33658	GEO	drug_gefitinib;drug_anastrozole;drug_fulvestrant
3537	GSM832409	1084	1084	1965	241648	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative			pr_negative										drug_anastrozole			pcr_no	er_pos	her2_negative	pr_negative			pcr_no	2	GPL570_GSE33658	GEO	drug_gefitinib;drug_anastrozole;drug_fulvestrant
3538	GSM832410	1085	1085	1966	241649	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive		pre_treatment		drug_anastrozole			pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE33658	GEO	drug_gefitinib;drug_anastrozole;drug_fulvestrant
3539	GSM832411	1086	1086	1967	241650	5995	4	GPL570	GSE33658		NA	er_pos						her2_negative									pr_positive				drug_anastrozole			pcr_no	er_pos	her2_negative	pr_positive			pcr_no	2	GPL570_GSE33658	GEO	drug_gefitinib;drug_anastrozole;drug_fulvestrant
3540	GSM842290	1087	1087	1968	244158	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3541	GSM842291	1088	1088	1969	244159	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3542	GSM842292	1089	1089	1970	244160	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3543	GSM842293	1090	1090	1971	244161	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3544	GSM842294	1091	1091	1972	244162	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3545	GSM842295	1092	1092	1973	244163	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3546	GSM842296	1093	1093	1974	244164	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3547	GSM842297	1094	1094	1975	244165	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3548	GSM842298	1095	1095	1976	244166	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3549	GSM842299	1096	1096	1977	244167	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3550	GSM842300	1097	1097	1978	244168	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3551	GSM842301	1098	1098	1979	244169	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3552	GSM842302	1099	1099	1980	244170	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3553	GSM842303	1100	1100	1981	244171	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3554	GSM842304	1101	1101	1982	244172	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3555	GSM842305	1102	1102	1983	244173	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3556	GSM842306	1103	1103	1984	244174	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3557	GSM842307	1104	1104	1985	244175	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3558	GSM842308	1105	1105	1986	244176	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3559	GSM842309	1106	1106	1987	244177	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3560	GSM842310	1107	1107	1988	244178	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3561	GSM842311	1108	1108	1989	244179	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3562	GSM842312	1109	1109	1990	244180	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3563	GSM842313	1110	1110	1991	244181	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3564	GSM842314	1111	1111	1992	244182	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3565	GSM842315	1112	1112	1993	244183	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3566	GSM842316	1113	1113	1994	244184	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3567	GSM842317	1114	1114	1995	244185	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3568	GSM842318	1115	1115	1996	244186	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3569	GSM842319	1116	1116	1997	244187	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3570	GSM842320	1117	1117	1998	244188	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3571	GSM842321	1118	1118	1999	244189	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3572	GSM842322	1119	1119	2000	244190	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3573	GSM842323	1120	1120	2001	244191	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3574	GSM842324	1121	1121	2002	244192	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3575	GSM842325	1122	1122	2003	244193	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3576	GSM842326	1123	1123	2004	244194	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3577	GSM842327	1124	1124	2005	244195	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3578	GSM842328	1125	1125	2006	244196	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3579	GSM842329	1126	1126	2007	244197	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3580	GSM842330	1127	1127	2008	244198	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3581	GSM842331	1128	1128	2009	244199	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3582	GSM842332	1129	1129	2010	244200	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3583	GSM842333	1130	1130	2011	244201	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3584	GSM842334	1131	1131	2012	244202	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3585	GSM842335	1132	1132	2013	244203	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3586	GSM842336	1133	1133	2014	244204	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3587	GSM842337	1134	1134	2015	244205	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3588	GSM842338	1135	1135	2016	244206	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3589	GSM842339	1136	1136	2017	244207	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3590	GSM842340	1137	1137	2018	244208	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3591	GSM842341	1138	1138	2019	244209	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3592	GSM842342	1139	1139	2020	244210	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3593	GSM842343	1140	1140	2021	244211	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3594	GSM842344	1141	1141	2022	244212	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3595	GSM842345	1142	1142	2023	244213	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3596	GSM842346	1143	1143	2024	244214	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3597	GSM842347	1144	1144	2025	244215	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3598	GSM842348	1145	1145	2026	244216	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3599	GSM842349	1146	1146	2027	244217	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3600	GSM842350	1147	1147	2028	244218	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3601	GSM842351	1148	1148	2029	244219	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3602	GSM842352	1149	1149	2030	244220	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3603	GSM842353	1150	1150	2031	244221	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3604	GSM842354	1151	1151	2032	244222	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3605	GSM842355	1152	1152	2033	244223	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3606	GSM842356	1153	1153	2034	244224	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3607	GSM842357	1154	1154	2035	244225	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3608	GSM842358	1155	1155	2036	244226	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3609	GSM842359	1156	1156	2037	244227	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3610	GSM842360	1157	1157	2038	244228	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3611	GSM842361	1158	1158	2039	244229	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3612	GSM842362	1159	1159	2040	244230	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3613	GSM842363	1160	1160	2041	244231	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3614	GSM842364	1161	1161	2042	244232	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3615	GSM842365	1162	1162	2043	244233	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3616	GSM842366	1163	1163	2044	244234	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3617	GSM842367	1164	1164	2045	244235	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3618	GSM842368	1165	1165	2046	244236	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3619	GSM842369	1166	1166	2047	244237	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3620	GSM842370	1167	1167	2048	244238	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3621	GSM842371	1168	1168	2049	244239	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3622	GSM842372	1169	1169	2050	244240	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3623	GSM842373	1170	1170	2051	244241	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3624	GSM842374	1171	1171	2052	244242	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3625	GSM842375	1172	1172	2053	244243	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3626	GSM842376	1173	1173	2054	244244	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3627	GSM842377	1174	1174	2055	244245	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3628	GSM842378	1175	1175	2056	244246	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3629	GSM842379	1176	1176	2057	244247	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3630	GSM842380	1177	1177	2058	244248	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3631	GSM842381	1178	1178	2059	244249	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3632	GSM842382	1179	1179	2060	244250	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3633	GSM842383	1180	1180	2061	244251	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3634	GSM842384	1181	1181	2062	244252	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3635	GSM842385	1182	1182	2063	244253	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3636	GSM842386	1183	1183	2064	244254	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3637	GSM842387	1184	1184	2065	244255	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3638	GSM842388	1185	1185	2066	244256	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3639	GSM842389	1186	1186	2067	244257	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3640	GSM842390	1187	1187	2068	244258	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3641	GSM842391	1188	1188	2069	244259	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3642	GSM842392	1189	1189	2070	244260	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3643	GSM842393	1190	1190	2071	244261	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3644	GSM842394	1191	1191	2072	244262	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3645	GSM842395	1192	1192	2073	244263	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3646	GSM842396	1193	1193	2074	244264	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3647	GSM842397	1194	1194	2075	244265	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3648	GSM842398	1195	1195	2076	244266	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3649	GSM842399	1196	1196	2077	244267	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3650	GSM842400	1197	1197	2078	244268	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3651	GSM842401	1198	1198	2079	244269	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3652	GSM842402	1199	1199	2080	244270	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3653	GSM842403	1200	1200	2081	244271	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3654	GSM842404	1201	1201	2082	244272	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3655	GSM842405	1202	1202	2083	244273	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3656	GSM842406	1203	1203	2084	244274	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3657	GSM842407	1204	1204	2085	244275	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3658	GSM842408	1205	1205	2086	244276	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3659	GSM842409	1206	1206	2087	244277	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3660	GSM842470	1207	1207	2088	244278	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3661	GSM842471	1208	1208	2089	244279	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3662	GSM842472	1209	1209	2090	244280	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3663	GSM842473	1210	1210	2091	244281	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3664	GSM842474	1211	1211	2092	244282	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3665	GSM842475	1212	1212	2093	244283	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3666	GSM842476	1213	1213	2094	244284	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3667	GSM842477	1214	1214	2095	244285	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3668	GSM842478	1215	1215	2096	244286	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3669	GSM842479	1216	1216	2097	244287	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3670	GSM842480	1217	1217	2098	244288	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3671	GSM842481	1218	1218	2099	244289	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide						her2_negative					NA	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3672	GSM842482	1219	1219	2100	244290	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3673	GSM842483	1220	1220	2101	244291	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3674	GSM842484	1221	1221	2102	244292	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3675	GSM842485	1222	1222	2103	244293	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3676	GSM842486	1223	1223	2104	244294	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3677	GSM842487	1224	1224	2105	244295	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3678	GSM842488	1225	1225	2106	244296	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3679	GSM842489	1226	1226	2107	244297	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3680	GSM842490	1227	1227	2108	244298	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3681	GSM842491	1228	1228	2109	244299	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3682	GSM842492	1229	1229	2110	244300	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3683	GSM842493	1230	1230	2111	244301	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3684	GSM842494	1231	1231	2112	244302	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3685	GSM842495	1232	1232	2113	244303	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3686	GSM842496	1233	1233	2114	244304	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3687	GSM842497	1234	1234	2115	244305	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3688	GSM842498	1235	1235	2116	244306	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3689	GSM842499	1236	1236	2117	244307	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3690	GSM842500	1237	1237	2118	244308	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3691	GSM842501	1238	1238	2119	244309	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3692	GSM842502	1239	1239	2120	244310	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3693	GSM842503	1240	1240	2121	244311	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3694	GSM842504	1241	1241	2122	244312	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3695	GSM842505	1242	1242	2123	244313	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3696	GSM842506	1243	1243	2124	244314	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3697	GSM842507	1244	1244	2125	244315	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3698	GSM842508	1245	1245	2126	244316	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3699	GSM842509	1246	1246	2127	244317	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3700	GSM842510	1247	1247	2128	244318	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3701	GSM842511	1248	1248	2129	244319	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide						her2_negative					NA	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3702	GSM842512	1249	1249	2130	244320	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3703	GSM842513	1250	1250	2131	244321	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide						her2_negative					NA	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3704	GSM842514	1251	1251	2132	244322	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3705	GSM842515	1252	1252	2133	244323	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3706	GSM842516	1253	1253	2134	244324	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3707	GSM842517	1254	1254	2135	244325	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3708	GSM842518	1255	1255	2136	244326	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3709	GSM842519	1256	1256	2137	244327	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3710	GSM842520	1257	1257	2138	244328	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3711	GSM842521	1258	1258	2139	244329	6096	416	GPL6884	GSE34138		NA							her2_negative											pre_treatment	drug_cyclophosphamide				pcr_no		her2_negative				pcr_no	2	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3712	GSM842522	1259	1259	2140	244330	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3713	GSM842523	1260	1260	2141	244331	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3714	GSM842524	1261	1261	2142	244332	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3715	GSM842525	1262	1262	2143	244333	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3716	GSM842526	1263	1263	2144	244334	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide
3717	GSM842527	1264	1264	2145	244335	6096	416	GPL6884	GSE34138		NA							her2_negative										pcr_yes	pre_treatment	drug_cyclophosphamide						her2_negative				pcr_yes	1	GPL6884_GSE34138	GEO	drug_doxorubicin;drug_cyclophosphamide